primaryid$caseid$caseversion$i_f_code$event_dt$mfr_dt$init_fda_dt$fda_dt$rept_cod$auth_num$mfr_num$mfr_sndr$lit_ref$age$age_cod$age_grp$sex$e_sub$wt$wt_cod$rept_dt$to_mfr$occp_cod$reporter_country$occr_country
100115733$10011573$3$F$20130801$20221118$20140314$20221123$EXP$$CA-MERCK-1403CAN005674$MERCK$$75$YR$$M$Y$58.05$KG$20221123$$HP$CA$CA
1002130537$10021305$37$F$20210415$20220928$20140319$20221005$EXP$$PHHY2014CA019281$NOVARTIS$$43$YR$$M$Y$$$20221005$$HP$CA$CA
100234223$10023422$3$F$20120301$20221003$20140320$20221007$EXP$$US-ROCHE-1362929$ROCHE$$67$YR$$F$Y$$$20221007$$LW$US$
100260594$10026059$4$F$20120101$20221124$20140320$20221130$EXP$DE-BFARM-13321363$DE-MYLANLABS-2014S1005326$MYLAN$$63$YR$$M$Y$88$KG$20221130$$HP$DE$DE
100518358$10051835$8$F$20130715$20221125$20140402$20221201$EXP$$CA-ROCHE-1247938$ROCHE$$50$YR$$F$Y$59$KG$20221201$$HP$CA$
100614443$10061444$3$F$$20221123$20140407$20221130$EXP$$EG-ROCHE-1372609$ROCHE$El-Dosouky I, ElHawari S, Emara M. and Hamed E. Types and predictors of interferon/ribavirin induced cardiac complications in the egyptian patients with chronic hepatitis c virus-Abs. no.P1107. Journal of Hepatology 2014 Apr;60 (SUPP 1):S446-7.$$$$$Y$$$20221130$$MD$EG$
1006401873$10064018$73$F$20121201$20221222$20140408$20221226$EXP$$CA-ROCHE-1173339$ROCHE$$71$YR$$F$Y$76$KG$20221226$$HP$CA$
100746869$10074686$9$F$20090714$20221222$20140414$20221230$EXP$$CA-ROCHE-1383185$ROCHE$$52$YR$$M$Y$$$20221230$$HP$CA$CA
100832487$10083248$7$F$20120201$20221108$20140417$20221116$EXP$$CA-ROCHE-1385175$ROCHE$$46$YR$$M$Y$$$20221116$$CN$CA$CA
100900002$10090000$2$F$20140101$20221021$20140421$20221027$EXP$$CA-JNJFOC-20140411796$JOHNSON AND JOHNSON$$54$YR$A$F$Y$57$KG$20221027$$HP$CA$CA
1009456310$10094563$10$F$20130101$20221004$20140422$20221011$PER$$US-PFIZER INC-2014108421$PFIZER$$46$YR$$F$Y$69$KG$20221011$$MD$US$US
101397357$10139735$7$F$20140101$20221008$20140429$20221012$EXP$$BR-SHIRE-BR201401513$TAKEDA$$16$YR$$M$Y$$$20221012$$HP$BR$BR
1014222242$10142222$42$F$20131201$20221216$20140430$20221221$EXP$$CA-ROCHE-1319269$ROCHE$$52$YR$$M$Y$88.2$KG$20221221$$MD$CA$
1015212328$10152123$28$F$20131205$20221115$20140505$20221123$EXP$$CA-ROCHE-1393055$ROCHE$$38$YR$$F$Y$110$KG$20221123$$CN$CA$CA
101530275$10153027$5$F$20131001$20220926$20140505$20221007$EXP$$US-ASTELLAS-2014US004619$ASTELLAS$$65$YR$$F$Y$$$20221007$$CN$US$US
1015648243$10156482$43$F$20121101$20221216$20140507$20221220$EXP$$CA-ROCHE-1162866$ROCHE$$65$YR$$F$Y$63.5$KG$20221220$$HP$CA$
1016133054$10161330$54$F$20120806$20221117$20140509$20221121$EXP$$CA-ROCHE-1113310$ROCHE$$66$YR$$F$Y$69$KG$20221121$$CN$CA$
1017572229$10175722$29$F$20121201$20221011$20140516$20221013$EXP$$CA-ROCHE-1176621$ROCHE$$65$YR$$F$Y$57$KG$20221013$$HP$CA$
101834686$10183468$6$F$20131216$20221003$20140520$20221004$EXP$$FR-SHIRE-ALL1-2014-01294$TAKEDA$$41$YR$$F$Y$61$KG$20221004$$CN$FR$FR
1020049437$10200494$37$F$20120801$20221227$20140528$20221229$EXP$$CA-ROCHE-1112151$ROCHE$$27$YR$$M$Y$80$KG$20221229$$HP$CA$
102151802$10215180$2$F$$20221031$20140603$20221102$EXP$$PHHY2014NL063730$NOVARTIS$Janssen S, Bergmans DCJJ, van Mook WNKA. Oxaliplatin induced multi organ failure: a condition intensivists should be aware of. NETH-J-CRIT-CARE. 2013;17(5):36$70$YR$$F$Y$$$20221102$$HP$NL$NL
102158494$10215849$4$F$20100101$20221130$20140604$20221207$PER$$US-AMGEN-USASP2014040911$AMGEN$$66$YR$E$F$Y$$$20221207$$CN$US$US
102184243$10218424$3$F$20121003$20221213$20140605$20221222$EXP$$FR-JNJFOC-20140600868$JOHNSON AND JOHNSON$$87$YR$E$M$Y$73$KG$20221222$$HP$FR$FR
1023164235$10231642$35$F$20120505$20221128$20140611$20221206$EXP$$PHHY2012CA036601$NOVARTIS$$55$YR$$F$Y$$$20221206$$HP$CA$CA
1023181918$10231819$18$F$20150818$20221109$20140612$20221117$EXP$$CA-ROCHE-1416720$ROCHE$$53$YR$$F$Y$$$20221117$$MD$CA$CA
1023233515$10232335$15$F$20130801$20221003$20140612$20221007$EXP$$PHHY2013CA066835$NOVARTIS$$72$YR$$M$Y$$$20221007$$HP$CA$CA
1023686418$10236864$18$F$20140101$20221007$20140613$20221011$EXP$$US-PFIZER INC-2014161083$PFIZER$$53$YR$$F$Y$$$20221011$$HP$US$US
102404993$10240499$3$F$20120723$20221003$20140617$20221006$EXP$$US-ROCHE-1418124$ROCHE$$61$YR$$F$Y$$$20221006$$LW$US$
1026087144$10260871$44$F$20120818$20221129$20140626$20221201$EXP$$CA-ROCHE-1131745$ROCHE$$57$YR$$F$Y$68$KG$20221201$$CN$CA$
102686218$10268621$8$F$20190319$20221109$20140630$20221111$EXP$$US-PFIZER INC-2014177544$PFIZER$$73$YR$$F$Y$$$20221111$$CN$US$US
1027487980$10274879$80$F$20151125$20221220$20140702$20221222$EXP$$CA-ROCHE-1404692$ROCHE$$46$YR$$M$Y$103$KG$20221222$$HP$CA$
1028518540$10285185$40$F$20140703$20221111$20140708$20221115$EXP$$CA-ROCHE-1267909$ROCHE$$49$YR$$F$Y$79$KG$20221115$$HP$CA$
102951214$10295121$4$F$$20211013$20140710$20221008$PER$$US-PURDUE-USA-2014-0113143$PURDUE$$$$$F$Y$$$20221008$$CN$US$US
1030948610$10309486$10$F$$20221014$20140717$20221121$EXP$$CA-ROCHE-1435384$ROCHE$$72$YR$$M$Y$$$20221121$$MD$CA$CA
103311375$10331137$5$F$20140714$20221103$20140722$20221202$EXP$$JP-AstraZeneca-2014SE52033$ASTRAZENECA$$21539$DY$$F$Y$71$KG$20221202$$MD$JP$
103343176$10334317$6$F$20140710$20221112$20140723$20221117$EXP$$PHHY2014IN087849$NOVARTIS$$35$YR$$F$Y$58$KG$20221117$$CN$IN$IN
103422754$10342275$4$F$$20221120$20140725$20221202$EXP$$FR-JNJFOC-20140709992$JOHNSON AND JOHNSON$$$$$$Y$$$20221202$$MD$FR$FR
103488627$10348862$7$F$20140710$20221205$20140729$20221216$EXP$$US-PFIZER INC-2014204200$PFIZER$$70$YR$$M$Y$90.7$KG$20221216$$MD$US$US
103613677$10361367$7$F$20130701$20221007$20140805$20221013$EXP$$US-ROCHE-1444666$ROCHE$$57$YR$$M$Y$85.352$KG$20221013$$MD$US$
103763213$10376321$3$F$20140523$20221111$20140811$20221121$EXP$SE-MPA-2014-004383$SE-PFIZER INC-2014219900$PFIZER$$91$YR$$F$Y$$$20221121$$MD$SE$SE
103830048$10383004$8$F$20140602$20221221$20140813$20221227$EXP$$US-SA-2014SA082625$SANOFI AVENTIS$$26$YR$A$F$Y$83.9$KG$20221227$$MD$US$US
1039251711$10392517$11$F$20170913$20221213$20140819$20221219$EXP$$PHHY2013AU123443$NOVARTIS$$63$YR$$M$Y$59.4$KG$20221219$$MD$AU$AU
103935282$10393528$2$F$$20221114$20140819$20221123$EXP$$ALCN2014AT004606$ALCON$Diesner SC, Bannert C, Gruber S, Dehlink E, Eiwegger T, Szepfalusi Z. The mydriaticum cyclopentolate induces severe allergy in a 5-year-old child. Klln Padiatr. 2014;226 (4):252-253$$$$$Y$$$20221123$$HP$AT$AT
1040513312$10405133$12$F$20110815$20221219$20140825$20221227$EXP$$CA-ROCHE-1454049$ROCHE$$56$YR$$F$Y$$$20221227$$CN$CA$CA
1041491122$10414911$22$F$20140217$20221117$20140828$20221130$EXP$$PHHY2012CA025137$NOVARTIS$$$$$F$Y$$$20221130$$HP$CA$CA
104249075$10424907$5$F$$20221012$20140902$20221018$PER$$US-JNJFOC-20140827232$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221018$$HP$US$US
104266825$10426682$5$F$20070101$20221107$20140903$20221117$PER$$US-JNJFOC-20140827260$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221117$$LW$US$US
1042881839$10428818$39$F$20140130$20221207$20140904$20221215$EXP$$CA-ROCHE-1457280$ROCHE$$54$YR$$F$Y$85$KG$20221215$$CN$CA$CA
104660044$10466004$4$F$20040423$20221222$20140922$20221227$EXP$$US-ROCHE-1464701$ROCHE$$51$YR$$F$Y$$$20221227$$LW$US$
1046886629$10468866$29$F$20120719$20221017$20140923$20221019$EXP$$CA-ROCHE-1101096$ROCHE$$33$YR$$F$Y$61$KG$20221019$$HP$CA$
104803045$10480304$5$F$20140908$20221004$20140929$20221010$EXP$$US-SHIRE-US201406146$TAKEDA$$52$YR$$F$Y$55.78$KG$20221010$$CN$US$US
1048329111$10483291$11$F$20150402$20221206$20140930$20221209$EXP$$CA-ROCHE-1467535$ROCHE$$52$YR$$F$Y$65$KG$20221209$$MD$CA$CA
1049624415$10496244$15$F$$20221111$20141003$20221117$EXP$$CA-009507513-1410CAN000297$MERCK$unknown. unknown. unknown$78$YR$$F$Y$$$20221117$$HP$CA$CA
105075462$10507546$2$F$$20221208$20141009$20221213$PER$$US-PFIZER INC-2014275038$PFIZER$$$$$F$Y$$$20221213$$CN$US$US
105099892$10509989$2$F$20130703$20221227$20141010$20221230$EXP$$RU-SHIRE-RU201406658$TAKEDA$$5$YR$$M$Y$$$20221230$$MD$RU$RU
105144242$10514424$2$F$20141002$20221115$20141013$20221121$EXP$$CA-JNJFOC-20141001651$JOHNSON AND JOHNSON$$37$YR$A$F$Y$62$KG$20221121$$HP$CA$CA
105154134$10515413$4$F$20120101$20221103$20141014$20221116$EXP$$FR-AUROBINDO-AUR-APL-2014-10735$AUROBINDO$Rabenkogo A, Vigue MG, Jeziorski E. Drug reaction with eosinophilia and systemic symptoms. Arch Pediatr. 2014$9$YR$$F$Y$$$20221116$$HP$FR$FR
1051596715$10515967$15$F$20131024$20221104$20141014$20221110$EXP$$PHHY2013CA024321$NOVARTIS$$70$YR$$M$Y$110.2$KG$20221110$$HP$CA$CA
105160162$10516016$2$F$$20221121$20141014$20221125$EXP$$PHHY2014SI129440$NOVARTIS$Kogoj A. Selective serotonin reuptake inhibitors-induced delirium: A case review. PSYCHIATRIA DANUBINA. 2014;26(3):277-80$86$YR$$M$Y$$$20221125$$HP$SI$SI
1052690053$10526900$53$F$20140701$20221103$20141020$20221107$EXP$$CA-ROCHE-1341517$ROCHE$$75$YR$$M$Y$78$KG$20221107$$CN$CA$
105323424$10532342$4$F$20140101$20221208$20141021$20221212$EXP$$US-PURDUE-USA-2014-0115432$PURDUE$$$$$F$Y$99.773$KG$20221212$$CN$US$US
1053322617$10533226$17$F$20180101$20221208$20141022$20221220$EXP$GB-MHRA-ADR 22718008$GB-Accord-026599$ACCORD$$66$YR$E$M$Y$98.97$KG$20221220$$PH$GB$GB
1054348110$10543481$10$F$20090101$20221014$20141027$20221020$EXP$$US-PFIZER INC-2014290373$PFIZER$$77$YR$$F$Y$59$KG$20221020$$CN$US$US
105559472$10555947$2$F$$20221003$20141030$20221010$EXP$$PHHY2014PL138837$NOVARTIS$Kusztal M, Piotrowski P, Mazanowska O, Misiak B, Kantorska-Janiec M, Boratynska M et al.. Catatonic episode after kidney transplantation. GENERAL HOSPITAL PSYCHIATRY. 2014;36(3):360e3-360e5$21$YR$$F$Y$$$20221010$$HP$PL$PL
105576044$10557604$4$F$$20221130$20141031$20221207$EXP$$CA-MALLINCKRODT-T201403798$SPECGX$$37$YR$$M$Y$122$KG$20221207$$HP$CA$CA
105636858$10563685$8$F$20140916$20161227$20141104$20221021$EXP$$JP-BAYER-2014-158276$BAYER$$55$YR$A$F$Y$64.5$KG$20221021$$MD$JP$JP
105701195$10570119$5$F$20130901$20221101$20141107$20221107$EXP$$CA-ROCHE-1159378$ROCHE$$67$YR$$F$Y$81$KG$20221107$$CN$CA$
105733332$10573333$2$F$$20221212$20141110$20221214$PER$$US-BAYER-2014-164943$BAYER$$$$$F$Y$$$20221214$$CN$US$US
105881184$10588118$4$F$20141106$20221109$20141117$20221114$EXP$$US-SHIRE-US201407776$TAKEDA$$53$YR$$F$Y$$$20221114$$CN$US$US
1058928655$10589286$55$F$20141101$20221018$20141118$20221025$EXP$$CA-ROCHE-1491350$ROCHE$$61$YR$$F$Y$$$20221026$$MD$CA$CA
105912134$10591213$4$F$20141001$20221212$20141118$20221216$EXP$$US-SHIRE-US201407553$TAKEDA$$9$YR$$M$Y$323$KG$20221216$$CN$US$US
105977282$10597728$2$F$20140801$20141113$20141121$20221123$PER$$US-AMGEN-USASP2014088321$AMGEN$$82$YR$E$F$Y$$$20221122$$CN$US$US
1060044427$10600444$27$F$$20221212$20141124$20221222$PER$$CA-AMGEN-CANSP2014090423$AMGEN$$51$YR$A$F$Y$110$KG$20221222$$HP$CA$CA
106022753$10602275$3$F$20131108$20221003$20141124$20221010$EXP$$JP-PFIZER INC-2014318472$PFIZER$Kikuchi, R.. A case of invasive thymoma complicated by tumour lysis syndrome by steroid pulse therapy. The 55th Meeting of the Japan Lung Cancer Society. 2014;54(5):606$72$YR$$F$Y$37$KG$20221010$$MD$JP$JP
106209603$10620960$3$F$$20221216$20141202$20221230$EXP$$DE-RANBAXY-2014RR-89307$RANBAXY$Koschny R, Lutz M, Seckinger J, Schwenger V, Stremmel W, Eisenbach C. Extracorporeal life support and plasmapheresis in a case of severe polyintoxication. J Emerg Med. 2014;47 (5):527-531$21$YR$$F$Y$$$20221230$$MD$DE$DE
1062481015$10624810$15$F$20120220$20221118$20141204$20221125$EXP$$CA-ROCHE-1325548$ROCHE$$15$YR$$M$Y$$$20221125$$CN$CA$CA
106335934$10633593$4$F$19970101$20221116$20141205$20221119$PER$$US-JNJFOC-20141119143$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221119$$LW$US$US
1063710644$10637106$44$F$20140101$20221220$20141208$20221227$EXP$$CA-ROCHE-1504349$ROCHE$$68$YR$$F$Y$95.238$KG$20221227$$HP$CA$CA
106386833$10638683$3$F$20140807$20160413$20141208$20221109$EXP$$JP-BAYER-2014-177858$BAYER$$54$YR$A$M$Y$$$20221109$$MD$JP$JP
1064526734$10645267$34$F$20131231$20221122$20141211$20221124$EXP$$CA-ROCHE-1303094$ROCHE$$47$YR$$F$Y$76.5$KG$20221124$$CN$CA$
1065715210$10657152$10$F$20140701$20220929$20141217$20221001$EXP$$FR-MERCK-1412FRA007081$MERCK$Renard S. Severe Pulmonary Arterial Hypertension in Patients treated for Hepatitis C with Sofosbuvir. CHEST. 2016;149 (3):e69-e73$48$YR$$M$Y$$$20221001$$HP$FR$FR
1067454612$10674546$12$F$20110407$20221008$20141224$20221013$EXP$$FR-SHIRE-FR201409190$TAKEDA$$8$YR$$M$Y$$$20221013$$HP$FR$FR
1068446226$10684462$26$F$20140101$20221108$20141231$20221114$EXP$$PHHY2013CA109032$NOVARTIS$$$$$F$Y$$$20221114$$HP$CA$CA
106876194$10687619$4$F$20080101$20221117$20150102$20221122$EXP$$US-PFIZER INC-2014360643$PFIZER$$21$YR$$M$Y$57$KG$20221122$$CN$US$US
106893282$10689328$2$F$20130415$20220922$20150105$20221004$EXP$$SE-AUROBINDO-AUR-APL-2014-13513$AUROBINDO$$1$MON$$F$Y$$$20221004$$MD$SE$SE
1069613621$10696136$21$F$20140806$20221109$20150107$20221111$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005629$BRISTOL MYERS SQUIBB$Watanabe R, et al. A case of fulminant type 1 diabetes mellitus developed in a patient after use of anti-PD-1 antibody. Folia Endocrinologica Japonica 2015;91(3):865.$74$YR$E$F$Y$42$KG$20221111$$MD$JP$JP
1069770312$10697703$12$F$20140701$20220929$20150108$20221004$EXP$$US-PFIZER INC-2015003827$PFIZER$$64$YR$$M$Y$99.79$KG$20221004$$CN$US$US
107025935$10702593$5$F$20080301$20221006$20150109$20221010$EXP$$CZ-009507513-1501CZE002662$MERCK$Demlova R, Melicharkova K, Rehal Z, Kren L, Oslejskova H, Sterba J et al. Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child. Current Oncology. 2014;21(6):E790-3$11$YR$$F$Y$$$20221010$$MD$CZ$CZ
1071271830$10712718$30$F$20130916$20220923$20150115$20221001$EXP$$CA-ROCHE-1520634$ROCHE$$44$YR$$F$Y$$$20221001$$MD$CA$CA
107137505$10713750$5$F$20150612$20221206$20150115$20221209$EXP$$US-PFIZER INC-2015011167$PFIZER$$62$YR$$M$Y$113$KG$20221209$$CN$US$US
107330945$10733094$5$F$$20221007$20150123$20221017$EXP$$CA-PFIZER INC-2015026574$PFIZER$$$$$M$Y$$$20221017$$HP$CA$CA
1074197910$10741979$10$F$$20221212$20150127$20221216$EXP$$US-PFIZER INC-2015030234$PFIZER$$62$YR$$F$Y$83.91$KG$20221216$$HP$US$US
107480794$10748079$4$F$$20221201$20150129$20221205$PER$$US-PFIZER INC-2015033492$PFIZER$$62$YR$$F$Y$$$20221205$$MD$US$US
1076503413$10765034$13$F$20080101$20221212$20150205$20221216$EXP$$US-PFIZER INC-2015048780$PFIZER$$62$YR$$F$Y$43.09$KG$20221216$$CN$US$US
107718025$10771802$5$F$20141201$20221021$20150206$20221025$EXP$$PHHY2014CA163869$NOVARTIS$$52$YR$$F$Y$$$20221025$$CN$CA$CA
107770836$10777083$6$F$$20221228$20150209$20221230$PER$$US-PFIZER INC-2015050888$PFIZER$$66$YR$$F$Y$61.23$KG$20221230$$HP$US$US
107971742$10797174$2$F$20111215$20220929$20150216$20221006$EXP$$US-TEVA-483390USA$TEVA$$$$$F$Y$$$20221006$$LW$US$US
108306052$10830605$2$F$$20221202$20150219$20221213$PER$$US-009507513-1502USA004838$MERCK$$$$$F$Y$$$20221213$$MD$US$US
1086958425$10869584$25$F$20131105$20221107$20150226$20221116$EXP$$CA-ROCHE-1544517$ROCHE$$38$YR$$M$Y$65$KG$20221116$$CN$CA$CA
1087204326$10872043$26$F$20150201$20220321$20150226$20221202$EXP$$US-JAZZ-2015-US-002582$JAZZ$$44$YR$$F$Y$$$20221202$$CN$US$US
108720446$10872044$6$F$20140711$20221205$20150226$20221212$PER$$US-JAZZ-2014-US-009109$JAZZ$$61$YR$$M$Y$117.91$KG$20221212$$MD$US$US
108788105$10878810$5$F$20141205$20221220$20150302$20221222$EXP$$US-ABBVIE-15P-163-1352741-00$ABBVIE$$24$YR$$M$Y$$$20221222$$MD$US$US
1088003252$10880032$52$F$20080117$20221024$20150302$20221027$EXP$$PHMT2008CA00492$GLAXOSMITHKLINE$$$$$$Y$$$20221027$$MD$CA$CA
108809815$10880981$5$F$20150127$20221209$20150303$20221216$EXP$$US-PFIZER INC-2015073270$PFIZER$$63$YR$$F$Y$$$20221216$$CN$US$US
108820173$10882017$3$F$20150227$20221019$20150303$20221024$EXP$$CA-PFIZER INC-2015070868$PFIZER$$54$YR$$M$Y$$$20221024$$CN$CA$CA
109165036$10916503$6$F$19820101$20221109$20150311$20221123$EXP$$2015-0731-SPO$ASCEND$$53$YR$$F$Y$75$KG$20221123$$CN$FR$FR
109199792$10919979$2$F$20070101$20221222$20150317$20221227$EXP$$US-ROCHE-1551243$ROCHE$$$$$F$Y$$$20221227$$LW$US$
109325263$10932526$3$F$20130101$20221010$20150320$20221018$PER$$US-JNJFOC-20140814052$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$LW$US$US
109337154$10933715$4$F$20030101$20221010$20150320$20221014$PER$$US-JNJFOC-20140814047$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221014$$HP$US$US
109399493$10939949$3$F$20020101$20221012$20150322$20221018$PER$$US-JNJFOC-20140814026$JOHNSON AND JOHNSON$$$$$M$Y$107.6$KG$20221018$$HP$US$US
109436708$10943670$8$F$20041020$20221207$20150322$20221212$EXP$$US-JNJFOC-20141115580$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221212$$HP$US$US
109439923$10943992$3$F$20120205$20221222$20150323$20221228$EXP$$US-ROCHE-1554779$ROCHE$$71$YR$$F$Y$$$20221228$$LW$US$
109460695$10946069$5$F$$20221012$20150322$20221018$PER$$US-JNJFOC-20140814018$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221018$$HP$US$US
109680228$10968022$8$F$20140307$20221213$20150330$20221219$EXP$$US-JAZZ-2014-US-002347$JAZZ$$56$YR$$M$Y$87.07$KG$20221219$$MD$US$US
109762043$10976204$3$F$20040601$20221019$20150401$20221027$EXP$$US-JNJFOC-20140414401$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221027$$LW$US$US
1098206351$10982063$51$F$20130101$20221221$20150403$20221225$EXP$$CA-ROCHE-1350337$ROCHE$$$$$F$Y$50$KG$20221226$$CN$CA$
109893398$10989339$8$F$20190114$20221129$20150406$20221202$EXP$$US-PFIZER INC-2015113764$PFIZER$$57$YR$$F$Y$113.4$KG$20221202$$CN$US$US
1099047554$10990475$54$F$20150312$20220928$20150406$20221004$EXP$$CA-ROCHE-1551832$ROCHE$$57$YR$$M$Y$84.6$KG$20221004$$HP$CA$
109912044$10991204$4$F$20010101$20221114$20150406$20221125$PER$$US-JNJFOC-20150403986$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221125$$LW$US$US
1100310630$11003106$30$F$20141226$20221228$20150409$20221230$EXP$$PHHY2014CA170176$NOVARTIS$$61$YR$$M$Y$$$20221230$$HP$CA$CA
1101084316$11010843$16$F$20160708$20221123$20150410$20221130$EXP$$PHHY2014CA055951$NOVARTIS$$45$YR$$M$Y$$$20221130$$MD$CA$CA
110205884$11020588$4$F$$20221013$20150413$20221014$EXP$$CA-ROCHE-1562340$ROCHE$$90$YR$$F$Y$$$20221014$$HP$CA$
1102411311$11024113$11$F$20140101$20221018$20150413$20221025$EXP$$PHHY2014CA064714$NOVARTIS$$68$YR$$M$Y$$$20221025$$HP$CA$CA
110524756$11052475$6$F$$20220929$20150421$20221012$PER$$US-JNJFOC-20150322333$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
110534575$11053457$5$F$20130101$20221107$20150421$20221111$EXP$$US-JNJFOC-20141108721$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221111$$LW$US$US
110579242$11057924$2$F$$20221110$20150423$20221114$EXP$$CA-ROCHE-1567485$ROCHE$$24$YR$$M$Y$$$20221114$$HP$CA$
1106106422$11061064$22$F$$20221021$20150424$20221027$EXP$$CA-ROCHE-1566475$ROCHE$$69$YR$$F$Y$$$20221027$$CN$CA$
1106154321$11061543$21$F$20140101$20221006$20150424$20221018$EXP$$US-PFIZER INC-2015135782$PFIZER$$60$YR$$F$Y$$$20221018$$MD$US$US
1106955816$11069558$16$F$20211001$20220926$20150427$20221003$EXP$$BR-GLAXOSMITHKLINE INC.-BR2015GSK056220$GLAXOSMITHKLINE$$$$$$Y$$$20221003$$CN$BR$BR
1107001411$11070014$11$F$20131127$20221102$20150427$20221108$EXP$$PHHY2013CA139827$NOVARTIS$$64$YR$$F$Y$$$20221108$$HP$CA$CA
1107395118$11073951$18$F$20100703$20201231$20150429$20221004$EXP$$CA-ROCHE-1512211$ROCHE$$52$YR$$M$Y$$$20221004$$CN$CA$CA
1107519838$11075198$38$F$20150211$20221024$20150429$20221102$EXP$$CA-ROCHE-1570320$ROCHE$$43$YR$$F$Y$$$20221102$$CN$CA$CA
110758042$11075804$2$F$$20221114$20150429$20221123$EXP$$JP-ROCHE-1570432$ROCHE$Hoshida Y, Watanabe K, Eguchi G, et al A case of monoclonal-associated PML in patient suffering from duodenal DLBCL treated with rituximab.. Proceedings of The Japanese Society of Pathology 2015 Mar;104 (1):441-.$$$$M$Y$$$20221123$$MD$JP$
1107681228$11076812$28$F$20130122$20221114$20150429$20221118$EXP$$PHHY2013CA007723$NOVARTIS$$66$YR$$M$Y$$$20221118$$HP$CA$CA
1107775736$11077757$36$F$20150416$20221213$20150430$20221220$EXP$$CA-ROCHE-1570993$ROCHE$$67$YR$$F$Y$88.2$KG$20221220$$MD$CA$CA
1108647915$11086479$15$F$20150416$20221027$20150504$20221102$EXP$$CA-ROCHE-1571124$ROCHE$$66$YR$$M$Y$$$20221101$$HP$CA$CA
111092653$11109265$3$F$20060101$20221116$20150513$20221127$PER$$US-JNJFOC-20150506074$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221127$$LW$US$US
111172966$11117296$6$F$20130402$20221013$20150515$20221016$EXP$$PHHY2015AU058774$NOVARTIS$$50$YR$$M$Y$90$KG$20221017$$MD$AU$AU
111398754$11139875$4$F$20140101$20221214$20150527$20221220$PER$$US-PFIZER INC-2015165209$PFIZER$$55$YR$$F$Y$73$KG$20221220$$CN$US$US
111402683$11140268$3$F$$20221107$20150525$20221113$EXP$$US-JNJFOC-20150107078$JOHNSON AND JOHNSON$$31$YR$A$M$Y$$$20221114$$HP$US$US
111405024$11140502$4$F$20090326$20221213$20150525$20221221$PER$$US-JNJFOC-20141117511$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221222$$HP$US$US
111405234$11140523$4$F$20030101$20221108$20150525$20221110$PER$$US-JNJFOC-20140813995$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221110$$HP$US$US
111411202$11141120$2$F$20030101$20221101$20150525$20221103$PER$$US-JNJFOC-20140814041$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221103$$HP$US$US
111411382$11141138$2$F$$20221107$20150525$20221109$PER$$US-JNJFOC-20141001973$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221109$$LW$US$US
1115384211$11153842$11$F$20150901$20221212$20150602$20221220$PER$$CA-AMGEN-CANSP2015052272$AMGEN$$56$YR$A$F$Y$$$20221220$$HP$CA$CA
1115594135$11155941$35$F$20150505$20221006$20150602$20221018$EXP$$NL-SA-2015SA071357$SANOFI AVENTIS$$38$YR$A$F$Y$62$KG$20221018$$HP$NL$NL
1115851226$11158512$26$F$20150101$20221004$20150603$20221014$EXP$$CA-PFIZER INC-2015183008$PFIZER$$60$YR$$F$Y$97$KG$20221014$$CN$CA$CA
111665232$11166523$2$F$20060101$20221101$20150605$20221104$PER$$US-JNJFOC-20150511251$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221104$$LW$US$US
111665242$11166524$2$F$20030101$20221108$20150605$20221111$PER$$US-JNJFOC-20150511292$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221111$$HP$US$US
111666043$11166604$3$F$20100101$20221108$20150605$20221111$PER$$US-JNJFOC-20150511288$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221111$$HP$US$US
111666182$11166618$2$F$20110101$20221012$20150605$20221021$PER$$US-JNJFOC-20150511336$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221021$$HP$US$US
111679973$11167997$3$F$20130620$20221222$20150605$20221227$EXP$$US-ROCHE-1589122$ROCHE$$66$YR$$F$Y$$$20221227$$LW$US$
1117339623$11173396$23$F$20130313$20221019$20150608$20221025$EXP$$PHHY2013CA025650$NOVARTIS$$40$YR$$M$Y$70$KG$20221025$$CN$CA$CA
111765028$11176502$8$F$20141203$20221011$20150610$20221014$EXP$$CA-ROCHE-1591119$ROCHE$$58$YR$$M$Y$128$KG$20221014$$MD$CA$CA
111770694$11177069$4$F$20071215$20220923$20150610$20221005$EXP$$US-ROCHE-1591609$ROCHE$$65$YR$$F$Y$$$20221005$$LW$US$
1117933919$11179339$19$F$$20221202$20150610$20221205$EXP$$CA-ROCHE-1590696$ROCHE$$72$YR$$F$Y$$$20221205$$MD$CA$
1118130018$11181300$18$F$20150122$20221101$20150611$20221107$EXP$$PHHY2015CA012543$NOVARTIS$$63$YR$$M$Y$$$20221107$$CN$CA$CA
1118855212$11188552$12$F$20121227$20221219$20150615$20221228$EXP$$CA-ROCHE-1593339$ROCHE$$62$YR$$F$Y$80$KG$20221228$$MD$CA$CA
1119006911$11190069$11$F$20211027$20221220$20150615$20221223$PER$$US-PFIZER INC-2015196944$PFIZER$$66$YR$$M$Y$$$20221223$$CN$US$US
111941595$11194159$5$F$20150101$20221103$20150616$20221108$EXP$$US-INCYTE CORPORATION-2015IN002663$INCYTE$$$$$$Y$$$20221108$$CN$US$US
111966503$11196650$3$F$$20221003$20150617$20221005$EXP$$US-PFIZER INC-2015198727$PFIZER$$60$YR$$M$Y$$$20221005$$CN$US$US
1119717612$11197176$12$F$20220628$20221025$20150617$20221103$PER$$US-SA-2014SA087746$SANOFI AVENTIS$$29$YR$A$F$Y$52.6$KG$20221103$$MD$US$US
1120064015$11200640$15$F$20150612$20221212$20150618$20221221$EXP$$CA-PFIZER INC-2015202903$PFIZER$$73$YR$$F$Y$$$20221221$$MD$CA$CA
1121096112$11210961$12$F$20150615$20221114$20150623$20221130$PER$$US-BIOMARINAP-US-2015-106664$BIOMARIN$$$$$$Y$$$20221130$$CN$US$US
1121119650$11211196$50$F$20150401$20221024$20150623$20221102$EXP$$CA-ROCHE-1597909$ROCHE$$62$YR$$F$Y$$$20221102$$CN$CA$CA
112113093$11211309$3$F$20150417$20221107$20150623$20221115$EXP$$CA-ROCHE-1597855$ROCHE$$55$YR$$M$Y$$$20221115$$MD$CA$CA
1121349812$11213498$12$F$20150612$20221212$20150623$20221220$PER$$CA-AMGEN-CANSP2015060003$AMGEN$$73$YR$E$F$Y$$$20221220$$HP$CA$CA
1121749410$11217494$10$F$20140717$20221129$20150625$20221206$EXP$$CA-ROCHE-1599129$ROCHE$$59$YR$$F$Y$126.4$KG$20221206$$MD$CA$CA
1123238628$11232386$28$F$20150602$20221121$20150701$20221122$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-041921$BRISTOL MYERS SQUIBB$Suzuki S, Ishikawa N, Konoeda F, Seki N, Fukushima S, Takahashi K, et al. Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan. Neurology 2017; 89: 1-8.$81$YR$E$M$Y$85$KG$20221122$$MD$JP$JP
1125764511$11257645$11$F$20140919$20221216$20150710$20221223$EXP$$CA-ROCHE-1605988$ROCHE$$38$YR$$F$Y$$$20221223$$CN$CA$CA
112598992$11259899$2$F$20141024$20201007$20150710$20221008$PER$$US-PURDUE-USA-2014-0118622$PURDUE$$0$YR$$F$Y$$$20221008$$CN$US$US
1126087925$11260879$25$F$20210101$20221221$20150710$20221226$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK098504$GLAXOSMITHKLINE$$$$$$Y$$$20221226$$CN$BR$BR
112626725$11262672$5$F$20150612$20211130$20150710$20221008$PER$$US-PURDUE-USA-2015-0124254$PURDUE$$72$YR$$F$Y$$$20221008$$CN$US$US
112654706$11265470$6$F$20150201$20220930$20150713$20221006$EXP$$PT-ABBVIE-15K-130-1422289-00$ABBVIE$$38$YR$$F$Y$$$20221006$$CN$PT$PT
1127535214$11275352$14$F$20140101$20221031$20150716$20221104$EXP$$CA-ROCHE-1455724$ROCHE$$70$YR$$F$Y$$$20221104$$CN$CA$CA
1128678323$11286783$23$F$20150101$20221018$20150721$20221025$EXP$$PHHY2015CA083694$NOVARTIS$$$$$M$Y$$$20221025$$MD$CA$CA
1130269516$11302695$16$F$20150710$20221220$20150723$20221227$EXP$$CA-ROCHE-1612329$ROCHE$$71$YR$$M$Y$$$20221227$$MD$COUNTRY NOT SPECIFIED$CA
1131096039$11310960$39$F$20150914$20221228$20150726$20221230$EXP$$CA-ROCHE-1610105$ROCHE$$47$YR$$F$Y$54$KG$20221230$$HP$CA$
113145096$11314509$6$F$$20221227$20150727$20221229$PER$$US-PFIZER INC-2015237832$PFIZER$$53$YR$$F$Y$91$KG$20221229$$CN$US$US
113153994$11315399$4$F$$20221125$20150728$20221128$EXP$$CA-ROCHE-1611796$ROCHE$$46$YR$$F$Y$73$KG$20221129$$HP$CA$
1132353620$11323536$20$F$20111216$20221107$20150730$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102901$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1132363620$11323636$20$F$20111216$20221107$20150730$20221109$EXP$$JP-GLAXOSMITHKLINE INC.-JP2015JPN102901$GLAXOSMITHKLINE$$$$$$Y$$$20221109$$MD$JP$JP
113262893$11326289$3$F$$20221123$20150731$20221129$EXP$$AU-Orion Corporation ORION PHARMA-TREX2015-0493$ORION$Watts M, Chan R. Survival versus a fatal outcome in two cases of Anncaliia algerae microsporidial myositis. Neuromuscular Disorders. 2012;22(9-10):855.$66$YR$E$M$Y$$$20221129$$MD$AU$
113276416$11327641$6$F$20140901$20221219$20150731$20221223$EXP$$CA-JNJFOC-20150719488$JOHNSON AND JOHNSON$$50$YR$A$F$Y$74$KG$20221223$$HP$CA$CA
1132997413$11329974$13$F$20121101$20221107$20150803$20221109$EXP$$JP-VIIV HEALTHCARE ULC-JP2015JPN107326$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1133067913$11330679$13$F$20121101$20221107$20150803$20221109$EXP$$JP-GLAXOSMITHKLINE-JP2015JPN107326$GLAXOSMITHKLINE$$$$$$Y$$$20221109$$MD$JP$JP
113365899$11336589$9$F$20150622$20221205$20150804$20221213$EXP$$IT-PFIZER INC-2015247986$PFIZER$$53$YR$$M$Y$65$KG$20221213$$MD$IT$IT
113624752$11362475$2$F$$20221024$20150810$20221031$EXP$$CA-GLAXOSMITHKLINE-CA2015GSK113983$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$MD$CA$CA
113689332$11368933$2$F$20150101$20221202$20150812$20221207$PER$$US-AMGEN-USASL2015080477$AMGEN$$46$YR$A$F$Y$$$20221207$$CN$US$US
1137703937$11377039$37$F$20150727$20221115$20150813$20221123$EXP$$CO-INCYTE CORPORATION-2015IN003787$INCYTE$$$$$$Y$$$20221123$$CN$CO$CO
113827153$11382715$3$F$20150101$20221117$20150814$20221128$EXP$$US-JAZZ-2015-US-011803$JAZZ$$$$$M$Y$$$20221128$$MD$US$US
113868657$11386865$7$F$20140201$20221111$20150817$20221116$PER$$US-PFIZER INC-2015267334$PFIZER$$60$YR$$F$Y$67$KG$20221116$$CN$US$US
1138896010$11388960$10$F$20220912$20221129$20150817$20221201$EXP$$US-PFIZER INC-2015273572$PFIZER$$69$YR$$F$Y$73$KG$20221201$$CN$US$US
113986072$11398607$2$F$20150804$20221103$20150820$20221118$EXP$$IT-AUROBINDO-AUR-APL-2015-07365$AUROBINDO$$56$YR$$F$Y$$$20221118$$MD$IT$IT
1143790613$11437906$13$F$20150612$20221206$20150831$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-056744$BRISTOL MYERS SQUIBB$$73$YR$E$F$Y$$$20221208$$MD$CA$CA
1144906030$11449060$30$F$20150502$20220524$20150902$20221123$EXP$$GB-ROCHE-1588876$ROCHE$$43$YR$$F$Y$80.6$KG$20221123$$MD$GB$GB
1146495518$11464955$18$F$20150305$20221219$20150907$20221222$EXP$$CA-ROCHE-1520973$ROCHE$$32$YR$$F$Y$71$KG$20221222$$HP$CA$
1146542812$11465428$12$F$$20221012$20150907$20221013$EXP$$CA-ROCHE-1630210$ROCHE$$54$YR$$M$Y$$$20221013$$HP$CA$
114722818$11472281$8$F$$20221219$20150908$20221222$PER$$US-PFIZER INC-2015283708$PFIZER$$60$YR$$F$Y$90.703$KG$20221222$$CN$US$US
114761366$11476136$6$F$20150515$20221223$20150909$20221226$EXP$$JP-SHIRE-JP201511107AA$TAKEDA$$74$YR$$F$Y$43$KG$20221226$$CN$JP$JP
114854362$11485436$2$F$$20221212$20150909$20221220$EXP$$US-JAZZ-2015-US-000175$JAZZ$$$$$F$Y$$$20221220$$CN$US$US
114880832$11488083$2$F$20150201$20221209$20150909$20221213$EXP$$US-JAZZ-2015-US-003504$JAZZ$$31$YR$$F$Y$$$20221213$$MD$US$US
1149767216$11497672$16$F$$20221201$20150911$20221206$EXP$$CA-INCYTE CORPORATION-2013IN000165$INCYTE$$$$$$Y$$$20221206$$CN$CA$CA
1151945664$11519456$64$F$20150901$20221212$20150918$20221216$PER$$CA-AMGEN-CANSP2015095516$AMGEN$$43$YR$$F$Y$68$KG$20221216$$HP$CA$CA
1152525487$11525254$87$F$$20221220$20150918$20221229$EXP$$CA-PFIZER INC-2015308388$PFIZER$$43$YR$$F$Y$68$KG$20221229$$HP$CA$CA
1152988110$11529881$10$F$20110101$20221212$20150921$20221220$EXP$$CA-PFIZER INC-2015293041$PFIZER$$65$YR$$F$Y$$$20221220$$CN$CA$CA
1153197313$11531973$13$F$20150101$20221128$20150921$20221206$EXP$$CA-PFIZER INC-2015300302$PFIZER$$69$YR$$M$Y$$$20221206$$CN$CA$CA
115334828$11533482$8$F$20140101$20221201$20150921$20221207$EXP$$US-JAZZ-2015-US-013813$JAZZ$$$$$M$Y$$$20221207$$MD$US$US
115334852$11533485$2$F$$20221206$20150921$20221212$EXP$$US-JAZZ-2015-US-013887$JAZZ$$$$$F$Y$$$20221212$$CN$US$US
115411145$11541114$5$F$$20221006$20150923$20221010$PER$$US-PFIZER INC-2015065708$PFIZER$$71$YR$$F$Y$48$KG$20221010$$CN$US$US
115492603$11549260$3$F$20150623$20221216$20150924$20221223$EXP$$US-INCYTE CORPORATION-2015IN002988$INCYTE$$$$$$Y$$$20221223$$CN$US$US
115576017$11557601$7$F$20140121$20221207$20150926$20221212$EXP$$PHHY2013CA121592$NOVARTIS$$63$YR$$F$Y$$$20221212$$HP$CA$CA
1156506845$11565068$45$F$$20221128$20150928$20221201$EXP$$CA-009507513-1509CAN012569$MERCK$$$$$F$Y$97$KG$20221201$$HP$CA$CA
1157420921$11574209$21$F$20140325$20221019$20150930$20221027$EXP$$CA-ROCHE-1639907$ROCHE$$63$YR$$M$Y$89$KG$20221027$$CN$CA$CA
1157787011$11577870$11$F$20150918$20221220$20150930$20221227$EXP$$US-PFIZER INC-2015319862$PFIZER$$17$YR$$M$Y$78$KG$20221227$$CN$US$US
1158070937$11580709$37$F$$20221010$20150930$20221029$EXP$$CA-ABBVIE-15K-028-1471671-00$ABBVIE$$$$$F$Y$$$20221029$$HP$CA$CA
115952949$11595294$9$F$20130101$20221102$20151006$20221108$EXP$$CA-ROCHE-1641632$ROCHE$$49$YR$$M$Y$$$20221108$$CN$CA$CA
1159703019$11597030$19$F$20150801$20221201$20151006$20221208$EXP$$GB-ROCHE-1641219$ROCHE$$73$YR$$F$Y$$$20221208$$HP$GB$GB
115990327$11599032$7$F$$20221018$20151006$20221021$PER$$US-PFIZER INC-2015330789$PFIZER$$70$YR$$F$Y$54$KG$20221021$$CN$US$US
116141494$11614149$4$F$$20221129$20151008$20221205$EXP$$US-JAZZ-2014-US-010846$JAZZ$$$$$F$Y$$$20221205$$CN$US$US
1161812065$11618120$65$F$20150416$20221205$20151010$20221209$EXP$$PHHY2012CA016363$NOVARTIS$$63$YR$$F$Y$$$20221209$$HP$CA$CA
116313906$11631390$6$F$20180829$20221215$20151014$20221223$EXP$$CA-ROCHE-1645569$ROCHE$$50$YR$$F$Y$$$20221223$$MD$CA$CA
116356689$11635668$9$F$20151002$20221005$20151016$20221006$EXP$$US-PFIZER INC-2015341707$PFIZER$$63$YR$$F$Y$97.506$KG$20221006$$HP$US$US
1163606321$11636063$21$F$20151002$20221214$20151016$20221221$EXP$$CA-ROCHE-1646696$ROCHE$$20$YR$$M$Y$$$20221221$$MD$CA$CA
116372803$11637280$3$F$$20221109$20151016$20221112$EXP$$US-SHIRE-US201512542$TAKEDA$$$$$F$Y$$$20221112$$MD$US$US
116506392$11650639$2$F$$20150528$20151021$20221020$PER$$US-NOVOPROD-448531$NOVO NORDISK$$$$$M$Y$$$20221020$$CN$US$US
116592596$11659259$6$F$20150728$20221103$20151026$20221110$EXP$$CA-ROCHE-1648222$ROCHE$$66$YR$$F$Y$$$20221110$$MD$CA$
116612706$11661270$6$F$20150801$20221115$20151026$20221121$EXP$$CA-TAKEDA-2015TUS011190$TAKEDA$$56$YR$$F$Y$$$20221121$$MD$CA$CA
1166243427$11662434$27$F$20150728$20221209$20151027$20221221$EXP$$CA-ROCHE-1650800$ROCHE$$71$YR$$F$Y$$$20221221$$MD$CA$CA
1166352368$11663523$68$F$20151001$20221209$20151027$20221213$EXP$$CA-ROCHE-1649929$ROCHE$$41$YR$$F$Y$85$KG$20221213$$HP$CA$
1166544319$11665443$19$F$20151001$20221012$20151027$20221018$EXP$$US-PFIZER INC-2015356674$PFIZER$$42$YR$$F$Y$64.5$KG$20221018$$HP$US$US
1167242234$11672422$34$F$20151001$20221221$20151028$20221222$EXP$$PHHY2015CA117737$NOVARTIS$$74$YR$$F$Y$$$20221222$$HP$CA$CA
1168069212$11680692$12$F$20150722$20221202$20151029$20221212$EXP$$CA-ROCHE-1650806$ROCHE$$77$YR$$F$Y$$$20221212$$MD$CA$CA
116847947$11684794$7$F$20150101$20221205$20151029$20221207$EXP$$PHHY2015CA138225$NOVARTIS$$36$YR$$M$Y$$$20221207$$CN$CA$CA
116866658$11686665$8$F$20150101$20221122$20151030$20221124$EXP$$US-PFIZER INC-2015365254$PFIZER$$65$YR$$M$Y$$$20221124$$CN$US$US
116876935$11687693$5$F$20150501$20221021$20151030$20221103$EXP$FR-JNJFOC-20151015480$FR-JNJFOC-20151015480$JOHNSON AND JOHNSON$$25$YR$A$M$Y$58$KG$20221103$$MD$FR$FR
1168789254$11687892$54$F$20150101$20221031$20151030$20221107$EXP$$PHHY2015CA139740$NOVARTIS$$$$$F$Y$$$20221107$$CN$CA$CA
1168870915$11688709$15$F$20130101$20221114$20151102$20221123$EXP$$CA-ROCHE-1652828$ROCHE$$54$YR$$M$Y$106$KG$20221123$$MD$CA$CA
1169056711$11690567$11$F$$20221018$20151102$20221020$EXP$$US-PFIZER INC-2015371949$PFIZER$$70$YR$$F$Y$62$KG$20221020$$CN$US$US
1169227552$11692275$52$F$20151011$20221103$20151103$20221107$EXP$$CA-ROCHE-1653795$ROCHE$$45$YR$$F$Y$90$KG$20221107$$HP$CA$
1169545367$11695453$67$F$20150804$20221027$20151104$20221104$EXP$$PHHY2015CA100891$NOVARTIS$$68$YR$$M$Y$$$20221104$$MD$CA$CA
1169665432$11696654$32$F$20160928$20221220$20151104$20221223$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK033029$GLAXOSMITHKLINE$$$$$$Y$$$20221223$$MD$BR$BR
117017308$11701730$8$F$20151020$20221117$20151105$20221121$EXP$$US-PFIZER INC-2015376270$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
117026999$11702699$9$F$20110101$20221209$20151105$20221216$EXP$$US-PFIZER INC-2015371915$PFIZER$$60$YR$$F$Y$54$KG$20221216$$CN$US$US
1171983620$11719836$20$F$20150801$20221124$20151110$20221202$EXP$$CA-ROCHE-1656679$ROCHE$$28$YR$$F$Y$$$20221202$$MD$CA$CA
1172654912$11726549$12$F$20130326$20221004$20151112$20221013$EXP$$CA-ROCHE-1659147$ROCHE$$73$YR$$M$Y$$$20221011$$MD$CA$CA
1172683929$11726839$29$F$20130913$20221201$20151112$20221209$EXP$$CA-ROCHE-1659165$ROCHE$$61$YR$$M$Y$$$20221209$$MD$CA$CA
117353303$11735330$3$F$20150829$20221006$20151113$20221010$EXP$$PHHO2015IE016349$NOVARTIS$$76$YR$$M$Y$85.3$KG$20221010$$MD$IE$IE
117401154$11740115$4$F$20100101$20221128$20151113$20221205$EXP$$US-JAZZ-2015-US-018836$JAZZ$$$$$F$Y$$$20221205$$MD$US$US
117430168$11743016$8$F$20150904$20221003$20151116$20221014$EXP$$CN-PFIZER INC-2015388713$PFIZER$$60$YR$$F$Y$80$KG$20221014$$MD$CN$CN
117431617$11743161$7$F$20140101$20221011$20151116$20221021$EXP$$US-ELI_LILLY_AND_COMPANY-US201511001495$ELI LILLY AND CO$$$$$M$Y$$$20221021$$CN$US$US
117474082$11747408$2$F$20150101$20220929$20151117$20221007$PER$$US-BAYER-2015-465878$BAYER$$60$YR$A$F$Y$$$20221007$$CN$US$US
1174958422$11749584$22$F$20130606$20221003$20151118$20221013$EXP$$CA-ROCHE-1660484$ROCHE$$63$YR$$F$Y$75$KG$20221011$$CN$CA$CA
117496992$11749699$2$F$20081120$20221102$20151118$20221108$EXP$$US-ROCHE-1661922$ROCHE$$48$YR$$F$Y$$$20221108$$MD$US$
117526432$11752643$2$F$$20221111$20151119$20221125$EXP$$US-MACLEODS PHARMACEUTICALS US LTD-MAC2015002161$MACLEODS$Hattab YA, Speredelozzi D, Bajwa O.. Rivaroxaban causing spontanuos splenic rupture.. American Journal of Respiratory and Critical Care Medicine.. 2015;191:A4632$$$$$Y$$$20221125$$MD$US$US
1175728427$11757284$27$F$20130805$20221019$20151120$20221025$EXP$$PHHY2013CA085930$NOVARTIS$$79$YR$$M$Y$$$20221025$$HP$CA$CA
117667363$11766736$3$F$20091004$20221102$20151123$20221108$EXP$$US-ROCHE-1661946$ROCHE$$58$YR$$F$Y$$$20221108$$MD$US$
1177184910$11771849$10$F$20151101$20221208$20151124$20221216$EXP$$US-PFIZER INC-2015398522$PFIZER$$72$YR$$F$Y$$$20221216$$CN$US$US
117749013$11774901$3$F$20130101$20211124$20151124$20221017$EXP$$US-JAZZ-2015-US-019706$JAZZ$$$$$M$Y$$$20221017$$MD$US$US
1178262525$11782625$25$F$20140201$20221122$20151127$20221129$EXP$$CA-ROCHE-1668392$ROCHE$$55$YR$$M$Y$78$KG$20221129$$MD$CA$CA
1178500220$11785002$20$F$20130429$20221109$20151130$20221114$EXP$$CA-ROCHE-1141931$ROCHE$$50$YR$$F$Y$106$KG$20221114$$CN$CA$
117862994$11786299$4$F$$20221006$20151130$20221019$EXP$$US-PFIZER INC-2015401364$PFIZER$Blair, P.. DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment. BMJ Case Reports. 2015;10.1136/bcr-2015-210907$79$YR$$M$Y$$$20221019$$HP$US$US
117876837$11787683$7$F$20150101$20221205$20151130$20221212$EXP$$US-JAZZ-2015-US-020315$JAZZ$$$$$F$Y$$$20221212$$HP$US$US
1178812812$11788128$12$F$20141201$20221212$20151201$20221219$EXP$$CA-ROCHE-1513163$ROCHE$$61$YR$$M$Y$83.9$KG$20221219$$CN$CA$
1178896360$11788963$60$F$20151112$20221206$20151201$20221208$EXP$$PHHY2015CA151030$NOVARTIS$$61$YR$$F$Y$$$20221208$$HP$CA$CA
117915402$11791540$2$F$20151120$20221012$20151201$20221020$EXP$$JP-BAUSCH-BL-2015-028453$BAUSCH AND LOMB$$59$YR$$M$Y$$$20221020$$MD$JP$JP
117917868$11791786$8$F$$20221004$20151201$20221004$EXP$$US-PFIZER INC-2015398901$PFIZER$$56$YR$$F$Y$$$20221004$$CN$US$US
117931714$11793171$4$F$$20220926$20151202$20221003$EXP$$CA-GLAXOSMITHKLINE-CA2014GSK054940$GLAXOSMITHKLINE$$$$$$Y$$$20221003$$CN$CA$CA
118100073$11810007$3$F$20180803$20221027$20151208$20221104$EXP$$CA-ROCHE-1674514$ROCHE$$53$YR$$F$Y$$$20221104$$CN$CA$CA
118129063$11812906$3$F$$20220930$20151209$20221004$EXP$$BR-PFIZER INC-2015411022$PFIZER$$75$YR$$M$Y$67$KG$20221004$$CN$BR$BR
118172843$11817284$3$F$20080101$20221116$20151210$20221121$PER$$US-JNJFOC-20151111235$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221122$$HP$US$US
118175423$11817542$3$F$20080101$20221205$20151210$20221208$PER$$US-JNJFOC-20151110244$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221208$$LW$US$US
118179684$11817968$4$F$20130101$20221020$20151210$20221102$PER$$US-JNJFOC-20151108020$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221102$$HP$US$US
118181404$11818140$4$F$20040101$20221017$20151210$20221021$PER$$US-JNJFOC-20151106146$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221021$$LW$US$US
118183087$11818308$7$F$20120101$20220922$20151210$20221003$PER$$US-JNJFOC-20151100778$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221003$$HP$US$US
118187334$11818733$4$F$20100101$20221031$20151210$20221108$PER$$US-JNJFOC-20151113973$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221108$$HP$US$US
118192197$11819219$7$F$20080101$20221003$20151210$20221012$EXP$$US-JNJFOC-20151114373$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221010$$HP$US$US
118193373$11819337$3$F$20040101$20221221$20151210$20221227$PER$$US-JNJFOC-20150923152$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221227$$LW$US$US
1182542956$11825429$56$F$20150101$20221109$20151211$20221112$EXP$$CA-ROCHE-1417303$ROCHE$$$$$F$Y$107$KG$20221112$$HP$CA$
1183072018$11830720$18$F$20151202$20221110$20151214$20221118$EXP$$CA-ROCHE-1676032$ROCHE$$61$YR$$F$Y$$$20221118$$MD$CA$CA
118317432$11831743$2$F$$20220927$20151214$20221011$EXP$$US-PFIZER INC-2015435456$PFIZER$Rafferty, E.. Allergy to multiple unrelated drugs containing FD+C no 2: The importance of excipients.. Annals of Allergy, Asthma and Immunology. 2015;115:5(1):A91$11$YR$$M$Y$$$20221011$$HP$US$US
118376622$11837662$2$F$20151123$20220927$20151215$20221003$EXP$$DE-009507513-1512DEU001161$MERCK$$63$YR$$F$Y$$$20221003$$MD$DE$DE
118462142$11846214$2$F$20150801$20221208$20151217$20221212$EXP$DE-BOEHRINGER INGELHEIM GMBH, GERMANY-2015-BI-66253DE$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2015-BI-66253DE$BOEHRINGER INGELHEIM$$97$YR$E$F$Y$49$KG$20221212$$PH$DE$DE
118480743$11848074$3$F$20160801$20221228$20151217$20221230$EXP$$US-JAZZ-2015-US-021584$JAZZ$$25$YR$$M$Y$$$20221230$$MD$US$US
1185237311$11852373$11$F$20150812$20221006$20151218$20221012$EXP$$FR-GILEAD-2015-0186154$GILEAD$$51$YR$A$M$Y$57$KG$20221012$$MD$FR$FR
118587596$11858759$6$F$$20220919$20151222$20221001$EXP$$CA-AUROBINDO-AUR-APL-2015-11455$AUROBINDO$Ashley M. Yu, BHSc and Joel G. DeKoven, MD, MHSc, FRCPC. Occupational Airborne Contact Dermatitis From Proton Pump Inhibitors. Dermatitis. 2015;26 (6):287-90$58$YR$$M$Y$$$20221001$$MD$CA$CA
1186359518$11863595$18$F$20140101$20221021$20151223$20221028$EXP$$PHHY2014CA154360$NOVARTIS$$$$$F$Y$$$20221028$$HP$CA$CA
118696776$11869677$6$F$20150423$20170515$20151228$20221108$EXP$$JP-ROCHE-1660326$ROCHE$Yamazaki O, Tachikawa S, Yamazaki O, Kono J. Skin Disorder Which Developed after Treatment for Advanced Malignant Melanoma Was Switched from Nivolumab to Vemurafenib (Abstract 72-O ). Journal of Environmental Dermatology and Cutaneous Allergology /; Abstracts of the 45th Annual Meeting of the Japanese Society for Dermatoallergology and Contact Dermatitis 2015 Nov;9 (5):452-.$62$YR$$F$Y$46$KG$20221108$$MD$JP$JP
1187110917$11871109$17$F$20141224$20221020$20151228$20221025$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN180189$VIIV$$$$$$Y$$$20221025$$MD$JP$JP
118782398$11878239$8$F$20151119$20221028$20151230$20221101$EXP$$PHHY2015CA154224$NOVARTIS$$48$YR$$F$Y$$$20221101$$MD$CA$CA
118804154$11880415$4$F$20150909$20221222$20151230$20221223$EXP$$CA-TAKEDA-2015TUS018178$TAKEDA$$59$YR$$F$Y$$$20221223$$CN$CA$CA
118876006$11887600$6$F$20211026$20221211$20160105$20221224$EXP$$GB-AUROBINDO-AUR-APL-2015-11984$AUROBINDO$Jessica Head. A 12-year-old Bella Donna. Archives of Disease in Childhood,. Education and Practice Edition. 2014;99 (5):173-80$12$YR$$F$Y$$$20221224$$MD$GB$GB
118951176$11895117$6$F$20170101$20221201$20160107$20221208$EXP$$US-PFIZER INC-2015442538$PFIZER$$41$YR$$M$Y$113$KG$20221208$$CN$US$US
119053443$11905344$3$F$20120301$20221012$20160109$20221020$PER$$US-JNJFOC-20151222368$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221020$$LW$US$US
119054788$11905478$8$F$$20221221$20160109$20221226$PER$$US-JNJFOC-20151222369$JOHNSON AND JOHNSON$$$$$M$Y$$$20221226$$LW$US$US
1191259921$11912599$21$F$20150101$20210331$20160113$20221214$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-093211$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20221214$$HP$CA$CA
1191791312$11917913$12$F$20140101$20221208$20160114$20221215$PER$$US-PFIZER INC-2016015258$PFIZER$$46$YR$$F$Y$73$KG$20221215$$CN$US$US
1193375733$11933757$33$F$20140806$20221215$20160121$20221219$EXP$$CA-ROCHE-1434589$ROCHE$$73$YR$$F$Y$87$KG$20221219$$HP$CA$
119338252$11933825$2$F$$20221012$20160121$20221014$EXP$$US-SHIRE-US201600378$TAKEDA$$$$$M$Y$$$20221014$$CN$US$US
1193535521$11935355$21$F$20150401$20221219$20160121$20221223$EXP$$US-PFIZER INC-2016017803$PFIZER$$74$YR$$M$Y$124$KG$20221223$$CN$US$US
1193793114$11937931$14$F$20160217$20221129$20160122$20221206$EXP$$CA-ROCHE-1698822$ROCHE$$42$YR$$M$Y$$$20221206$$HP$CA$CA
119538505$11953850$5$F$20161225$20221114$20160126$20221116$PER$$US-PFIZER INC-2015476213$PFIZER$$41$YR$$F$Y$$$20221116$$HP$US$US
119539343$11953934$3$F$$20221107$20160125$20221107$PER$$US-BIOGEN-2016BI00173051$BIOGEN$$$$$F$Y$$$20221107$$CN$US$US
1196876532$11968765$32$F$20141208$20221212$20160128$20221214$EXP$$CA-ROCHE-1219752$ROCHE$$40$YR$$M$Y$67$KG$20221214$$MD$CA$
119760027$11976002$7$F$20120319$20221026$20160129$20221104$EXP$$CA-ROCHE-1132487$ROCHE$$39$YR$$F$Y$77$KG$20221104$$HP$CA$
119768444$11976844$4$F$$20221018$20160129$20221021$PER$$US-BIOGEN-2016BI00177407$BIOGEN$$$$$M$Y$$$20221021$$CN$US$US
1199484817$11994848$17$F$20151201$20220930$20160203$20221007$EXP$$GB-ROCHE-1677596$ROCHE$$69$YR$$F$Y$$$20221007$$MD$GB$GB
1203751634$12037516$34$F$20150601$20221031$20160208$20221103$EXP$$PHHY2015CA076388$NOVARTIS$$65$YR$$F$Y$$$20221103$$HP$CA$CA
120375559$12037555$9$F$20151224$20221019$20160208$20221031$EXP$$PHHY2016CO015670$NOVARTIS$$38$YR$$F$Y$55$KG$20221031$$CN$CO$CO
1204027945$12040279$45$F$20201127$20221104$20160208$20221108$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK160212$GLAXOSMITHKLINE$$$$$$Y$$$20221108$$MD$BR$BR
120510172$12051017$2$F$20140305$20220913$20160208$20221001$PER$$US-ABBVIE-15P-163-1392790-00$ABBVIE$$45$YR$$F$Y$$$20221001$$HP$US$US
120685052$12068505$2$F$$20221208$20160211$20221213$PER$$US-BIOGEN-2016BI00179440$BIOGEN$$$$$F$Y$$$20221213$$CN$US$US
120723023$12072302$3$F$20090101$20221222$20160212$20221229$EXP$$PHHY2016CR018492$NOVARTIS$$$$$M$Y$$$20221229$$CN$CR$CR
1207531612$12075316$12$F$$20221026$20160212$20221110$EXP$$CA-AUROBINDO-AUR-APL-2016-01463$AUROBINDO$Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG, Gardner DM.. Incidence of oculogyric crisis and long-term outcomes with second-generation antipsychotics in a first-episode psychosis program. Journal of Clinical Psychopharmacology. 2015;35(6):715-718$22$YR$$F$Y$$$20221110$$MD$CA$CA
1207853042$12078530$42$F$20150101$20221123$20160216$20221129$EXP$$CA-ROCHE-1711280$ROCHE$$46$YR$$F$Y$$$20221129$$MD$CA$CA
1207965615$12079656$15$F$$20221207$20160216$20221212$EXP$$US-PFIZER INC-2016088306$PFIZER$$62$YR$$F$Y$$$20221212$$HP$US$US
120822789$12082278$9$F$20121205$20221124$20160217$20221128$EXP$$CA-ROCHE-1177020$ROCHE$$54$YR$$F$Y$53$KG$20221128$$CN$CA$
1208261920$12082619$20$F$$20221222$20160217$20221230$EXP$$GB-drreddys-GER/UKI/12/0025687$DR REDDYS$$15$YR$T$F$Y$$$20221230$$MD$GB$GB
120847822$12084782$2$F$$20221006$20160217$20221018$EXP$$DE-PFIZER INC-2016091452$PFIZER$Barthel, D.. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. Journal of Rheumatology. 2015;42 (11):2160-2165$17$YR$$F$Y$$$20221018$$MD$DE$DE
120858434$12085843$4$F$20150801$20221024$20160217$20221030$EXP$$BR-BIOGEN-2016BI00190635$BIOGEN$$30$YR$$F$Y$62$KG$20221030$$HP$BR$BR
120914922$12091492$2$F$$20221006$20160218$20221018$EXP$$DE-PFIZER INC-2016091453$PFIZER$Barthel, D.. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics. Journal of Rheumatology. 2015;42 (11):2160-2165$17$YR$$M$Y$$$20221018$$MD$DE$DE
120968074$12096807$4$F$20140101$20221012$20160220$20221020$EXP$$US-ACORDA-ACO_108922_2015$ACORDA$$$$$F$Y$$$20221020$$MD$US$US
121037492$12103749$2$F$20221212$20221212$20160223$20221215$PER$$US-BIOGEN-2016BI00190216$BIOGEN$$53$YR$$F$Y$$$20221215$$CN$US$US
1211751215$12117512$15$F$20151002$20221130$20160225$20221208$EXP$$CA-ROCHE-1716708$ROCHE$$35$YR$$F$Y$$$20221208$$MD$CA$CA
121182282$12118228$2$F$$20221213$20160226$20221222$PER$$US-AMGEN-USASL2016021584$AMGEN$$55$YR$A$F$Y$$$20221222$$CN$US$US
121210476$12121047$6$F$$20221208$20160226$20221215$PER$$US-PFIZER INC-2016060858$PFIZER$$39$YR$$F$Y$$$20221215$$CN$US$US
1212230538$12122305$38$F$20151219$20221011$20160226$20221014$EXP$$PHHY2015CA172640$NOVARTIS$$61$YR$$F$Y$$$20221014$$CN$CA$CA
121249903$12124990$3$F$20150101$20220930$20160229$20221010$PER$$US-AMGEN-USASL2016023986$AMGEN$$45$YR$A$F$Y$$$20221009$$CN$US$US
121262314$12126231$4$F$20150814$20221025$20160229$20221103$EXP$$CA-009507513-1602CAN010951$MERCK$$47$YR$$F$Y$$$20221103$$PH$CA$CA
121275712$12127571$2$F$$20221221$20160229$20221229$EXP$GB-MHRA-ADR 23357992$GB-PERRIGO-16GB001878$PERRIGO$$$$$$Y$$$20221229$$HP$GB$GB
121283862$12128386$2$F$$20221221$20160229$20221227$EXP$$US-JAZZ-2016-US-003401$JAZZ$$$$$F$Y$$$20221227$$CN$US$US
1213337524$12133375$24$F$$20221212$20160301$20221220$PER$$CA-AMGEN-CANSP2016018438$AMGEN$$65$YR$E$F$Y$$$20221220$$HP$CA$CA
121336525$12133652$5$F$$20221222$20160301$20221229$EXP$GB-MHRA-ADR 23357992$PHHY2016GB024615$NOVARTIS$$4$MON$$$Y$$$20221229$$MD$GB$GB
1213390062$12133900$62$F$20141010$20220924$20160301$20221003$EXP$$CA-ROCHE-1474767$ROCHE$$49$YR$$M$Y$70$KG$20221003$$HP$CA$
121379633$12137963$3$F$$20221215$20160302$20221220$EXP$$GB-AstraZeneca-2016SE19198$ASTRAZENECA$$20$WK$$$Y$$$20221219$$MD$GB$
121389339$12138933$9$F$$20221128$20160302$20221130$EXP$$US-PFIZER INC-2016132391$PFIZER$$68$YR$$F$Y$48$KG$20221130$$CN$US$US
1213946921$12139469$21$F$20121119$20221021$20160303$20221027$EXP$$CA-ROCHE-1162790$ROCHE$$43$YR$$F$Y$63$KG$20221027$$HP$CA$
121453152$12145315$2$F$20151116$20220916$20160304$20221109$EXP$$PHHY2016CA028172$NOVARTIS$$40$YR$$F$Y$$$20221109$$MD$CA$CA
1214630877$12146308$77$F$$20221212$20160304$20221227$EXP$$CA-PFIZER INC-2016130747$PFIZER$$63$YR$$F$Y$$$20221227$$MD$CA$CA
121474823$12147482$3$F$$20221025$20160304$20221031$EXP$$CA-GLAXOSMITHKLINE-CA2016GSK029540$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$PH$CA$CA
121480403$12148040$3$F$20160101$20221005$20160304$20221007$EXP$$CA-TAKEDA-2016TUS003625$TAKEDA$$42$YR$$F$Y$$$20221007$$CN$CA$CA
121532082$12153208$2$F$$20221028$20160305$20221101$PER$$US-BIOGEN-2016BI00194396$BIOGEN$$$$$F$Y$$$20221101$$CN$US$US
121591643$12159164$3$F$$20221130$20160308$20221209$EXP$GB-MHRA-ADR 23357992$GB-APOTEX-2016AP006943$APOTEX$$$$N$$Y$$$20221209$$MD$GB$GB
121611666$12161166$6$F$$20220929$20160308$20221101$EXP$$CA-ABBVIE-10P-163-0641882-00$ABBVIE$$52$YR$$M$Y$$$20221101$$HP$CA$CA
121699232$12169923$2$F$$20221118$20160310$20221123$PER$$PHEH2016US005763$NOVARTIS$Kim S, Chen L, Hebert A, Slopis J, Koenig MK, Patel A. Erythema nodosum in the setting of everolimus use. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016;AB98$35$YR$$F$Y$$$20221123$$HP$US$US
121701502$12170150$2$F$$20221118$20160311$20221123$PER$$PHEH2016US005686$NOVARTIS$Kim S, Chen L, Hebert A, Slopis J, Koenig MK, Patel A. Erythema nodosum in the setting of everolimus use. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2016;AB98$25$YR$$M$Y$$$20221123$$HP$US$US
1217131112$12171311$12$F$20160101$20221111$20160311$20221114$PER$$US-PFIZER INC-2016108785$PFIZER$$79$YR$$F$Y$73$KG$20221114$$HP$US$US
121758873$12175887$3$F$20150805$20221013$20160314$20221020$EXP$$US-BIOGEN-2015BI154964$BIOGEN$$42$YR$$F$Y$$$20221020$$MD$US$US
121804805$12180480$5$F$$20221003$20160315$20221007$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-016441$BRISTOL MYERS SQUIBB$$84$YR$E$F$Y$$$20221007$$CN$GB$GB
121826693$12182669$3$F$20131012$20221003$20160316$20221006$EXP$$AT-SHIRE-AT201603091$TAKEDA$$68$YR$$M$Y$$$20221006$$MD$AT$AT
121860583$12186058$3$F$$20221130$20160317$20221208$EXP$$JP-ROCHE-1726721$ROCHE$PRIVACY P, Sato K, Sumi M, Kaiume H, Ueki T, Hiroshima Y, Kobayashi H et al Perforated upper gastrointestinal ulcers potentially attributable to mycophenolate mofetil after allogeneic hematopoietic stem cell transplantation. The Japanese Journal of Clinical Hematology 2022;63(10):1402-1408.$46$YR$$M$Y$$$20221208$$MD$JP$JP
1218664123$12186641$23$F$20151201$20221221$20160317$20221228$EXP$$CA-ROCHE-1727203$ROCHE$$11$YR$$F$Y$$$20221228$$MD$CA$CA
121984753$12198475$3$F$20120101$20220926$20160322$20221006$PER$$US-JNJFOC-20160308491$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221006$$LW$US$US
122091106$12209110$6$F$20151201$20221121$20160324$20221125$EXP$$DE-ABBVIE-16K-062-1589815-00$ABBVIE$$60$YR$$M$Y$$$20221125$$MD$DE$DE
1222015118$12220151$18$F$20151020$20221207$20160330$20221214$EXP$$CA-ROCHE-1546279$ROCHE$$60$YR$$M$Y$105$KG$20221214$$HP$CA$
122306663$12230666$3$F$$20221222$20160401$20221229$EXP$$CA-BAXTER-2016BAX016268$BAXTER$$27$YR$$F$Y$$$20221229$$HP$CA$CA
1223243925$12232439$25$F$20160101$20221012$20160401$20221017$EXP$$CA-TAKEDA-2016TUS005281$TAKEDA$$60$YR$$F$Y$$$20221017$$HP$CA$CA
1223244413$12232444$13$F$$20221214$20160401$20221222$PER$$US-PFIZER INC-2016186718$PFIZER$$21$YR$$M$Y$77.11$KG$20221222$$MD$US$US
1223270414$12232704$14$F$20150827$20221118$20160401$20221124$EXP$$CA-TAKEDA-2016TUS004214$TAKEDA$$54$YR$$F$Y$$$20221124$$CN$CA$CA
122367384$12236738$4$F$$20221213$20160405$20221226$EXP$$GB-AUROBINDO-AUR-APL-2016-02203$AUROBINDO$$20$WK$$$Y$$$20221226$$MD$GB$GB
122422523$12242252$3$F$20150825$20190902$20160406$20221017$EXP$$JP-JNJFOC-20150904854$JOHNSON AND JOHNSON$$68$YR$E$F$Y$52$KG$20221017$$MD$JP$JP
122426543$12242654$3$F$20160323$20221107$20160406$20221115$EXP$$US-BIOGEN-2016BI00213721$BIOGEN$$64$YR$$F$Y$$$20221115$$CN$US$US
1224266314$12242663$14$F$20081101$20221118$20160406$20221123$EXP$$US-PFIZER INC-2016015358$PFIZER$$58$YR$$F$Y$81$KG$20221123$$HP$US$US
1224450765$12244507$65$F$20120901$20221220$20160407$20221222$EXP$$CA-ROCHE-1132730$ROCHE$$66$YR$$F$Y$61$KG$20221222$$HP$CA$
122454192$12245419$2$F$20160318$20221014$20160407$20221017$PER$$US-BIOGEN-2016BI00212652$BIOGEN$$67$YR$$F$Y$$$20221017$$CN$US$US
122653124$12265312$4$F$20160301$20221107$20160413$20221110$EXP$$US-SHIRE-US201604300$TAKEDA$$8$YR$$M$Y$22.676$KG$20221110$$CN$US$US
122657786$12265778$6$F$$20221214$20160413$20221221$EXP$$CA-BAXALTA-2016BLT002214$TAKEDA$$27$YR$$F$Y$$$20221221$$HP$CA$CA
122801899$12280189$9$F$20141111$20221113$20160419$20221121$EXP$$CA-ROCHE-1742724$ROCHE$$48$YR$$F$Y$$$20221121$$MD$CA$CA
122808493$12280849$3$F$20160122$20220920$20160419$20221004$EXP$$SE-AUROBINDO-AUR-APL-2016-04852$AUROBINDO$$33$YR$$F$Y$$$20221004$$MD$SE$SE
1228955324$12289553$24$F$20140101$20221213$20160421$20221219$EXP$$PHHY2014CA116710$NOVARTIS$$67$YR$$F$Y$77.098$KG$20221219$$CN$CA$CA
1229013121$12290131$21$F$20210101$20220930$20160421$20221004$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK011740$GLAXOSMITHKLINE$$$$$$Y$$$20221004$$CN$BR$BR
1229416317$12294163$17$F$20121120$20221213$20160422$20221220$EXP$$CA-ROCHE-1745200$ROCHE$$41$YR$$M$Y$122.7$KG$20221220$$CN$CA$CA
123033222$12303322$2$F$$20220926$20160426$20221003$PER$$US-JNJFOC-20160406141$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
123033787$12303378$7$F$20090203$20220929$20160426$20221012$PER$$US-JNJFOC-20160402019$JOHNSON AND JOHNSON$$7$YR$C$M$Y$25.424$KG$20221012$$HP$US$US
123040763$12304076$3$F$20030316$20221116$20160426$20221125$PER$$US-JNJFOC-20160412153$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221125$$HP$US$US
1230456623$12304566$23$F$20150701$20221118$20160426$20221123$EXP$$PHHY2016CA055639$NOVARTIS$$55$YR$$F$Y$$$20221123$$MD$CA$CA
1230619210$12306192$10$F$20160701$20221123$20160426$20221128$EXP$$US-PFIZER INC-2016226395$PFIZER$$57$YR$$M$Y$113$KG$20221128$$CN$US$US
123069373$12306937$3$F$20080301$20221214$20160426$20221221$EXP$$US-JAZZ-JPI-P-003173$JAZZ$$48$YR$$F$Y$$$20221221$$CN$US$US
123088954$12308895$4$F$20140101$20221221$20160427$20221226$EXP$$US-JAZZ-2015-US-011496$JAZZ$$$$$M$Y$$$20221226$$MD$US$US
1231139711$12311397$11$F$20150717$20221026$20160427$20221107$EXP$$DE-INCYTE CORPORATION-2016IN000383$INCYTE$$$$$$Y$$$20221107$$MD$DE$DE
1231249417$12312494$17$F$20090209$20221220$20160428$20221227$PER$$CA-AMGEN-CANSP2016039095$AMGEN$$57$YR$A$M$Y$$$20221227$$HP$CA$CA
123158604$12315860$4$F$20150101$20221209$20160428$20221215$EXP$$US-JAZZ-2016-US-007509$JAZZ$$$$$M$Y$126.98$KG$20221215$$HP$US$US
1232125915$12321259$15$F$20160119$20220906$20160502$20221202$EXP$$GB-ROCHE-1748037$ROCHE$$80$YR$$F$Y$$$20221202$$MD$GB$GB
123214566$12321456$6$F$$20181010$20160502$20221231$PER$$PHEH2016US010509$NOVARTIS$$$$$F$Y$86$KG$20221231$$HP$US$US
1232155510$12321555$10$F$$20221212$20160502$20221220$PER$$CA-AMGEN-CANSP2016054806$AMGEN$$58$YR$A$F$Y$$$20221220$$HP$CA$CA
1232522011$12325220$11$F$20150901$20221201$20160502$20221206$EXP$$CA-DSJP-DSU-2015-130567$DAIICHI$$74$YR$$F$Y$$$20221206$$HP$CA$CA
123255648$12325564$8$F$$20180310$20160503$20221229$EXP$$PHEH2016US010512$NOVARTIS$$$$$$Y$$$20221229$$MD$US$US
123262568$12326256$8$F$$20221121$20160503$20221123$EXP$$CA-ROCHE-1750136$ROCHE$$50$YR$$M$Y$$$20221123$$HP$CA$
1232625826$12326258$26$F$20150801$20221024$20160503$20221102$EXP$$CA-ROCHE-1750044$ROCHE$$34$YR$$M$Y$$$20221101$$CN$CA$CA
1233195424$12331954$24$F$19900101$20221216$20160504$20221227$EXP$$US-PFIZER INC-2016204050$PFIZER$$33$YR$$F$Y$52.154$KG$20221227$$MD$US$US
1233264520$12332645$20$F$20160410$20221216$20160504$20221222$EXP$$US-PFIZER INC-2016230773$PFIZER$$77$YR$$F$Y$58$KG$20221222$$CN$US$US
123356804$12335680$4$F$20160428$20221206$20160505$20221207$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-033720$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20221207$$HP$US$US
123389598$12338959$8$F$20160502$20221208$20160505$20221214$PER$$US-PFIZER INC-2016243931$PFIZER$$59$YR$$F$Y$71.67$KG$20221214$$HP$US$US
123394074$12339407$4$F$20150101$20221012$20160505$20221018$EXP$$US-JAZZ-2015-US-012623$JAZZ$$$$$F$Y$$$20221018$$HP$US$US
123415128$12341512$8$F$$20221013$20160506$20221020$EXP$$PHHY2016CA059634$NOVARTIS$$$$$M$Y$$$20221020$$CN$CA$CA
1234662210$12346622$10$F$20190801$20221220$20160509$20221223$EXP$$US-PFIZER INC-2016150950$PFIZER$$26$YR$$M$Y$$$20221223$$HP$US$US
123483287$12348328$7$F$20150901$20221102$20160509$20221118$EXP$$FR-JNJFOC-20151101884$JOHNSON AND JOHNSON$$31$YR$A$M$Y$52$KG$20221118$$MD$FR$FR
123559386$12355938$6$F$$20221213$20160511$20221215$EXP$$US-JAZZ-2016-US-008484$JAZZ$$$$$F$Y$$$20221215$$CN$US$US
123562423$12356242$3$F$$20221014$20160511$20221021$PER$$US-BIOGEN-2016BI00235995$BIOGEN$$$$$M$Y$$$20221021$$CN$US$US
123565437$12356543$7$F$20160101$20221005$20160511$20221010$EXP$$PHHY2016CA053475$NOVARTIS$$28$YR$$M$Y$$$20221010$$MD$CA$CA
1235836628$12358366$28$F$20131029$20221111$20160512$20221121$EXP$$CA-ROCHE-1756306$ROCHE$$51$YR$$F$Y$$$20221121$$CN$CA$CA
1236543817$12365438$17$F$20140101$20221021$20160512$20221028$EXP$$BR-BIOGEN-2016BI00235292$BIOGEN$$$$$F$Y$69$KG$20221028$$CN$BR$BR
123656032$12365603$2$F$$20221206$20160513$20221213$EXP$$CN-ROCHE-1755331$ROCHE$Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D, You Y, Zhong Z, Li W, Hu Y and Xia L Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. Doi: 10.1016/j.leu. Leukemia Research 2016 Jul 01;46:61-8.$$$$$Y$$$20221213$$HP$CN$
123671773$12367177$3$F$$20221107$20160513$20221116$PER$$US-JNJFOC-20160500360$JOHNSON AND JOHNSON$$$$$M$Y$$$20221116$$LW$US$US
1237099728$12370997$28$F$20160101$20221212$20160516$20221222$PER$$CA-AMGEN-CANSP2016061225$AMGEN$$63$YR$A$F$Y$$$20221221$$HP$CA$CA
123711785$12371178$5$F$$20221214$20160516$20221222$PER$$US-PFIZER INC-2016224142$PFIZER$$63$YR$$F$Y$63$KG$20221222$$CN$US$US
123714736$12371473$6$F$20150730$20220706$20160516$20221219$EXP$$US-ROCHE-1756698$ROCHE$$62$YR$$M$Y$72.6$KG$20221219$$MD$US$
123743135$12374313$5$F$20131201$20221215$20160517$20221221$EXP$$US-JAZZ-2015-US-013892$JAZZ$$36$YR$$F$Y$$$20221221$$CN$US$US
1237554632$12375546$32$F$20150101$20221212$20160517$20221222$EXP$$CA-PFIZER INC-2015440794$PFIZER$$42$YR$$F$Y$97$KG$20221222$$MD$CA$CA
1238083419$12380834$19$F$20160401$20221215$20160518$20221222$EXP$$CA-ROCHE-1758483$ROCHE$$23$YR$$F$Y$$$20221222$$MD$CA$CA
1238547412$12385474$12$F$20160101$20221006$20160519$20221012$EXP$$PHHY2016AR068913$NOVARTIS$$69$YR$$F$Y$$$20221012$$CN$AR$AR
123865166$12386516$6$F$$20221031$20160519$20221108$EXP$$US-JAZZ-2015-US-021618$JAZZ$$$$$M$Y$$$20221108$$MD$US$US
1238769511$12387695$11$F$20141201$20221117$20160520$20221121$EXP$$CA-ROCHE-1761274$ROCHE$$45$YR$$F$Y$$$20221121$$CN$COUNTRY NOT SPECIFIED$CA
1239002315$12390023$15$F$20151201$20221103$20160520$20221111$EXP$$US-JAZZ-2016-US-000603$JAZZ$$47$YR$$F$Y$$$20221111$$MD$US$US
1239210611$12392106$11$F$20130617$20221114$20160523$20221121$EXP$$CA-ROCHE-1760131$ROCHE$$40$YR$$F$Y$57$KG$20221121$$HP$CA$CA
1239630314$12396303$14$F$20160514$20221203$20160524$20221209$EXP$$CO-SHIRE-CO201606313$TAKEDA$$3$YR$$M$Y$46$KG$20221209$$HP$CO$CO
123980633$12398063$3$F$20160517$20221213$20160524$20221216$EXP$$US-ROCHE-1762004$ROCHE$$$$$M$Y$$$20221216$$MD$US$
124067318$12406731$8$F$20100101$20221222$20160526$20221226$EXP$$US-JAZZ-2015-US-015583$JAZZ$$$$$M$Y$$$20221226$$CN$US$US
124096415$12409641$5$F$$20221212$20160526$20221222$EXP$$CO-INCYTE CORPORATION-2016IN003124$INCYTE$$$$$$Y$$$20221222$$CN$CO$CO
124111243$12411124$3$F$20210415$20221026$20160527$20221102$EXP$$CA-ROCHE-1764540$ROCHE$$45$YR$$F$Y$$$20221102$$MD$CA$CA
124128583$12412858$3$F$20080101$20221221$20160527$20221227$PER$$US-JAZZ-2016-US-009492$JAZZ$$33$YR$$F$Y$$$20221227$$MD$US$US
1241398810$12413988$10$F$20160101$20221206$20160527$20221213$EXP$$US-JAZZ-2016-US-009575$JAZZ$$$$$F$Y$$$20221213$$MD$US$US
124140502$12414050$2$F$20220714$20220812$20160527$20221026$PER$$US-JAZZ-2015-US-016307$JAZZ$$35$YR$$M$Y$$$20221026$$HP$US$US
124168389$12416838$9$F$$20221201$20160530$20221201$EXP$$US-PFIZER INC-2016280298$PFIZER$$76$YR$$F$Y$$$20221201$$CN$US$US
1241761815$12417618$15$F$20131130$20221024$20160530$20221027$EXP$$PHHY2016CO071682$NOVARTIS$$58$YR$$F$Y$71$KG$20221027$$CN$CO$CO
124207668$12420766$8$F$20130627$20221216$20160531$20221220$EXP$$ES-009507513-1504ESP009226$MERCK$$66$YR$$F$Y$$$20221220$$HP$ES$ES
124253344$12425334$4$F$20160125$20221109$20160601$20221111$EXP$FR-AFSSAPS-PA20160131$FR-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-34467FF$BOEHRINGER INGELHEIM$$49$YR$A$M$Y$$$20221111$$HP$FR$FR
1242661011$12426610$11$F$20140528$20221108$20160601$20221115$EXP$$PHHY2013CA144082$NOVARTIS$$83$YR$$F$Y$$$20221115$$HP$CA$CA
124316183$12431618$3$F$20160510$20221027$20160603$20221104$EXP$$US-SHIRE-US201606609$TAKEDA$$24$YR$$M$Y$55$KG$20221104$$HP$US$US
124457012$12445701$2$F$20060101$20220926$20160608$20221006$PER$$US-JNJFOC-20160523024$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221006$$HP$US$US
124457535$12445753$5$F$$20221019$20160608$20221027$PER$$US-JNJFOC-20160411835$JOHNSON AND JOHNSON$$$$$M$Y$$$20221027$$LW$US$US
124462127$12446212$7$F$$20221126$20160608$20221207$PER$$US-BIOGEN-2016BI00240291$BIOGEN$$$$$F$Y$63.5$KG$20221207$$CN$US$US
124500342$12450034$2$F$$20221024$20160609$20221027$PER$$US-BIOGEN-2016BI00241319$BIOGEN$$$$$F$Y$$$20221027$$CN$US$US
124505682$12450568$2$F$20121001$20221101$20160609$20221114$EXP$IT-MLMSERVICE-20160526-0293587-1$IT-LUPIN PHARMACEUTICALS INC.-2016-02427$LUPIN$Del Casale A, Rapinesi C, Brugnoli R, Girardi P, Sacco M, Giardini M, et al.. Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, gilbert syndrome, and exacerbation of psychosis. Psychiatria Danubina. 2016;28(1):91-94$28$YR$$M$Y$$$20221114$$MD$IT$IT
124604347$12460434$7$F$$20221202$20160613$20221208$EXP$$US-PFIZER INC-2016266871$PFIZER$$72$YR$$F$Y$$$20221208$$CN$US$US
1246649225$12466492$25$F$20120801$20221109$20160615$20221118$EXP$$CA-ROCHE-1775252$ROCHE$$79$YR$$F$Y$$$20221118$$CN$CA$CA
124681188$12468118$8$F$20150901$20221207$20160615$20221212$EXP$$US-PFIZER INC-2016287804$MYLAN$$67$YR$$M$Y$77$KG$20221212$$CN$US$US
124681349$12468134$9$F$20060101$20221221$20160615$20221227$EXP$$US-PFIZER INC-2016297763$PFIZER$$70$YR$$F$Y$56.961$KG$20221227$$MD$US$US
1247755431$12477554$31$F$20151221$20221019$20160617$20221025$EXP$$PHHY2015CA169582$NOVARTIS$$59$YR$$F$Y$$$20221025$$CN$CA$CA
124813377$12481337$7$F$20080101$20221026$20160620$20221031$EXP$$US-BIOGEN-2010BI033734$BIOGEN$$$$$F$Y$93.524$KG$20221031$$CN$US$US
124825915$12482591$5$F$$20221017$20160620$20221021$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006617$TAKEDA$$$$$M$Y$79$KG$20221021$$MD$US$US
124828986$12482898$6$F$20150715$20221221$20160620$20221223$EXP$$PHHY2016CO012426$NOVARTIS$$67$YR$$F$Y$67$KG$20221223$$CN$CO$CO
124845626$12484562$6$F$20140901$20221128$20160621$20221205$EXP$$US-JAZZ-2016-US-011104$JAZZ$$41$YR$$F$Y$$$20221205$$MD$US$US
124904574$12490457$4$F$20160101$20221011$20160622$20221018$EXP$$US-JAZZ-2016-US-011165$JAZZ$$$$$F$Y$$$20221018$$CN$US$US
124930793$12493079$3$F$$20220929$20160623$20221012$EXP$$US-PFIZER INC-2016295837$PFIZER$Thind, G.. A case of Takotsubo cardiomyopathy in a patient with anaphylaxis treated with epinephrine. Journal of General Internal Medicine. 2016;31:2(1):S497$58$YR$$F$Y$$$20221012$$MD$US$US
125008673$12500867$3$F$20160530$20221118$20160627$20221123$EXP$$CA-BIOGEN-2016BI00253886$BIOGEN$$42$YR$$M$Y$$$20221123$$MD$CA$CA
1250841710$12508417$10$F$20160702$20221117$20160629$20221123$EXP$$CA-PFIZER INC-2016305222$PFIZER$$71$YR$$M$Y$$$20221123$$CN$CA$CA
1251723525$12517235$25$F$20160101$20221116$20160630$20221124$EXP$$CA-ROCHE-1785228$ROCHE$$68$YR$$F$Y$$$20221124$$CN$CA$CA
125172424$12517242$4$F$$20221115$20160630$20221121$EXP$$AU-PFIZER INC-2970434$PFIZER$Kennedy, B.. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection. Journal of Antimicrobial Chemotherapy. 2015;70(7):2171-2173$8$DEC$$M$Y$$$20221121$$HP$AU$AU
125173072$12517307$2$F$$20221114$20160630$20221122$EXP$$CA-AstraZeneca-2016SE68616$ASTRAZENECA$$56$YR$$F$Y$91$KG$20221122$$MD$CA$
1251759423$12517594$23$F$20160205$20221209$20160630$20221216$EXP$$PHHY2016CL088658$NOVARTIS$$$$$F$Y$69.5$KG$20221216$$MD$CL$CL
1252085719$12520857$19$F$20190318$20221219$20160701$20221227$EXP$$US-PFIZER INC-2016320631$PFIZER$$66$YR$$F$Y$120$KG$20221227$$CN$US$US
125216122$12521612$2$F$$20221014$20160701$20221018$EXP$$PHHY2016CA090326$NOVARTIS$$$$$F$Y$$$20221018$$CN$CA$CA
1252758724$12527587$24$F$20121001$20221005$20160705$20221013$EXP$$CA-ROCHE-1786206$ROCHE$$70$YR$$M$Y$$$20221011$$CN$CA$CA
125295212$12529521$2$F$20121201$20221003$20160706$20221028$EXP$SE-ABBVIE-16K-150-1665610-00$SE-ABBVIE-16K-150-1665610-00$ABBVIE$$62$YR$$M$Y$$$20221028$$MD$SE$SE
125321247$12532124$7$F$20160304$20220929$20160706$20221004$EXP$$CA-TAKEDA-2016TUS002594$TAKEDA$$61$YR$$F$Y$$$20221004$$HP$CA$CA
125332002$12533200$2$F$$20200526$20160706$20221008$PER$$US-PURDUE-USA-2015-0127244$PURDUE$$$$$F$Y$$$20221008$$LW$US$US
125377179$12537717$9$F$$20221031$20160707$20221107$EXP$$US-ARIAD PHARMACEUTICALS, INC-2016US006397$TAKEDA$$$$$F$Y$70$KG$20221107$$CN$US$US
125383772$12538377$2$F$20160301$20211028$20160707$20221017$EXP$$US-JAZZ-2016-US-012221$JAZZ$$55$YR$$F$Y$$$20221017$$CN$US$US
125387485$12538748$5$F$20160702$20221108$20160708$20221111$EXP$$FR-ROCHE-1789528$ROCHE$$67$YR$$M$Y$81$KG$20221111$$MD$FR$
125418069$12541806$9$F$20160629$20221121$20160708$20221126$EXP$$JP-BAXALTA-2016BXJ004710$TAKEDA$$67$YR$$M$Y$63$KG$20221126$$CN$JP$JP
125462377$12546237$7$F$20160621$20221007$20160711$20221012$EXP$$CA-TAKEDA-2016TUS011508$TAKEDA$$64$YR$$M$Y$$$20221012$$CN$CA$CA
1254955512$12549555$12$F$20130101$20221205$20160712$20221209$EXP$$US-PFIZER INC-2016335757$PFIZER$$72$YR$$F$Y$59$KG$20221209$$CN$US$US
125497395$12549739$5$F$20160530$20221026$20160712$20221102$EXP$$US-PFIZER INC-2016304153$PFIZER$$71$YR$$F$Y$94.8$KG$20221102$$CN$US$US
125549212$12554921$2$F$$20221121$20160713$20221124$PER$$US-BIOGEN-2016BI00263439$BIOGEN$$$$$F$Y$$$20221124$$CN$US$US
125579983$12557998$3$F$20140101$20220929$20160714$20221026$PER$$US-JAZZ-2016-US-000698$JAZZ$$$$$F$Y$58.957$KG$20221026$$MD$US$US
125595733$12559573$3$F$20150720$20221215$20160715$20221221$EXP$$PHHY2015CA076195$NOVARTIS$$50$YR$$F$Y$$$20221222$$MD$CA$CA
125635877$12563587$7$F$20160707$20221123$20160715$20221129$EXP$$US-JAZZ-2016-US-012720$JAZZ$$50$YR$$M$Y$$$20221129$$MD$US$US
1256496029$12564960$29$F$20150721$20221106$20160718$20221108$EXP$$GB-ROCHE-1657697$ROCHE$$75$YR$$F$Y$$$20221108$$MD$GB$GB
1256922210$12569222$10$F$20161205$20221102$20160719$20221107$EXP$$PHHY2016CO096699$NOVARTIS$$73$YR$$M$Y$80$KG$20221107$$CN$CO$CO
1257115229$12571152$29$F$$20221221$20160719$20221230$EXP$$CA-PFIZER INC-2016324063$PFIZER$$85$YR$$M$Y$$$20221230$$MD$CA$CA
125801184$12580118$4$F$$20180312$20160721$20221228$EXP$$PHHY2016PT099049$NOVARTIS$$$$$$Y$$$20221228$$CN$PT$PT
1258496617$12584966$17$F$20160101$20221116$20160722$20221123$EXP$$BR-TAKEDA-2016TUS012630$TAKEDA$$$$$M$Y$59.5$KG$20221123$$CN$BR$BR
125867747$12586774$7$F$$20221118$20160725$20221122$EXP$$US-PFIZER INC-2016350543$PFIZER$$71$YR$$M$Y$$$20221122$$CN$US$US
1258700620$12587006$20$F$20160401$20220930$20160725$20221007$EXP$$CA-ROCHE-1799664$ROCHE$$60$YR$$F$Y$$$20221007$$CN$CA$CA
125908492$12590849$2$F$20140101$20221202$20160726$20221213$PER$$US-AMGEN-USASL2016094749$AMGEN$$55$YR$A$F$Y$$$20221212$$CN$US$US
1259605213$12596052$13$F$20200201$20221221$20160727$20221228$EXP$$CA-ROCHE-1801131$ROCHE$$46$YR$$F$Y$$$20221228$$CN$CA$CA
125964479$12596447$9$F$20010101$20221221$20160726$20221229$EXP$$US-PFIZER INC-2016320501$PFIZER$$55$YR$$M$Y$108.8$KG$20221229$$HP$US$US
1260155920$12601559$20$F$20141209$20221025$20160728$20221031$EXP$$PHHY2013CA096983$NOVARTIS$$64$YR$$F$Y$$$20221031$$MD$CA$CA
126026383$12602638$3$F$$20221114$20160728$20221117$EXP$$JP-GLAXOSMITHKLINE-JP2016JPN107167$GLAXOSMITHKLINE$$$$$$Y$$$20221117$$MD$JP$JP
1260344212$12603442$12$F$20160720$20221115$20160728$20221123$EXP$$ES-ROCHE-1799367$ROCHE$$75$YR$$F$Y$60$KG$20221123$$MD$ES$
1260584815$12605848$15$F$20140523$20221118$20160729$20221122$EXP$$PHHY2014CA065852$NOVARTIS$$32$YR$$F$Y$$$20221122$$HP$CA$CA
1260602521$12606025$21$F$20160101$20221115$20160729$20221118$EXP$$US-PFIZER INC-2016332106$PFIZER$$76$YR$$F$Y$63$KG$20221118$$CN$US$US
1261389712$12613897$12$F$20160718$20221013$20160802$20221018$PER$$US-PFIZER INC-2016354161$PFIZER$$72$YR$$F$Y$83$KG$20221018$$CN$US$US
126142597$12614259$7$F$20221226$20221227$20160802$20221229$EXP$$US-JAZZ-2016-US-002901$JAZZ$$64$YR$$M$Y$$$20221229$$MD$US$US
1261461516$12614615$16$F$20160101$20221103$20160802$20221111$EXP$$US-PFIZER INC-2016022099$PFIZER$$66$YR$$F$Y$86$KG$20221111$$CN$US$US
1261829811$12618298$11$F$20151016$20221207$20160803$20221213$EXP$$PHHY2015CO136842$NOVARTIS$$40$YR$$M$Y$75$KG$20221213$$CN$CO$CO
1262095310$12620953$10$F$20160322$20220912$20160804$20221006$EXP$$PHHY2016IT104278$NOVARTIS$$15$YR$$M$Y$64.5$KG$20221006$$MD$IT$IT
126218886$12621888$6$F$20160701$20221011$20160804$20221019$EXP$FR-PURDUE PHARMA-GBR-2016-0039405$FR-PURDUE PHARMA-GBR-2016-0039405$PURDUE$$76$YR$$F$Y$$$20221019$$MD$FR$FR
126287463$12628746$3$F$$20221101$20160808$20221114$EXP$CA-MLMSERVICE-20160721-0357315-1$CA-Accord-042925$ACCORD$$39$YR$A$M$Y$$$20221114$$HP$CA$CA
1263897021$12638970$21$F$20160711$20221212$20160809$20221221$EXP$$CL-BIOMARINAP-CL-2016-110693$BIOMARIN$$$$$$Y$$$20221221$$CN$US$CL
126396072$12639607$2$F$20120101$20221004$20160810$20221017$EXP$BE-MLMSERVICE-20160721-0358575-1$BE-Accord-042975$ACCORD$$55$YR$A$M$Y$$$20221017$$MD$BE$BE
126404793$12640479$3$F$20160601$20221121$20160810$20221124$EXP$$FR-PFIZER INC-2016371969$PFIZER$$36$YR$$F$Y$47$KG$20221124$$MD$FR$FR
126409323$12640932$3$F$20160524$20221206$20160810$20221213$EXP$FR-AFSSAPS-NT20161022$FR-GLAXOSMITHKLINE-FR2016GSK114734$GLAXOSMITHKLINE$$$$$$Y$$$20221213$$MD$FR$FR
126415634$12641563$4$F$20160701$20221220$20160810$20221228$PER$$US-PFIZER INC-2016366813$PFIZER$$37$YR$$M$Y$85$KG$20221228$$MD$US$US
126439252$12643925$2$F$20160708$20221108$20160811$20221123$EXP$$IT-AUROBINDO-AUR-APL-2016-09996$AUROBINDO$$33$YR$$F$Y$$$20221123$$MD$IT$IT
1264583516$12645835$16$F$20151218$20221017$20160811$20221024$EXP$$PHHY2016CA007779$NOVARTIS$$45$YR$$M$Y$$$20221024$$MD$CA$CA
126473764$12647376$4$F$20160307$20221107$20160812$20221111$EXP$$PHHY2016CA108699$NOVARTIS$$20$YR$$F$Y$$$20221111$$MD$CA$CA
1264903716$12649037$16$F$20160801$20221019$20160812$20221025$EXP$$PHHY2016IN109563$NOVARTIS$$42$YR$$M$Y$$$20221025$$MD$IN$IN
126518236$12651823$6$F$20150101$20221116$20160815$20221118$EXP$$PHHY2016CA111149$NOVARTIS$$$$$F$Y$$$20221118$$MD$CA$CA
1265259313$12652593$13$F$20160805$20221206$20160815$20221212$EXP$$US-PFIZER INC-2016387053$PFIZER$$72$YR$$M$Y$95.5$KG$20221212$$CN$US$US
126591833$12659183$3$F$$20221110$20160817$20221117$EXP$$PHHY2016CA111169$NOVARTIS$$$$$F$Y$$$20221117$$MD$CA$CA
1266158614$12661586$14$F$20160819$20221102$20160817$20221104$PER$$US-PFIZER INC-2016387665$PFIZER$$62$YR$$F$Y$70$KG$20221104$$MD$US$US
126675208$12667520$8$F$20100101$20221130$20160819$20221206$EXP$$US-PFIZER INC-2016392132$PFIZER$$58$YR$$F$Y$115$KG$20221206$$CN$US$US
126683269$12668326$9$F$20160801$20221207$20160819$20221213$EXP$$PHHY2016CA113655$NOVARTIS$$35$YR$$F$Y$$$20221213$$HP$CA$CA
126708007$12670800$7$F$$20221107$20160822$20221114$EXP$$US-JAZZ-2016-US-006149$JAZZ$$$$$M$Y$$$20221114$$MD$US$US
1267308828$12673088$28$F$20160301$20221128$20160822$20221201$EXP$$PHHY2016CA038348$NOVARTIS$$52$YR$$F$Y$$$20221201$$HP$CA$CA
1267361023$12673610$23$F$20160803$20221101$20160822$20221111$EXP$$GB-ELI_LILLY_AND_COMPANY-GB201608008113$ELI LILLY AND CO$$69$YR$$F$Y$101$KG$20221111$$CN$GB$GB
1267604332$12676043$32$F$$20220718$20160823$20221003$EXP$$CA-SA-2015SA146389$SANOFI AVENTIS$$43$YR$A$F$Y$$$20221003$$MD$CA$CA
1267742711$12677427$11$F$20160803$20221013$20160823$20221017$EXP$GB-MHRA-EYC 00143637$PHHY2016GB112616$NOVARTIS$$69$YR$$F$Y$101$KG$20221017$$PH$GB$GB
126774969$12677496$9$F$20210101$20221124$20160823$20221130$EXP$$CA-PFIZER INC-2016373806$PFIZER$$50$YR$$F$Y$$$20221130$$CN$CA$CA
126785298$12678529$8$F$20160802$20221116$20160823$20221121$EXP$$PHHY2016CA115075$NOVARTIS$$66$YR$$M$Y$$$20221121$$MD$CA$CA
1268190131$12681901$31$F$20160803$20221222$20160824$20221229$EXP$GB-MHRA-EYC 00143637$GB-MYLANLABS-2016M1034603$MYLAN$$69$YR$$F$Y$101$KG$20221229$$PH$GB$GB
1268278111$12682781$11$F$20160803$20221101$20160825$20221114$EXP$$GB-MACLEODS PHARMACEUTICALS US LTD-MAC2016003010$MACLEODS$$$$$$Y$$$20221114$$PH$GB$GB
126843893$12684389$3$F$20160101$20221223$20160825$20221229$EXP$FR-AFSSAPS-RE20160793$FR-VIIV HEALTHCARE LIMITED-FR2016GSK121710$VIIV$$$$$$Y$$$20221229$$MD$FR$FR
126848493$12684849$3$F$20160101$20221223$20160825$20221229$EXP$FR-AFSSAPS-RE20160793$FR-GLAXOSMITHKLINE-FR2016GSK121710$GLAXOSMITHKLINE$$$$$$Y$$$20221229$$MD$FR$FR
1268961213$12689612$13$F$20150401$20221107$20160826$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2016JPN121032$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1269022429$12690224$29$F$20160803$20221117$20160826$20221125$EXP$GB-MHRA-EYC 00143637$GB-drreddys-GER/UKI/16/0082539$DR REDDYS$$69$YR$E$F$Y$101$KG$20221125$$PH$GB$GB
126924094$12692409$4$F$20160126$20221221$20160828$20221223$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-006994$BRISTOL MYERS SQUIBB$$53$YR$A$M$Y$$$20221223$$CN$CA$CA
1269299310$12692993$10$F$20160407$20221209$20160829$20221216$EXP$$CA-ROCHE-1821507$ROCHE$$70$YR$$M$Y$77$KG$20221216$$MD$CA$CA
126963186$12696318$6$F$$20221021$20160830$20221101$EXP$$NP-CIPLA LTD.-2016NP17824$CIPLA$Hirachan A., Baral S., Shareef M., Rijal R. and Tibrewala L.. Amlodipine overdose with hypotension and noncardiogenic pulmonary edema. Nepalese Heart Journal. 2016;13 (1):27 to 29$23$YR$$F$Y$$$20221101$$MD$NP$NP
1269705218$12697052$18$F$20160803$20221115$20160830$20221213$EXP$$GB-AUROBINDO-AUR-APL-2016-10627$AUROBINDO$$69$YR$$F$Y$101$KG$20221213$$PH$GB$GB
126984695$12698469$5$F$20080731$20221003$20160830$20221013$PER$$US-JNJFOC-20160709016$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221013$$HP$US$US
126995653$12699565$3$F$20221220$20221220$20160830$20221228$EXP$$US-KAMADA LIMITED-2016US001402$TAKEDA$$69$YR$$M$Y$$$20221228$$CN$US$US
127001772$12700177$2$F$20160811$20221116$20160830$20221122$EXP$$US-SHIRE-US201610863$TAKEDA$$41$YR$$F$Y$134.24$KG$20221122$$HP$US$US
1270337819$12703378$19$F$20140617$20221107$20160831$20221117$EXP$$JP-JNJFOC-20160824209$JOHNSON AND JOHNSON$$62$YR$A$M$Y$$$20221117$$MD$JP$JP
127106412$12710641$2$F$20010101$20221208$20160902$20221215$EXP$$US-SHIRE-US201610636$TAKEDA$$$$$F$Y$91$KG$20221215$$MD$US$US
127116162$12711616$2$F$20160101$20221221$20160902$20221228$EXP$$CR-009507513-1609CRI000234$MERCK$$54$YR$$M$Y$$$20221228$$MD$CR$CR
127145078$12714507$8$F$20160101$20221118$20160905$20221125$EXP$$US-JAZZ-2016-US-008662$JAZZ$$$$$F$Y$$$20221125$$CN$US$US
1271532816$12715328$16$F$$20221005$20160906$20221008$EXP$$CA-ROCHE-1825208$ROCHE$$74$YR$$F$Y$$$20221008$$MD$CA$
1271619613$12716196$13$F$20140701$20221108$20160906$20221114$EXP$$PHHY2014CA097752$NOVARTIS$$$$E$F$Y$68$KG$20221114$$HP$CA$CA
127173267$12717326$7$F$20150807$20221129$20160906$20221212$EXP$$PH-BEH-2015053085$CSL BEHRING$$11$YR$C$M$Y$30$KG$20221212$$HP$US$PH
127208505$12720850$5$F$20140101$20221129$20160907$20221202$EXP$$US-JAZZ-2016-US-016598$JAZZ$$$$$F$Y$$$20221202$$CN$US$US
127219635$12721963$5$F$20160824$20221220$20160907$20221227$PER$$US-PFIZER INC-2016409271$PFIZER$$57$YR$$M$Y$92$KG$20221227$$MD$US$US
127247949$12724794$9$F$20160822$20221208$20160908$20221215$EXP$$AU-PFIZER INC-2016407637$PFIZER$$71$YR$$F$Y$101$KG$20221215$$MD$AU$AU
127255474$12725547$4$F$20160101$20221206$20160908$20221212$EXP$$US-JAZZ-2016-US-016834$JAZZ$$$$$F$Y$$$20221212$$MD$US$US
1272747531$12727475$31$F$20160609$20221125$20160909$20221202$EXP$$CA-ROCHE-1827432$ROCHE$$62$YR$$F$Y$74$KG$20221202$$CN$CA$CA
1272907414$12729074$14$F$20160705$20221202$20160909$20221207$EXP$$CA-TAKEDA-2016TUS012100$TAKEDA$$45$YR$$F$Y$$$20221207$$HP$CA$CA
127319598$12731959$8$F$20150101$20221028$20160912$20221102$EXP$$US-PFIZER INC-2016427778$PFIZER$$72$YR$$F$Y$68.027$KG$20221102$$CN$US$US
1273810627$12738106$27$F$20150414$20221116$20160913$20221123$EXP$$FI-SA-2015SA076433$SANOFI AVENTIS$$42$YR$A$M$Y$91.9$KG$20221123$$MD$FI$FI
127435816$12743581$6$F$20160822$20221215$20160914$20221222$EXP$$JP-INCYTE CORPORATION-2016IN005568$INCYTE$$$$$$Y$$$20221222$$MD$JP$JP
1275802011$12758020$11$F$20160101$20221107$20160919$20221111$EXP$$US-PFIZER INC-2016434097$PFIZER$$83$YR$$F$Y$$$20221111$$CN$US$US
127650047$12765004$7$F$20140801$20221130$20160921$20221208$EXP$$CA-ROCHE-1832465$ROCHE$$51$YR$$M$Y$$$20221208$$MD$CA$CA
127674619$12767461$9$F$$20221206$20160921$20221207$EXP$$US-PFIZER INC-2016422273$PFIZER$$74$YR$$F$Y$59.864$KG$20221207$$MD$US$US
127715263$12771526$3$F$20050424$20221201$20160922$20221209$EXP$$US-BIOGEN-2008BI026805$BIOGEN$$42$YR$$F$Y$$$20221209$$CN$US$US
127726833$12772683$3$F$$20221118$20160922$20221122$EXP$$PHHY2015CA105683$NOVARTIS$$$$$F$Y$$$20221122$$MD$CA$CA
1277328617$12773286$17$F$20160101$20221028$20160922$20221104$EXP$$CA-TAKEDA-2016TUS016639$TAKEDA$$52$YR$$F$Y$$$20221104$$MD$CA$CA
1277437223$12774372$23$F$$20220325$20160923$20221222$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076813$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221223$$HP$CA$CA
1277463014$12774630$14$F$20160531$20180626$20160923$20221028$EXP$$PHHY2016US126962$NOVARTIS$$12$YR$$F$Y$53.3$KG$20221028$$MD$US$US
1277830949$12778309$49$F$$20221207$20160926$20221215$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075856$BRISTOL MYERS SQUIBB$$42$YR$A$F$Y$97$KG$20221215$$HP$CA$CA
1278124222$12781242$22$F$20150101$20221128$20160926$20221205$EXP$$PHHY2015CA109453$NOVARTIS$$65$YR$$F$Y$$$20221205$$CN$CA$CA
127827902$12782790$2$F$20100101$20221205$20160927$20221223$PER$$US-BIOGEN-2016BI00294221$BIOGEN$$$$$F$Y$77.1$KG$20221223$$CN$US$US
1278807624$12788076$24$F$20150729$20221031$20160928$20221111$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077476$BRISTOL MYERS SQUIBB$$41$YR$A$M$Y$90$KG$20221111$$HP$CA$CA
127891172$12789117$2$F$20160904$20221101$20160928$20221102$PER$$US-SHIRE-US201612229$TAKEDA$$48$YR$$F$Y$$$20221102$$MD$US$US
127900308$12790030$8$F$$20221115$20160928$20221121$EXP$$BR-PFIZER INC-2016448927$PFIZER$$41$YR$$M$Y$$$20221121$$CN$BR$BR
1279156719$12791567$19$F$20160916$20221122$20160929$20221129$EXP$$CA-ROCHE-1835532$ROCHE$$40$YR$$M$Y$$$20221129$$CN$CA$CA
127924905$12792490$5$F$20080201$20220929$20160929$20221012$PER$$US-JNJFOC-20160916929$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221010$$LW$US$US
127966189$12796618$9$F$20160826$20221212$20160929$20221215$EXP$$US-PFIZER INC-2016407480$PFIZER$$42$YR$$F$Y$92$KG$20221215$$MD$US$US
127971963$12797196$3$F$20160801$20221118$20160930$20221123$PER$$US-PFIZER INC-2016456524$PFIZER$$64$YR$$F$Y$49.9$KG$20221123$$HP$US$US
1279748818$12797488$18$F$20140610$20221026$20160930$20221031$EXP$$PHHY2011CA40965$NOVARTIS$$79$YR$$F$Y$$$20221031$$HP$CA$CA
1279856612$12798566$12$F$20120625$20221109$20160930$20221124$EXP$$FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-124801$RANBAXY$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H et al. Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study. Encephale. 2016;13 Sep:Epub ahead of print$34$YR$$M$Y$$$20221124$$MD$FR$FR
128004404$12800440$4$F$20140101$20221010$20160930$20221014$EXP$$US-JAZZ-2016-US-018638$JAZZ$$$$$F$Y$$$20221014$$CN$US$US
128044032$12804403$2$F$$20160923$20161003$20221003$EXP$$PHHY2016US132664$NOVARTIS$Williams JR, Tenforde MW, Chan JD, Ko A, Graham SM. Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection. MEDICAL MYCOLOGY CASE REPORTS. 2016;13:1-4$71$YR$$F$Y$$$20221003$$HP$US$US
1280942514$12809425$14$F$20160903$20221004$20161005$20221007$EXP$$CA-TAKEDA-2016TUS017672$TAKEDA$$63$YR$$M$Y$$$20221007$$CN$CA$CA
1282551316$12825513$16$F$20221017$20221026$20161006$20221102$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144027$GLAXOSMITHKLINE$$$$$$Y$$$20221102$$CN$BR$BR
128268562$12826856$2$F$$20220318$20161006$20221014$PER$$US-INDIVIOR LIMITED-INDV-088194-2016$RECKITT BENCKISER$$$$$M$Y$$$20221014$$CN$US$US
128413273$12841327$3$F$20161005$20221111$20161012$20221114$EXP$$JP-B.I. Pharmaceuticals,Inc./Ridgefield-2016-NB-000137$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$66.4$KG$20221114$$MD$JP$JP
128415612$12841561$2$F$20000711$20221213$20161012$20221219$EXP$$US-JNJFOC-20161006407$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221219$$HP$US$US
1284257851$12842578$51$F$$20221222$20161013$20221227$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-1958$ORION$$63$YR$A$F$Y$$$20221228$$MD$CA$
128452457$12845245$7$F$20170101$20221019$20161013$20221021$EXP$$CA-TAKEDA-2016TUS013310$TAKEDA$$53$YR$$M$Y$$$20221021$$MD$CA$CA
1284910512$12849105$12$F$20160921$20221116$20161014$20221122$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-084065$BRISTOL MYERS SQUIBB$$86$YR$E$F$Y$78$KG$20221122$$CN$CA$CA
128540802$12854080$2$F$20080101$20220928$20161017$20221006$EXP$$US-JNJFOC-20161009352$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221006$$HP$US$US
1285693810$12856938$10$F$20160901$20221201$20161018$20221206$PER$$US-PFIZER INC-2016482587$PFIZER$$62$YR$$M$Y$74$KG$20221206$$CN$US$US
128592433$12859243$3$F$20161010$20221031$20161018$20221101$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-085274$BRISTOL MYERS SQUIBB$Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, et al. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell richter transformation of CLL. Blood Advances. 2022; 1-24.doi:10.1182/bloodadvances.2022008790.$$$$M$Y$$$20221102$$MD$US$US
128598976$12859897$6$F$20160725$20221123$20161018$20221123$EXP$$US-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-066895$BOEHRINGER INGELHEIM$$90$YR$E$M$Y$70.8$KG$20221123$$MD$US$US
128620415$12862041$5$F$20160829$20170119$20161019$20221211$EXP$$FR-TEVA-704749ACC$TEVA$$71$YR$E$M$Y$$$20221212$$HP$FR$FR
128630377$12863037$7$F$20160901$20221215$20161019$20221221$PER$$US-PFIZER INC-2016487980$PFIZER$$64$YR$$M$Y$90.703$KG$20221221$$HP$US$US
128639229$12863922$9$F$20201231$20221228$20161019$20221230$EXP$$CA-TAKEDA-2016TUS018720$TAKEDA$$49$YR$$F$Y$$$20221230$$CN$CA$CA
128640405$12864040$5$F$20150601$20221024$20161019$20221029$EXP$$US-SHIRE-US201614677$TAKEDA$$44$YR$$F$Y$107.4$KG$20221029$$CN$US$US
128672216$12867221$6$F$20160101$20221212$20161020$20221220$EXP$$US-JAZZ-2016-US-014683$JAZZ$$$$$F$Y$$$20221220$$HP$US$US
128694655$12869465$5$F$20221030$20221215$20161021$20221222$EXP$$PHHY2016CA141723$NOVARTIS$$60$YR$$F$Y$$$20221222$$CN$CA$CA
128702817$12870281$7$F$20151105$20221221$20161021$20221226$EXP$$FR-GLAXOSMITHKLINE-FR2016GSK150405$GLAXOSMITHKLINE$$$$$$Y$$$20221226$$MD$FR$FR
128714059$12871405$9$F$20101124$20221222$20161021$20221223$EXP$$US-NAPPMUNDI-USA-2016-0131102$PURDUE$$70$YR$$M$Y$220$KG$20221223$$CN$US$US
128731326$12873132$6$F$20160531$20161219$20161021$20221031$EXP$$PHHO2016US013356$NOVARTIS$$12$YR$$F$Y$50.1$KG$20221031$$MD$US$US
128754122$12875412$2$F$20081209$20221206$20161024$20221213$EXP$$US-ROCHE-606607$ROCHE$$62$YR$$F$Y$$$20221213$$MD$US$US
1287853810$12878538$10$F$20151120$20221115$20161024$20221116$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-029278$BRISTOL MYERS SQUIBB$Ishii D, et al. A case of renal disorder during nivolumab therapy. The Japanese Journal of Nephrology 2017;59(6):914.$79$YR$E$M$Y$50$KG$20221116$$MD$JP$JP
1287997515$12879975$15$F$20161101$20221123$20161025$20221128$EXP$$US-PFIZER INC-2016495242$PFIZER$$83$YR$$F$Y$72$KG$20221128$$CN$US$US
128803473$12880347$3$F$20160901$20221216$20161025$20221222$EXP$$US-PFIZER INC-2016489834$PFIZER$$65$YR$$F$Y$99.34$KG$20221222$$CN$US$US
128813593$12881359$3$F$20070101$20220926$20161025$20221005$PER$$US-JNJFOC-20150713734$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221005$$HP$US$US
128814264$12881426$4$F$$20220922$20161025$20221002$PER$$US-JNJFOC-20161011983$JOHNSON AND JOHNSON$$$$$M$Y$$$20221002$$HP$US$US
128814453$12881445$3$F$20061001$20220922$20161025$20221003$EXP$$US-JNJFOC-20161011989$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221003$$HP$US$US
128814466$12881446$6$F$20060901$20221020$20161025$20221027$EXP$$US-JNJFOC-20161011990$JOHNSON AND JOHNSON$$21$YR$A$M$Y$128.94$KG$20221027$$HP$US$US
128814504$12881450$4$F$20030301$20221020$20161025$20221028$PER$$US-JNJFOC-20161011992$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221028$$HP$US$US
128815225$12881522$5$F$20061201$20221014$20161025$20221018$PER$$US-JNJFOC-20161012337$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20221018$$HP$US$US
128815334$12881533$4$F$20080401$20220922$20161025$20221001$PER$$US-JNJFOC-20161012352$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221001$$HP$US$US
128826632$12882663$2$F$20161005$20221116$20161025$20221121$PER$$US-PFIZER INC-2016495644$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
128890973$12889097$3$F$20220701$20221025$20161027$20221031$EXP$$US-PFIZER INC-2016495265$PFIZER$$58$YR$$F$Y$$$20221031$$CN$US$US
1289195012$12891950$12$F$$20220921$20161028$20221003$EXP$$CA-APOPHARMA INC-2016AP013468$APOTEX$$58$YR$$M$Y$$$20221003$$HP$CA$CA
128946893$12894689$3$F$$20221006$20161028$20221011$EXP$$KR-SA-2016SA192117$SANOFI AVENTIS$Kim H, Bang ES, Lim S-K, Lee JM.. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: Case report.. Int J Clin Pharmacol Ther.. 2016;54(10):808-15.$25$YR$A$F$Y$40$KG$20221011$$PH$KR$KR
128981617$12898161$7$F$20161010$20221206$20161031$20221208$EXP$$CA-TAKEDA-2016TUS019342$TAKEDA$$51$YR$$M$Y$$$20221208$$CN$CA$CA
129015668$12901566$8$F$20161025$20221116$20161102$20221122$EXP$$DE-ROCHE-1848167$ROCHE$$67$YR$$M$Y$$$20221122$$MD$DE$
1290698912$12906989$12$F$20160725$20221223$20161103$20221229$EXP$$PHHY2016CA148830$NOVARTIS$$58$YR$$M$Y$$$20221229$$CN$CA$CA
129082513$12908251$3$F$$20220921$20161103$20221004$EXP$$JP-PFIZER INC-2016511210$PFIZER$Urae, S.. Tumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the Literature. Internal Medicine. 2016;55 (20):3029-3034$77$YR$$M$Y$$$20221004$$MD$JP$JP
1291173227$12911732$27$F$20180614$20221214$20161104$20221220$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144075$GLAXOSMITHKLINE$$$$$$Y$$$20221220$$CN$BR$BR
129132333$12913233$3$F$$20220921$20161104$20221004$EXP$$JP-PFIZER INC-2016511338$PFIZER$Yang, S.. Steroid-induced tumor lysis symdrome in a patient with preleukemia. Clinical Nephrology. 2003;59 (3):201-205$32$YR$$M$Y$$$20221004$$MD$TW$TW
129132746$12913274$6$F$20160425$20221129$20161104$20221206$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-035678$BRISTOL MYERS SQUIBB$$69$YR$E$F$Y$$$20221206$$CN$CA$CA
1291330611$12913306$11$F$$20221201$20161104$20221206$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091788$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221206$$MD$CA$CA
1291742713$12917427$13$F$20180101$20220928$20161107$20221012$EXP$$US-PFIZER INC-2016514720$MYLAN$$$$$F$Y$97$KG$20221012$$HP$US$US
129175146$12917514$6$F$20150701$20221206$20161107$20221213$EXP$$PHHY2015CA089817$NOVARTIS$$41$YR$$F$Y$$$20221213$$CN$CA$CA
1292320724$12923207$24$F$20201127$20221124$20161109$20221129$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK044940$GLAXOSMITHKLINE$$$$$$Y$$$20221129$$CN$BR$BR
129235696$12923569$6$F$20160821$20221004$20161108$20221012$EXP$$BR-BIOGEN-2016BI00315184$BIOGEN$$0$YR$$M$Y$2.85$KG$20221012$$CN$BR$BR
129272294$12927229$4$F$20161001$20221206$20161109$20221212$EXP$$US-JAZZ-2016-US-021819$JAZZ$$56$YR$$F$Y$$$20221213$$CN$US$US
1292783615$12927836$15$F$20130417$20221013$20161110$20221020$EXP$$CA-ROCHE-1851729$ROCHE$$49$YR$$F$Y$$$20221020$$CN$CA$CA
1292888834$12928888$34$F$$20220728$20161110$20221222$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091881$BRISTOL MYERS SQUIBB$$55$YR$A$F$Y$$$20221222$$HP$CA$CA
1292888921$12928889$21$F$$20221020$20161110$20221026$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-091709$BRISTOL MYERS SQUIBB$$66$YR$E$F$Y$$$20221026$$MD$CA$CA
129293364$12929336$4$F$20160528$20221229$20161110$20221230$EXP$$FR-009507513-1611FRA003790$MERCK$$79$YR$$M$Y$103.5$KG$20221230$$HP$FR$FR
129301778$12930177$8$F$$20221020$20161110$20221025$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-093180$BRISTOL MYERS SQUIBB$$62$YR$A$F$Y$$$20221025$$CN$CA$CA
129321032$12932103$2$F$20161104$20221006$20161111$20221013$EXP$$ES-ROCHE-1853276$ROCHE$$74$YR$$M$Y$66$KG$20221011$$MD$ES$ES
129402602$12940260$2$F$20160317$20221105$20161115$20221118$EXP$$IT-AUROBINDO-AUR-APL-2016-13847$AUROBINDO$$48$YR$$F$Y$$$20221118$$MD$IT$IT
129431622$12943162$2$F$$20151002$20161115$20221020$PER$$US-NOVOPROD-466507$NOVO NORDISK$$40$YR$$F$Y$$$20221020$$MD$US$US
129432722$12943272$2$F$$20160225$20161115$20221020$PER$$US-NOVOPROD-482415$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
129432752$12943275$2$F$$20160121$20161115$20221020$PER$$US-NOVOPROD-482122$NOVO NORDISK$$60$YR$$F$Y$$$20221020$$CN$US$US
129433102$12943310$2$F$20160716$20160718$20161115$20221020$PER$$US-NOVOPROD-503338$NOVO NORDISK$$86$YR$$F$Y$$$20221020$$CN$US$US
129433212$12943321$2$F$20160701$20160727$20161115$20221020$PER$$US-NOVOPROD-504848$NOVO NORDISK$$58$YR$$F$Y$$$20221020$$CN$US$US
129433222$12943322$2$F$20150101$20160616$20161115$20221020$PER$$US-NOVOPROD-498599$NOVO NORDISK$$71$YR$$F$Y$$$20221020$$MD$US$US
1294337732$12943377$32$F$20220401$20221111$20161115$20221114$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK075816$GLAXOSMITHKLINE$$$$$$Y$$$20221114$$MD$BR$BR
129460879$12946087$9$F$$20221227$20161115$20221230$EXP$$US-JAZZ-2016-US-022236$JAZZ$$$$$M$Y$$$20221230$$MD$US$US
1294773419$12947734$19$F$20150101$20221026$20161117$20221102$EXP$$CA-ROCHE-1854413$ROCHE$$61$YR$$F$Y$141$KG$20221102$$MD$CA$CA
1294979814$12949798$14$F$20150901$20221221$20161117$20221228$EXP$$PHHY2016CA114428$NOVARTIS$$52$YR$$F$Y$$$20221228$$MD$CA$CA
1295427710$12954277$10$F$20160328$20221031$20161118$20221102$EXP$$JP-SHIRE-JP201616794AA$TAKEDA$$0$YR$$F$Y$5.4$KG$20221102$$MD$JP$JP
129565822$12956582$2$F$$20221128$20161118$20221202$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034$BOEHRINGER INGELHEIM$$40$YR$A$F$Y$94$KG$20221202$$PH$CA$CA
1295753112$12957531$12$F$20111201$20221207$20161118$20221212$EXP$$US-SHIRE-US201617384$TAKEDA$$1$YR$$M$Y$29$KG$20221212$$HP$US$US
129575899$12957589$9$F$20130101$20221020$20161118$20221026$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-093145$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$$$20221027$$MD$CA$CA
129582968$12958296$8$F$$20221124$20161121$20221227$EXP$$CA-ROCHE-1627311$ROCHE$$40$YR$$F$Y$$$20221227$$MD$CA$
1296415627$12964156$27$F$20160310$20221206$20161122$20221213$EXP$$PHHY2016CA034937$NOVARTIS$$71$YR$$F$Y$$$20221213$$CN$CA$CA
1296897411$12968974$11$F$$20221128$20161123$20221201$PER$$US-PFIZER INC-2016545465$PFIZER$$72$YR$$F$Y$56.689$KG$20221201$$CN$US$US
1296928613$12969286$13$F$20160101$20221221$20161123$20221222$EXP$$PHHY2016CA151435$NOVARTIS$$67$YR$$M$Y$$$20221222$$CN$CA$CA
1297160410$12971604$10$F$20160501$20221027$20161123$20221102$EXP$$US-JAZZ-2016-US-023004$JAZZ$$38$YR$$M$Y$$$20221102$$MD$US$US
129740596$12974059$6$F$20161117$20221012$20161124$20221013$EXP$$FR-ROCHE-1858054$ROCHE$$71$YR$$M$Y$80$KG$20221013$$MD$FR$FR
1297420329$12974203$29$F$20141127$20221222$20161125$20221227$EXP$$CA-ROCHE-1858307$ROCHE$$42$YR$$F$Y$$$20221227$$CN$CA$CA
1297591114$12975911$14$F$20110101$20220928$20161125$20221006$EXP$$GB-MYLANLABS-2016M1035518$MYLAN$$44$YR$$F$Y$114$KG$20221006$$MD$GB$GB
1297671514$12976715$14$F$20200109$20221015$20161128$20221021$EXP$$PHHY2016CA084468$NOVARTIS$$86$YR$$M$Y$$$20221021$$CN$CA$CA
129781427$12978142$7$F$$20221214$20161128$20221222$PER$$US-PFIZER INC-2016448534$PFIZER$$62$YR$$F$Y$$$20221222$$HP$US$US
1297914824$12979148$24$F$20221011$20221026$20161128$20221031$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK087434$GLAXOSMITHKLINE$$$$$$Y$$$20221031$$CN$BR$BR
129816348$12981634$8$F$20190719$20221212$20161129$20221219$EXP$$CA-ROCHE-1860859$ROCHE$$39$YR$$M$Y$$$20221219$$HP$CA$CA
1298165814$12981658$14$F$20160927$20221027$20161129$20221103$EXP$$CA-ROCHE-1860260$ROCHE$$52$YR$$F$Y$$$20221103$$CN$CA$CA
129849016$12984901$6$F$$20221104$20161129$20221108$EXP$$US-PURDUE-USA-2016-0134131$PURDUE$$$$$F$Y$67.59$KG$20221108$$MD$US$US
129879488$12987948$8$F$20160101$20221005$20161130$20221010$EXP$$US-BAXALTA-2016BLT008577$TAKEDA$$$$$F$Y$91$KG$20221010$$HP$US$US
129889867$12988986$7$F$$20221216$20161201$20221221$EXP$$CA-ROCHE-1860198$ROCHE$$$$$M$Y$$$20221221$$HP$CA$
129907712$12990771$2$F$$20221221$20161201$20221230$EXP$$CA-JNJFOC-20161128255$JOHNSON AND JOHNSON$$52$YR$A$F$Y$63.56$KG$20221230$$HP$CA$CA
1299241836$12992418$36$F$20161123$20220930$20161202$20221013$EXP$$CA-ROCHE-1862239$ROCHE$$53$YR$$F$Y$$$20221013$$CN$CA$CA
129925948$12992594$8$F$20161101$20221214$20161202$20221221$PER$$JP-AMGEN-JPNSP2016152588$AMGEN$$47$YR$A$M$Y$85$KG$20221221$$MD$JP$JP
1299455328$12994553$28$F$20160101$20221114$20161202$20221119$EXP$$PHHY2016CA074240$NOVARTIS$$$$$M$Y$$$20221119$$CN$CA$CA
129975195$12997519$5$F$20140212$20221212$20161205$20221215$EXP$$CA-ROCHE-1342887$ROCHE$$63$YR$$F$Y$82.8$KG$20221214$$HP$CA$
1299861416$12998614$16$F$20160614$20221221$20161205$20221227$EXP$$GB-TAKEDA-2016TUS021619$TAKEDA$$$$A$M$Y$$$20221227$$MD$GB$GB
129997106$12999710$6$F$20161116$20221117$20161205$20221121$EXP$$PHHY2016CA166327$NOVARTIS$$32$YR$$M$Y$$$20221121$$CN$CA$CA
130007592$13000759$2$F$20161003$20221105$20161206$20221119$EXP$$IT-AUROBINDO-AUR-APL-2016-14713$AUROBINDO$$51$YR$$F$Y$$$20221119$$MD$IT$IT
1300136918$13001369$18$F$20160101$20220929$20161206$20221001$EXP$$PHHY2016CA114488$NOVARTIS$$$$$F$Y$75$KG$20221001$$CN$CA$CA
130036203$13003620$3$F$20160528$20221221$20161206$20221228$EXP$$FR-ELI_LILLY_AND_COMPANY-FR201611009644$ELI LILLY AND CO$$79$YR$$M$Y$103.5$KG$20221228$$CN$FR$FR
130036768$13003676$8$F$$20221208$20161206$20221208$EXP$$US-PFIZER INC-2015308077$PFIZER$$63$YR$$F$Y$73.8$KG$20221208$$CN$US$US
130040622$13004062$2$F$$20161031$20161206$20221026$PER$$US-JAZZ-2016-US-021669$JAZZ$$$$$M$Y$$$20221026$$HP$US$US
130041264$13004126$4$F$$20221227$20161206$20221229$EXP$$US-JAZZ-2016-US-021749$JAZZ$$$$$F$Y$$$20221229$$HP$US$US
130049454$13004945$4$F$20120625$20221109$20161207$20221121$EXP$FR-MLMSERVICE-20161123-0509896-1$FR-LUPIN PHARMACEUTICALS INC.-2016-05377$LUPIN$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H et al. Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study. Encephale. 2016$34$YR$$M$Y$$$20221121$$MD$FR$FR
130076682$13007668$2$F$20160818$20220927$20161207$20221003$PER$$US-AMGEN-USASL2016172854$AMGEN$$68$YR$E$F$Y$$$20221003$$CN$US$US
130099103$13009910$3$F$20140720$20221227$20161208$20221230$EXP$$PHHY2014IN084165$NOVARTIS$$34$YR$$F$Y$$$20221230$$CN$IN$IN
1301226122$13012261$22$F$20170823$20221227$20161209$20221230$EXP$$US-PFIZER INC-2016561839$PFIZER$$57$YR$$F$Y$114$KG$20221230$$CN$US$US
130177477$13017747$7$F$$20221107$20161212$20221111$EXP$$US-PFIZER INC-2016564692$PFIZER$$83$YR$$F$Y$$$20221111$$CN$US$US
1302193810$13021938$10$F$20120623$20221103$20161213$20221117$EXP$$FR-AUROBINDO-AUR-APL-2016-15207$AUROBINDO$Cuny P, Houot M, Ginisty S, Horowicz S, Plassart F, Mentec H, Eftekhari  P. et al. Quetiapine and anticholinergic drugs induced ischaemic colitis. A case study Encephale. 2016;43:81-84$34$YR$$M$Y$$$20221117$$MD$FR$FR
1302369512$13023695$12$F$20151222$20221007$20161213$20221013$EXP$$US-PFIZER INC-2016571070$PFIZER$$68$YR$$M$Y$84$KG$20221013$$CN$US$US
1302401114$13024011$14$F$20161101$20211116$20161213$20221212$EXP$$US-PFIZER INC-2016569208$PFIZER$$40$YR$$F$Y$$$20221212$$CN$US$US
130301234$13030123$4$F$$20221107$20161215$20221117$EXP$$PHJP2016JP036265$NOVARTIS$$$$A$M$Y$$$20221117$$MD$JP$JP
1303510110$13035101$10$F$20050201$20221012$20161216$20221018$EXP$$US-PFIZER INC-2016579864$PFIZER$$63$YR$$M$Y$95$KG$20221018$$CN$US$US
130358825$13035882$5$F$20130201$20221006$20161216$20221007$PER$$US-PFIZER INC-2016584425$PFIZER$$60$YR$$F$Y$112$KG$20221007$$CN$US$US
130369477$13036947$7$F$20160101$20221219$20161216$20221223$EXP$$CA-TAKEDA-2016TUS021434$TAKEDA$$48$YR$$F$Y$$$20221223$$CN$CA$CA
1303863515$13038635$15$F$20151228$20221011$20161219$20221019$EXP$$JP-AEGERION PHARMACEUTICAL INC.-AEGR002872$AEGERION$$$$$$Y$$$20221019$$MD$JP$JP
130420884$13042088$4$F$20120601$20221001$20161219$20221004$PER$$US-PFIZER INC-2016584349$PFIZER$$31$YR$$F$Y$111.1$KG$20221004$$LW$US$US
130469199$13046919$9$F$20220101$20221004$20161220$20221010$EXP$$PHHY2016CA172480$NOVARTIS$$60$YR$$M$Y$$$20221010$$CN$CA$CA
130476542$13047654$2$F$20161101$20221117$20161220$20221125$EXP$$US-JAZZ-2016-US-023967$JAZZ$$75$YR$$M$Y$$$20221125$$CN$US$US
130483473$13048347$3$F$20161129$20221129$20161221$20221208$EXP$$JP-TEVA-721834ISR$TEVA$$35$YR$A$F$Y$$$20221208$$MD$JP$JP
1305843511$13058435$11$F$$20221220$20161223$20221230$EXP$$CA-APOTEX-2016AP015741$APOTEX$$73$YR$$F$Y$$$20221230$$MD$CA$CA
130586493$13058649$3$F$20120301$20221005$20161223$20221006$PER$$US-PFIZER INC-2016596189$PFIZER$$42$YR$$F$Y$$$20221006$$LW$US$US
1305905611$13059056$11$F$$20221122$20161223$20221202$EXP$$CA-APOTEX-2016AP015753$APOTEX$$72$YR$$F$Y$$$20221202$$MD$CA$CA
130595802$13059580$2$F$$20221014$20161223$20221017$EXP$$ES-GLAXOSMITHKLINE-ES2016GSK189344$GLAXOSMITHKLINE$Ventura-Ribes O, Machancoses FH, Rosel Remirez JF. Vasculitis after blood pressure monitoring. Reumatol-Clin. 2016;12(4):216-218$80$YR$$M$Y$$$20221017$$HP$ES$ES
130598962$13059896$2$F$20101225$20221003$20161223$20221010$EXP$IT-MINISAL02-387319$IT-MYLANLABS-2016M1056156$MYLAN$Annaloro C, Costa A, Fracchiolla NS, Mometto G, Artuso S, Saporiti G, et al. Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: A case report.. Clinical Case Reports. 2015;3 (7):650-5$55$YR$$M$Y$$$20221010$$HP$IT$IT
130623974$13062397$4$F$20160101$20221214$20161226$20221222$EXP$$CA-TAKEDA-2016TUS022808$TAKEDA$$85$YR$$F$Y$$$20221222$$HP$CA$CA
1306563712$13065637$12$F$20090222$20221205$20161227$20221209$EXP$$US-PFIZER INC-2016595970$PFIZER$$59$YR$$F$Y$73$KG$20221209$$CN$US$US
1307079914$13070799$14$F$20090209$20221227$20161229$20221230$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-2790$ORION$$57$YR$A$M$Y$$$20221230$$MD$CA$
1307383416$13073834$16$F$20161128$20221213$20161229$20221217$EXP$$CA-TAKEDA-2016TUS023148$TAKEDA$$67$YR$$F$Y$$$20221217$$CN$CA$CA
130748976$13074897$6$F$20161214$20221220$20161230$20221227$PER$$US-PFIZER INC-2016596467$PFIZER$$35$YR$$M$Y$104$KG$20221227$$MD$US$US
130753587$13075358$7$F$20150603$20221006$20161230$20221011$EXP$$US-AstraZeneca-2016SF36386$ASTRAZENECA$$82$YR$$M$Y$83.5$KG$20221011$$LW$US$
1307700011$13077000$11$F$20161206$20221219$20161230$20221230$EXP$$CZ-BIOGEN-2016BI00328821$BIOGEN$$29$YR$$M$Y$$$20221230$$MD$CZ$CZ
130804845$13080484$5$F$$20220929$20170103$20221006$EXP$$CA-PFIZER INC-2016523517$PFIZER$$35$YR$$F$Y$$$20221006$$CN$CA$CA
130810228$13081022$8$F$$20221005$20170103$20221007$PER$$US-PFIZER INC-2016601370$PFIZER$$65$YR$$F$Y$$$20221007$$CN$US$US
1308165710$13081657$10$F$20080101$20221229$20170103$20221230$EXP$$US-PFIZER INC-2016598166$PFIZER$$38$YR$$F$Y$49.9$KG$20221230$$CN$US$US
130846534$13084653$4$F$20160912$20170118$20170104$20221212$EXP$IT-MINISAL02-389561$IT-TEVA-725686ACC$TEVA$$43$YR$A$F$Y$$$20221212$$MD$IT$IT
1308545212$13085452$12$F$$20221208$20170104$20221215$EXP$$US-PFIZER INC-2015269766$PFIZER$$83$YR$$F$Y$55$KG$20221215$$MD$US$US
130877668$13087766$8$F$20100329$20220930$20170105$20221008$EXP$$US-AstraZeneca-2017SE00122$ASTRAZENECA$$18575$DY$$F$Y$113.9$KG$20221008$$LW$US$
130895609$13089560$9$F$20201123$20221129$20170105$20221201$PER$$US-PFIZER INC-2017004247$PFIZER$$66$YR$$M$Y$71$KG$20221201$$CN$US$US
1309076910$13090769$10$F$$20221025$20170106$20221109$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-130668$RANBAXY$$30$YR$$M$Y$$$20221109$$PH$GB$GB
1309116614$13091166$14$F$$20221215$20170106$20221228$EXP$$GB-AUROBINDO-AUR-APL-2016-16077$AUROBINDO$$30$YR$$M$Y$$$20221228$$PH$GB$GB
130939163$13093916$3$F$20221101$20221215$20170106$20221221$EXP$$US-PFIZER INC-2016010159$PFIZER$$62$YR$$F$Y$$$20221221$$HP$US$US
1309437313$13094373$13$F$20181201$20221215$20170106$20221221$EXP$$US-PFIZER INC-2017005477$PFIZER$$63$YR$$F$Y$65.76$KG$20221221$$HP$US$US
130954754$13095475$4$F$$20221010$20170108$20221017$EXP$$GB-MYLANLABS-2017M1000526$MYLAN$$$$$M$Y$$$20221017$$MD$GB$GB
130955484$13095548$4$F$$20221222$20170108$20221227$EXP$$US-BIOGEN-2017BI00338624$BIOGEN$$$$$F$Y$$$20221227$$CN$US$US
1309595312$13095953$12$F$20160226$20221104$20170109$20221110$EXP$$CA-ROCHE-1782427$ROCHE$$$$A$F$Y$123.5$KG$20221110$$MD$CA$CA
130970466$13097046$6$F$20161208$20221212$20170109$20221219$PER$$US-PFIZER INC-2017007183$PFIZER$$65$YR$$F$Y$98$KG$20221219$$CN$US$US
131000368$13100036$8$F$$20221130$20170110$20221205$EXP$$CA-ROCHE-1877137$ROCHE$$69$YR$$F$Y$$$20221205$$MD$CA$
1310187616$13101876$16$F$20170101$20221031$20170110$20221102$EXP$$US-PFIZER INC-2017006260$PFIZER$$72$YR$$F$Y$73.3$KG$20221102$$CN$US$US
131044923$13104492$3$F$$20221212$20170111$20221216$PER$$US-BIOGEN-2017BI00340115$BIOGEN$$$$$F$Y$$$20221216$$CN$US$US
1310615211$13106152$11$F$20161209$20221207$20170111$20221213$PER$$US-PFIZER INC-2017007803$PFIZER$$61$YR$$M$Y$95.25$KG$20221213$$MD$US$US
131070847$13107084$7$F$$20221121$20170111$20221124$EXP$$CA-ROCHE-1789917$ROCHE$$$$$F$Y$$$20221124$$MD$CA$
1310779811$13107798$11$F$20150612$20221220$20170112$20221226$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-0119$ORION$$73$YR$E$F$Y$$$20221226$$MD$CA$
131095753$13109575$3$F$20070101$20221109$20170112$20221114$EXP$$US-TAKEDA-2017TUS000775$TAKEDA$$$$$$Y$$$20221114$$CN$US$US
131115623$13111562$3$F$$20221118$20170112$20221125$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-000750$BRISTOL MYERS SQUIBB$Reuss JE, Kunk PR, Stowman AM, Gru AA, Slingluff CL, Gaughan EM. Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report andamp; review of the literature. Journal for ImmunoTherapy of cancer. 2016; 4(94): 1-6.doi:10.1186/s40425-016-0199-9.$32$YR$A$F$Y$$$20221125$$CN$US$US
1311187019$13111870$19$F$$20221121$20170113$20221122$EXP$$CA-ROCHE-1717236$ROCHE$$$$$F$Y$$$20221122$$MD$CA$
1311312211$13113122$11$F$$20221212$20170113$20221218$PER$$CA-AMGEN-CANSP2017001862$AMGEN$$58$YR$A$F$Y$$$20221218$$MD$CA$CA
1311313323$13113133$23$F$20130101$20221222$20170113$20221228$EXP$$CA-Orion Corporation ORION PHARMA-TREX2016-0862$ORION$$65$YR$E$F$Y$$$20221228$$MD$CA$
131135934$13113593$4$F$$20221213$20170113$20221214$EXP$$US-BIOGEN-2017BI00342151$BIOGEN$$$$$F$Y$$$20221214$$CN$US$US
131155734$13115573$4$F$20160101$20220721$20170114$20221026$PER$$US-JAZZ-2016-US-022692$JAZZ$$$$$F$Y$$$20221026$$CN$US$US
131162183$13116218$3$F$20161214$20221125$20170116$20221206$PER$$GB-AMGEN-GBRSP2016180759$AMGEN$$54$YR$A$F$Y$$$20221205$$CN$GB$GB
1311644513$13116445$13$F$$20220921$20170116$20221006$EXP$$CA-BAUSCH-BL-2017-001069$BAUSCH AND LOMB$$74$YR$$F$Y$$$20221006$$CN$CA$CA
131167729$13116772$9$F$$20221201$20170116$20221202$EXP$$CA-ROCHE-1878330$ROCHE$$57$YR$$F$Y$$$20221202$$MD$CA$
1311681612$13116816$12$F$$20221031$20170116$20221102$PER$$US-PFIZER INC-2017015915$PFIZER$$69$YR$$F$Y$$$20221102$$CN$US$US
131178844$13117884$4$F$20040101$20221012$20170116$20221020$PER$$US-JNJFOC-20170104055$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221021$$LW$US$US
131178983$13117898$3$F$$20221213$20170116$20221215$EXP$$US-JNJFOC-20170106074$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$HP$US$US
131200397$13120039$7$F$20100101$20221018$20170117$20221025$EXP$$US-AstraZeneca-2017SE02375$ASTRAZENECA$$57$YR$$F$Y$42.2$KG$20221025$$LW$US$
1312053711$13120537$11$F$20161201$20221208$20170117$20221213$PER$$US-PFIZER INC-2017013282$PFIZER$$75$YR$$F$Y$$$20221213$$CN$US$US
131205603$13120560$3$F$20140201$20221122$20170117$20221128$PER$$US-PFIZER INC-2017014247$PFIZER$$65$YR$$F$Y$64.853$KG$20221128$$CN$US$US
131215063$13121506$3$F$20161208$20221220$20170117$20221229$EXP$$CA-BIOGEN-2017BI00343393$BIOGEN$$49$YR$$F$Y$$$20221229$$MD$CA$CA
1312164812$13121648$12$F$$20221212$20170117$20221219$EXP$$CA-PFIZER INC-2017017327$PFIZER$$58$YR$$F$Y$$$20221219$$CN$CA$CA
131226566$13122656$6$F$20060101$20221128$20170117$20221206$EXP$$CA-SA-2016SA086812$SANOFI AVENTIS$$50$YR$A$M$Y$$$20221206$$MD$CA$CA
131237885$13123788$5$F$20070101$20221108$20170118$20221111$EXP$$US-AstraZeneca-2017SE03009$ASTRAZENECA$$444$MON$$M$Y$89.8$KG$20221111$$LW$US$
1312599736$13125997$36$F$20170110$20221206$20170118$20221213$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK017485$GLAXOSMITHKLINE$$$$$$Y$$$20221213$$CN$BR$BR
131299688$13129968$8$F$$20221028$20170119$20221101$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-002909$BRISTOL MYERS SQUIBB$$58$YR$A$F$Y$$$20221101$$MD$GB$GB
131307153$13130715$3$F$20150101$20221024$20170119$20221027$PER$$US-JAZZ-2017-US-000387$JAZZ$$$$$F$Y$$$20221027$$CN$US$US
1313143216$13131432$16$F$20170110$20220928$20170119$20221004$EXP$$IE-MYLANLABS-2017M1002906$MYLAN$$44$YR$$M$Y$$$20221004$$MD$IE$IE
131317407$13131740$7$F$20160701$20221215$20170119$20221220$EXP$$US-PFIZER INC-2017024415$PFIZER$$69$YR$$M$Y$$$20221220$$CN$US$US
1313261510$13132615$10$F$$20221218$20170120$20221220$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-0240$ORION$$58$YR$A$F$Y$$$20221220$$MD$CA$
131352782$13135278$2$F$$20221220$20170120$20221222$EXP$$US-PFIZER INC-2016308561$PFIZER$$67$YR$$F$Y$$$20221222$$CN$US$US
131357277$13135727$7$F$20160101$20221101$20170120$20221108$PER$$US-PFIZER INC-2017020229$PFIZER$$20$YR$$M$Y$113.4$KG$20221108$$CN$US$US
131393333$13139333$3$F$20161201$20221222$20170123$20221230$EXP$$FR-PFIZER INC-2017020968$PFIZER$$72$YR$$F$Y$100$KG$20221230$$MD$FR$FR
131403488$13140348$8$F$20170101$20221219$20170123$20221227$EXP$$US-PFIZER INC-2017030225$PFIZER$$76$YR$$F$Y$$$20221227$$CN$US$US
131422307$13142230$7$F$20161201$20221123$20170124$20221125$EXP$$CA-TAKEDA-2017TUS001307$TAKEDA$$66$YR$$M$Y$122$KG$20221125$$CN$CA$CA
131427527$13142752$7$F$20150420$20221212$20170124$20221219$EXP$$JP-PFIZER INC-2017028174$PFIZER$$31$YR$$F$Y$50$KG$20221219$$MD$JP$JP
1314326411$13143264$11$F$20160101$20221123$20170124$20221130$EXP$$FR-GLAXOSMITHKLINE-FR2016GSK093577$GLAXOSMITHKLINE$$$$$$Y$$$20221130$$HP$FR$FR
1314540416$13145404$16$F$$20221024$20170124$20221027$PER$$US-PFIZER INC-2017029857$PFIZER$$64$YR$$F$Y$$$20221027$$CN$US$US
1314726614$13147266$14$F$$20221206$20170125$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005239$BRISTOL MYERS SQUIBB$$49$YR$A$F$Y$73$KG$20221209$$CN$CA$CA
131502044$13150204$4$F$20170119$20221014$20170125$20221020$EXP$$US-SHIRE-US201701265$TAKEDA$$16$YR$$M$Y$$$20221019$$MD$US$US
131531928$13153192$8$F$$20221223$20170126$20221227$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005886$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20221228$$CN$CA$CA
1315320010$13153200$10$F$$20221129$20170126$20221201$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005842$BRISTOL MYERS SQUIBB$$64$YR$A$F$Y$$$20221201$$CN$CA$CA
131537144$13153714$4$F$$20221212$20170126$20221219$EXP$$CA-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-003440$BOEHRINGER INGELHEIM$$85$YR$E$M$Y$$$20221219$$MD$CA$CA
1315500814$13155008$14$F$$20221011$20170126$20221014$EXP$$US-PFIZER INC-2017029933$PFIZER$$75$YR$$F$Y$90.72$KG$20221014$$CN$US$US
131584894$13158489$4$F$20161101$20221218$20170127$20221221$EXP$$CA-TAKEDA-2016TUS021205$TAKEDA$$30$YR$$M$Y$$$20221221$$MD$CA$CA
131588424$13158842$4$F$$20170130$20170127$20221212$EXP$$DE-TEVA-732118GER$TEVA$$79$YR$E$F$Y$50$KG$20221212$$HP$DE$DE
1315892219$13158922$19$F$20070101$20221020$20170127$20221025$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005391$BRISTOL MYERS SQUIBB$$41$YR$A$F$Y$$$20221025$$HP$CA$CA
131656122$13165612$2$F$$20221129$20170131$20221205$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-004945$BRISTOL MYERS SQUIBB$$67$YR$E$F$Y$$$20221205$$CN$CA$CA
131675254$13167525$4$F$$20221130$20170131$20221205$PER$$US-PFIZER INC-2017040672$PFIZER$$44$YR$$F$Y$$$20221205$$CN$US$US
1316786110$13167861$10$F$$20221207$20170131$20221208$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-005498$BRISTOL MYERS SQUIBB$$59$YR$A$F$Y$58$KG$20221208$$CN$CA$CA
1317870811$13178708$11$F$$20221103$20170202$20221109$EXP$$CA-ROCHE-1886825$ROCHE$$51$YR$$F$Y$$$20221109$$HP$CA$
131790076$13179007$6$F$$20221220$20170202$20221227$PER$$US-PFIZER INC-2017045002$PFIZER$$58$YR$$M$Y$74.84$KG$20221227$$CN$US$US
131795173$13179517$3$F$20150915$20220929$20170202$20221006$EXP$$US-TAKEDA-2017TUS002251$TAKEDA$$24$YR$$F$Y$79.83$KG$20221006$$HP$US$US
131799375$13179937$5$F$20161130$20221222$20170202$20221228$EXP$$US-INCYTE CORPORATION-2017IN000613$INCYTE$$$$$$Y$$$20221228$$CN$US$US
131826877$13182687$7$F$20190801$20221109$20170203$20221111$EXP$$US-PFIZER INC-2017045478$PFIZER$$56$YR$$F$Y$$$20221111$$CN$US$US
131826984$13182698$4$F$20211001$20221208$20170203$20221215$PER$$US-PFIZER INC-2017045712$PFIZER$$64$YR$$F$Y$$$20221215$$CN$US$US
131830144$13183014$4$F$20130401$20221102$20170203$20221107$EXP$$US-009507513-1702USA001550$MERCK$$74$YR$$F$Y$68.027$KG$20221107$$CN$US$US
1318310313$13183103$13$F$20170101$20221020$20170203$20221028$EXP$$CA-TAKEDA-2017TUS002274$TAKEDA$$51$YR$$M$Y$$$20221028$$HP$CA$CA
1318771613$13187716$13$F$20160101$20221020$20170206$20221024$EXP$$US-PFIZER INC-2017047673$PFIZER$$85$YR$$F$Y$51.26$KG$20221024$$CN$US$US
1319115616$13191156$16$F$20161102$20220929$20170207$20221004$EXP$$CA-ROCHE-1889462$ROCHE$$60$YR$$M$Y$$$20221004$$MD$CA$CA
131914403$13191440$3$F$20150301$20221003$20170207$20221011$EXP$$FR-Accord-047915$ACCORD$Yapo Kouadio CG, Hasseine L, Goubaux B, Gari Toussaint M. (Disseminated fungal infection due to Magnusiomyces capitatus in a liver graft patient). J Mycol Med. 2016 Sep 26(3):261-4.$62$YR$A$M$Y$$$20221011$$HP$FR$FR
131932045$13193204$5$F$20170127$20221012$20170207$20221017$EXP$$JP-Eisai Medical Research-EC-2017-024575$EISAI$$73$YR$E$F$Y$59$KG$20221017$$MD$JP$
131943423$13194342$3$F$20161121$20220810$20170207$20221026$PER$$US-JAZZ-2016-US-023752$JAZZ$$31$YR$$M$Y$$$20221026$$HP$US$US
1319527628$13195276$28$F$20160606$20221109$20170208$20221118$EXP$$CA-ROCHE-1889780$ROCHE$$66$YR$$M$Y$85$KG$20221118$$MD$CA$CA
132005322$13200532$2$F$20160201$20221013$20170208$20221020$EXP$$PR-BIOGEN-2017BI00354587$BIOGEN$$55$YR$$F$Y$$$20221020$$CN$PR$PR
1320300811$13203008$11$F$$20220922$20170209$20221003$EXP$$US-PFIZER INC-2017054855$PFIZER$$69$YR$$F$Y$$$20221003$$HP$US$US
132079994$13207999$4$F$$20170220$20170209$20221212$EXP$$ES-TEVA-735074ISR$TEVA$$71$YR$E$F$Y$$$20221212$$HP$ES$ES
132134076$13213407$6$F$20150101$20221129$20170210$20221201$PER$$US-PFIZER INC-2017056695$PFIZER$$63$YR$$F$Y$75$KG$20221201$$HP$US$US
132135254$13213525$4$F$20170121$20221113$20170210$20221123$PER$$US-INCYTE CORPORATION-2017IN000639$INCYTE$$$$$$Y$$$20221123$$CN$US$US
1321461214$13214612$14$F$$20221025$20170210$20221101$EXP$$BE-PFIZER INC-2017059786$PFIZER$Heyrman, B.. A case report of immunosuppression-related Kaposi^s sarcoma after autologous stem cell transplantation. BMC Research Notes. 2016;9:188$61$YR$$M$Y$$$20221101$$HP$BE$BE
132246763$13224676$3$F$$20200520$20170213$20221219$EXP$$GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2017R1-132891$RANBAXY$Alghabra L, Iskandarani M. Spontaneous retroperitoneal haematoma resulting in bowel ischaemia. Br J Surg. 2019;106sup62$69$YR$$M$Y$$$20221219$$MD$GB$GB
1322689610$13226896$10$F$$20221018$20170213$20221020$EXP$$US-PFIZER INC-2017058171$PFIZER$$65$YR$$M$Y$$$20221020$$HP$US$US
132278815$13227881$5$F$20170206$20221222$20170213$20221229$EXP$$GB-MYLANLABS-2017M1007946$MYLAN$$38$YR$$M$Y$$$20221229$$MD$GB$GB
1322794413$13227944$13$F$20130919$20221018$20170213$20221025$EXP$$PHHY2017GB018424$NOVARTIS$$55$YR$$M$Y$$$20221025$$MD$GB$GB
1322882941$13228829$41$F$20130919$20221214$20170213$20221225$PER$US-ASTRAZENECA-2017SE07280$GB-AMGEN-GBRSP2017022053$AMGEN$$55$YR$A$M$Y$$$20221225$$MD$GB$GB
132300859$13230085$9$F$$20221221$20170214$20221227$EXP$$US-PFIZER INC-2017063888$PFIZER$$74$YR$$F$Y$87$KG$20221227$$CN$US$US
132345893$13234589$3$F$$20221027$20170215$20221031$PER$$US-PFIZER INC-2017062345$PFIZER$$62$YR$$F$Y$$$20221031$$MD$US$US
132382382$13238238$2$F$20161201$20221209$20170216$20221219$EXP$$US-SHIRE-US201702379$TAKEDA$$56$YR$$F$Y$48$KG$20221219$$CN$US$US
132387703$13238770$3$F$$20221206$20170216$20221210$EXP$$PHHY2017CA022870$NOVARTIS$$$$A$F$Y$$$20221210$$CN$CA$CA
132447002$13244700$2$F$$20220927$20170216$20221026$PER$$US-JAZZ-2017-US-000341$JAZZ$$$$$M$Y$$$20221026$$MD$US$US
132447379$13244737$9$F$20170101$20221013$20170216$20221026$PER$$US-JAZZ-2017-US-001025$JAZZ$$46$YR$$F$Y$$$20221026$$CN$US$US
132447445$13244744$5$F$20130101$20220809$20170216$20221026$PER$$US-JAZZ-2017-US-000946$JAZZ$$$$$F$Y$102.77$KG$20221026$$HP$US$US
1324667931$13246679$31$F$20130919$20221130$20170217$20221213$EXP$GB-MHRA-ADR 23836748$GB-Accord-048162$ACCORD$$55$YR$A$M$Y$$$20221213$$MD$GB$GB
132535656$13253565$6$F$20161201$20221121$20170220$20221130$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-001926$ACADIA PHARMACEUTICALS$$63$YR$$M$Y$108$KG$20221201$$CN$US$US
132535742$13253574$2$F$$20221205$20170220$20221214$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-001969$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221215$$CN$US$US
1325627411$13256274$11$F$20161013$20221019$20170221$20221025$EXP$$CA-TAKEDA-2015TUS015633$TAKEDA$$25$YR$$F$Y$$$20221025$$HP$CA$CA
132596439$13259643$9$F$20161201$20221017$20170222$20221018$EXP$$US-PFIZER INC-2017077124$PFIZER$$67$YR$$M$Y$79.83$KG$20221018$$CN$US$US
132606723$13260672$3$F$20170208$20221213$20170222$20221221$PER$$JP-Eisai Medical Research-EC-2017-025034$EISAI$$72$YR$E$F$Y$$$20221221$$MD$JP$
132622114$13262211$4$F$$20221121$20170222$20221122$EXP$$CA-ROCHE-1662402$ROCHE$$41$YR$$F$Y$$$20221122$$MD$CA$
132635746$13263574$6$F$20040101$20220915$20170223$20221005$EXP$$FR-ABBVIE-16P-056-1791361-00$ABBVIE$$$$$F$Y$$$20221005$$HP$FR$FR
132642314$13264231$4$F$$20221109$20170223$20221111$PER$$US-PFIZER INC-2017079350$PFIZER$$66$YR$$M$Y$$$20221111$$CN$US$US
1326434415$13264344$15$F$20170101$20221111$20170223$20221117$EXP$$CA-PFIZER INC-2017076339$PFIZER$$63$YR$$F$Y$$$20221117$$CN$CA$CA
1326573912$13265739$12$F$20160707$20221116$20170223$20221120$EXP$$PHHY2016CA100024$NOVARTIS$$77$YR$$F$Y$$$20221121$$HP$CA$CA
1326710920$13267109$20$F$20170101$20221101$20170224$20221115$EXP$GB-MHRA-ADR 23845327$GB-Accord-048413$ACCORD$$82$YR$E$M$Y$50$KG$20221115$$PH$GB$GB
1327603117$13276031$17$F$$20221107$20170228$20221114$EXP$$CA-ROCHE-1898975$ROCHE$$42$YR$$F$Y$97$KG$20221114$$HP$CA$
1327610816$13276108$16$F$20120713$20221107$20170228$20221109$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2015JPN102192$VIIV$$$$$$Y$$$20221109$$MD$JP$JP
1328179114$13281791$14$F$20170101$20221227$20170301$20221229$PER$$US-PFIZER INC-2017086148$PFIZER$$69$YR$$F$Y$67.12$KG$20221229$$HP$US$US
132843414$13284341$4$F$$20221128$20170301$20221209$EXP$$CA-SA-2017SA029762$SANOFI AVENTIS$$40$YR$A$F$Y$$$20221209$$HP$CA$CA
1328785310$13287853$10$F$20170220$20221206$20170302$20221215$PER$$US-PFIZER INC-2016570442$PFIZER$$17$YR$$M$Y$59$KG$20221215$$CN$US$US
132888667$13288866$7$F$$20221021$20170302$20221108$30DAY$$US-PFIZER INC-2017091257$PFIZER$$31$YR$$F$Y$159.4$KG$20221108$$MD$US$US
132891263$13289126$3$F$20170120$20221114$20170302$20221124$PER$$TR-AMGEN-TURSP2017030474$AMGEN$Imre E.; Seker A.; Dilek G. Y.. Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing^s Syndrome. Turkish Journal of Endocrinology and Metabolism. 2022;26 (3):181-183$45$YR$A$F$Y$71$KG$20221124$$HP$TR$TR
132984048$13298404$8$F$20140101$20221004$20170306$20221011$EXP$$US-BIOGEN-2017BI00365344$BIOGEN$$$$$F$Y$$$20221011$$CN$US$US
133026733$13302673$3$F$20170223$20221107$20170307$20221120$EXP$$PHHO2017US004465$NOVARTIS$$5$YR$$F$Y$24.2$KG$20221121$$MD$US$US
133036784$13303678$4$F$20170217$20221001$20170307$20221004$EXP$$CO-BAXALTA-2017BLT001601$TAKEDA$$18$YR$$F$Y$46$KG$20221004$$CN$CO$CO
133070782$13307078$2$F$20160301$20221013$20170308$20221021$EXP$$CA-AstraZeneca-2017SE22106$ASTRAZENECA$$24$YR$$M$Y$52.2$KG$20221021$$MD$CA$
133097835$13309783$5$F$$20220922$20170309$20221001$PER$$US-JNJFOC-20170216832$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221001$$HP$US$US
133098364$13309836$4$F$$20221020$20170309$20221103$PER$$US-JNJFOC-20170216980$JOHNSON AND JOHNSON$$$$$M$Y$$$20221103$$LW$US$US
133098524$13309852$4$F$20131114$20220929$20170309$20221013$PER$$US-JNJFOC-20170216800$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221013$$HP$US$US
133098565$13309856$5$F$20070101$20221003$20170309$20221013$PER$$US-JNJFOC-20170216889$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221013$$LW$US$US
133098644$13309864$4$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216990$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221018$$LW$US$US
133098874$13309887$4$F$20130701$20221020$20170309$20221028$EXP$$US-JNJFOC-20170216823$JOHNSON AND JOHNSON$$54$YR$A$M$Y$$$20221028$$LW$US$US
133098884$13309888$4$F$19981001$20220922$20170309$20221002$EXP$$US-JNJFOC-20170216981$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221002$$HP$US$US
133099203$13309920$3$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216781$JOHNSON AND JOHNSON$$$$$M$Y$$$20221026$$LW$US$US
133099303$13309930$3$F$20020901$20220929$20170309$20221012$PER$$US-JNJFOC-20170216985$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221010$$LW$US$US
133100745$13310074$5$F$20061101$20221121$20170309$20221128$EXP$$US-JNJFOC-20170110056$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221129$$HP$US$US
133101884$13310188$4$F$20160101$20221031$20170309$20221108$PER$$US-JNJFOC-20170201268$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20221108$$LW$US$US
133101954$13310195$4$F$$20221020$20170309$20221030$PER$$US-JNJFOC-20170201260$JOHNSON AND JOHNSON$$$$$M$Y$$$20221030$$LW$US$US
133101975$13310197$5$F$$20220922$20170309$20221003$EXP$$US-JNJFOC-20170201232$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
133102056$13310205$6$F$20170305$20221114$20170309$20221116$PER$$US-JNJFOC-20170201266$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221116$$HP$US$US
133102115$13310211$5$F$20160506$20221031$20170309$20221104$PER$$US-JNJFOC-20170201274$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20221104$$HP$US$US
133102145$13310214$5$F$$20221031$20170309$20221102$PER$$US-JNJFOC-20170201276$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
133102153$13310215$3$F$$20221031$20170309$20221114$PER$$US-JNJFOC-20170201277$JOHNSON AND JOHNSON$$$$$M$Y$$$20221114$$LW$US$US
133102174$13310217$4$F$20120101$20221020$20170309$20221030$PER$$US-JNJFOC-20170201254$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221030$$HP$US$US
133102244$13310224$4$F$20170305$20221031$20170309$20221103$PER$$US-JNJFOC-20170201270$JOHNSON AND JOHNSON$$46$YR$A$M$Y$$$20221104$$HP$US$US
133102253$13310225$3$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170201271$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
133102424$13310242$4$F$$20221006$20170309$20221016$PER$$US-JNJFOC-20170201284$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221016$$HP$US$US
133102474$13310247$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170201287$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133102515$13310251$5$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170201290$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
133102525$13310252$5$F$$20221006$20170309$20221017$PER$$US-JNJFOC-20170201291$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133102544$13310254$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170201292$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221014$$HP$US$US
133102576$13310257$6$F$20120401$20221020$20170309$20221028$PER$$US-JNJFOC-20170201406$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221028$$HP$US$US
133102635$13310263$5$F$20010401$20221020$20170309$20221102$PER$$US-JNJFOC-20170201415$JOHNSON AND JOHNSON$$42$YR$A$M$Y$$$20221102$$HP$US$US
133102665$13310266$5$F$$20221006$20170309$20221017$PER$$US-JNJFOC-20170201293$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133102694$13310269$4$F$20081217$20221020$20170309$20221027$EXP$$US-JNJFOC-20170201297$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221027$$LW$US$US
133103054$13310305$4$F$20080901$20221020$20170309$20221030$PER$$US-JNJFOC-20170201426$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20221030$$HP$US$US
133103165$13310316$5$F$20071121$20221020$20170309$20221102$PER$$US-JNJFOC-20170201422$JOHNSON AND JOHNSON$$29$YR$A$M$Y$$$20221102$$HP$US$US
133103246$13310324$6$F$20090601$20220922$20170309$20221002$EXP$$US-JNJFOC-20170201413$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221002$$HP$US$US
133103476$13310347$6$F$20110501$20221014$20170309$20221020$EXP$$US-JNJFOC-20170202573$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221020$$HP$US$US
133103933$13310393$3$F$20110101$20221121$20170309$20221125$EXP$$US-JNJFOC-20170202972$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221125$$LW$US$US
133104224$13310422$4$F$20110601$20221014$20170309$20221020$PER$$US-JNJFOC-20170202640$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221020$$HP$US$US
133106184$13310618$4$F$20090612$20221219$20170309$20221222$PER$$US-JNJFOC-20170118418$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221222$$LW$US$US
133106694$13310669$4$F$$20221205$20170309$20221208$EXP$$US-JNJFOC-20170124442$JOHNSON AND JOHNSON$$$$$M$Y$$$20221209$$LW$US$US
133106884$13310688$4$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170201256$JOHNSON AND JOHNSON$$$$$M$Y$$$20221009$$LW$US$US
133106915$13310691$5$F$20140101$20221020$20170309$20221030$PER$$US-JNJFOC-20170201264$JOHNSON AND JOHNSON$$6$DEC$A$M$Y$$$20221030$$HP$US$US
133107024$13310702$4$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170202591$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133107095$13310709$5$F$20100401$20221014$20170309$20221019$EXP$$US-JNJFOC-20170202568$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20221019$$HP$US$US
133107225$13310722$5$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170202597$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133107236$13310723$6$F$20030501$20221014$20170309$20221018$EXP$$US-JNJFOC-20170202577$JOHNSON AND JOHNSON$$36$YR$A$M$Y$$$20221018$$HP$US$US
133107256$13310725$6$F$20130814$20221014$20170309$20221025$PER$$US-JNJFOC-20170202580$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20221025$$HP$US$US
133107395$13310739$5$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170202628$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221025$$HP$US$US
133107455$13310745$5$F$20170305$20220922$20170309$20221002$PER$$US-JNJFOC-20170202630$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221002$$HP$US$US
133107566$13310756$6$F$20060201$20221014$20170309$20221021$EXP$$US-JNJFOC-20170202644$JOHNSON AND JOHNSON$$33$YR$A$M$Y$$$20221021$$HP$US$US
133107576$13310757$6$F$20080101$20221014$20170309$20221027$PER$$US-JNJFOC-20170202645$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221027$$HP$US$US
133107824$13310782$4$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170202625$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
133107834$13310783$4$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170202626$JOHNSON AND JOHNSON$$$$$M$Y$$$20221025$$HP$US$US
133107855$13310785$5$F$20080101$20221014$20170309$20221020$PER$$US-JNJFOC-20170202627$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20221020$$HP$US$US
133107886$13310788$6$F$20100101$20221020$20170309$20221025$PER$$US-JNJFOC-20170202657$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221025$$HP$US$US
133107947$13310794$7$F$20170305$20221012$20170309$20221018$PER$$US-JNJFOC-20170202612$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221018$$HP$US$US
133107965$13310796$5$F$20070815$20221006$20170309$20221013$PER$$US-JNJFOC-20170202615$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20221013$$HP$US$US
133108045$13310804$5$F$20080101$20221014$20170309$20221018$PER$$US-JNJFOC-20170202624$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221018$$HP$US$US
133109024$13310902$4$F$20000101$20221020$20170309$20221026$PER$$US-JNJFOC-20150923148$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221026$$HP$US$US
133109595$13310959$5$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170213617$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$HP$US$US
133109675$13310967$5$F$20140610$20221020$20170309$20221102$PER$$US-JNJFOC-20170213604$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221102$$HP$US$US
133109804$13310980$4$F$$20220929$20170309$20221012$PER$$US-JNJFOC-20170213611$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221011$$LW$US$US
133109905$13310990$5$F$$20221006$20170309$20221013$EXP$$US-JNJFOC-20170213759$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$HP$US$US
133109915$13310991$5$F$$20221031$20170309$20221108$PER$$US-JNJFOC-20170213760$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221109$$HP$US$US
133110074$13311007$4$F$20130101$20221014$20170309$20221020$EXP$$US-JNJFOC-20170213645$JOHNSON AND JOHNSON$$2$DEC$A$M$Y$$$20221020$$HP$US$US
133110105$13311010$5$F$$20221014$20170309$20221025$PER$$US-JNJFOC-20170213647$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221025$$HP$US$US
133110205$13311020$5$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170213616$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$HP$US$US
133110235$13311023$5$F$19990507$20221020$20170309$20221027$PER$$US-JNJFOC-20170213648$JOHNSON AND JOHNSON$$41$YR$A$M$Y$$$20221027$$HP$US$US
133110355$13311035$5$F$$20221006$20170309$20221016$PER$$US-JNJFOC-20170213653$JOHNSON AND JOHNSON$$$$$M$Y$$$20221017$$HP$US$US
133110404$13311040$4$F$20130101$20220929$20170309$20221012$PER$$US-JNJFOC-20170213711$JOHNSON AND JOHNSON$$57$YR$A$M$Y$$$20221010$$LW$US$US
133110415$13311041$5$F$20170116$20220929$20170309$20221007$EXP$$US-JNJFOC-20170213734$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221007$$HP$US$US
133110435$13311043$5$F$$20221031$20170309$20221109$PER$$US-JNJFOC-20170213631$JOHNSON AND JOHNSON$$$$$M$Y$$$20221109$$HP$US$US
133110665$13311066$5$F$$20221006$20170309$20221014$PER$$US-JNJFOC-20170213973$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$HP$US$US
133110705$13311070$5$F$20170301$20220922$20170309$20221001$PER$$US-JNJFOC-20170213658$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221001$$HP$US$US
133110874$13311087$4$F$$20221020$20170309$20221026$PER$$US-JNJFOC-20170213716$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$LW$US$US
133111144$13311114$4$F$20050101$20221031$20170309$20221110$PER$$US-JNJFOC-20170213633$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221110$$HP$US$US
133111265$13311126$5$F$20170201$20221006$20170309$20221014$PER$$US-JNJFOC-20170213693$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221014$$LW$US$US
133111334$13311133$4$F$20140204$20221014$20170309$20221026$PER$$US-JNJFOC-20170213884$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221026$$LW$US$US
133111385$13311138$5$F$20120101$20220929$20170309$20221012$PER$$US-JNJFOC-20170213724$JOHNSON AND JOHNSON$$4$DEC$A$M$Y$$$20221010$$HP$US$US
133111495$13311149$5$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170213642$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$HP$US$US
133112035$13311203$5$F$20170306$20220929$20170309$20221007$EXP$$US-JNJFOC-20170213636$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221007$$HP$US$US
133112194$13311219$4$F$$20221006$20170309$20221013$PER$$US-JNJFOC-20170213852$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221014$$LW$US$US
133114242$13311424$2$F$$20220928$20170309$20221007$PER$$US-JNJFOC-20170300750$JOHNSON AND JOHNSON$$$$$M$Y$$$20221007$$LW$US$US
133114543$13311454$3$F$20110922$20221107$20170309$20221115$PER$$US-JNJFOC-20170300759$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221115$$HP$US$US
133115155$13311515$5$F$$20221020$20170309$20221102$PER$$US-JNJFOC-20170216626$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
133116735$13311673$5$F$20170310$20221006$20170309$20221017$PER$$US-JNJFOC-20170216831$JOHNSON AND JOHNSON$$25$YR$A$M$Y$$$20221017$$HP$US$US
133116785$13311678$5$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216805$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$HP$US$US
133116823$13311682$3$F$20170101$20221031$20170309$20221109$PER$$US-JNJFOC-20170216658$JOHNSON AND JOHNSON$$30$YR$A$M$Y$$$20221109$$LW$US$US
133116855$13311685$5$F$20090205$20221006$20170309$20221015$PER$$US-JNJFOC-20170216816$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221015$$HP$US$US
133116965$13311696$5$F$20130901$20221006$20170309$20221017$PER$$US-JNJFOC-20170216822$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221017$$LW$US$US
133117324$13311732$4$F$20121109$20220922$20170309$20221001$PER$$US-JNJFOC-20170216815$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221001$$HP$US$US
133117385$13311738$5$F$20170308$20221020$20170309$20221103$PER$$US-JNJFOC-20170216836$JOHNSON AND JOHNSON$$58$YR$A$M$Y$$$20221103$$HP$US$US
133117394$13311739$4$F$$20221031$20170309$20221103$PER$$US-JNJFOC-20170216837$JOHNSON AND JOHNSON$$$$$M$Y$$$20221103$$HP$US$US
133117415$13311741$5$F$$20221006$20170309$20221018$PER$$US-JNJFOC-20170216818$JOHNSON AND JOHNSON$$$$$M$Y$$$20221018$$HP$US$US
133117495$13311749$5$F$20170305$20221014$20170309$20221021$PER$$US-JNJFOC-20170216879$JOHNSON AND JOHNSON$$27$YR$A$M$Y$$$20221021$$HP$US$US
133117584$13311758$4$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216780$JOHNSON AND JOHNSON$$$$$M$Y$$$20221026$$LW$US$US
133117604$13311760$4$F$20130201$20220929$20170309$20221012$EXP$$US-JNJFOC-20170216809$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20221009$$HP$US$US
133117645$13311764$5$F$$20221014$20170309$20221026$PER$$US-JNJFOC-20170216783$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221026$$HP$US$US
133122166$13312216$6$F$$20221121$20170309$20221124$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-019157$BRISTOL MYERS SQUIBB$$65$YR$E$M$Y$$$20221124$$HP$GB$GB
133148272$13314827$2$F$$20221025$20170309$20221101$EXP$$US-BAXALTA-2017BLT001752$TAKEDA$$$$$M$Y$93$KG$20221101$$HP$US$US
133154696$13315469$6$F$$20221121$20170310$20221123$EXP$$CA-ROCHE-1808080$ROCHE$$64$YR$$F$Y$$$20221123$$HP$CA$
133179788$13317978$8$F$20170303$20221205$20170310$20221208$PER$$US-PFIZER INC-2017104329$PFIZER$$70$YR$$F$Y$$$20221208$$CN$US$US
133197684$13319768$4$F$$20221121$20170310$20221123$PER$$US-BIOGEN-2017BI00369252$BIOGEN$$$$$F$Y$$$20221123$$CN$US$US
133216718$13321671$8$F$20170101$20221222$20170310$20221227$EXP$$US-PFIZER INC-2017095248$PFIZER$$61$YR$$F$Y$$$20221227$$CN$US$US
133217873$13321787$3$F$20170222$20221104$20170310$20221118$EXP$$US-CORCEPT THERAPEUTICS INC.-US-2017CRT000159$CORCEPT$$61$YR$$F$Y$$$20221118$$CN$US$US
1332677614$13326776$14$F$20170224$20221130$20170312$20221206$EXP$$US-SHIRE-US201704221$TAKEDA$$43$YR$$F$Y$$$20221206$$PH$US$US
133341646$13334164$6$F$20081201$20221013$20170313$20221019$EXP$$US-BIOGEN-2008BI033337$BIOGEN$$46$YR$$M$Y$76.272$KG$20221019$$CN$US$US
133361274$13336127$4$F$20060911$20221109$20170315$20221117$EXP$$CA-ROCHE-1562582$ROCHE$$$$A$M$Y$67$KG$20221117$$CN$CA$CA
133404316$13340431$6$F$$20221207$20170316$20221209$PER$$US-PFIZER INC-2017106540$PFIZER$$65$YR$$F$Y$51.701$KG$20221209$$CN$US$US
133410403$13341040$3$F$20170130$20221020$20170316$20221109$EXP$$PL-TAKEDA-2017MPI000816$TAKEDA$$75$YR$$M$Y$90$KG$20221109$$MD$PL$PL
133420836$13342083$6$F$20150101$20221118$20170316$20221124$EXP$$US-ROCHE-1817225$ROCHE$$67$YR$$M$Y$$$20221124$$CN$US$
133427165$13342716$5$F$$20221219$20170316$20221222$EXP$$US-PFIZER INC-2017109378$PFIZER$$72$YR$$F$Y$$$20221222$$CN$US$US
133436492$13343649$2$F$20160101$20221207$20170316$20221213$EXP$$US-JAZZ-2017-US-003225$JAZZ$$$$$F$Y$$$20221213$$CN$US$US
1334444610$13344446$10$F$20170307$20221013$20170317$20221017$EXP$$CN-ROCHE-1903883$ROCHE$$64$YR$$F$Y$48$KG$20221017$$MD$CN$
1334561719$13345617$19$F$20150501$20221228$20170317$20221230$EXP$$GB-ROCHE-1614575$ROCHE$$79$YR$$F$Y$$$20221230$$MD$GB$GB
133464982$13346498$2$F$$20221024$20170317$20221027$EXP$$FR-TAKEDA-2017TUS003359$TAKEDA$$48$YR$$F$Y$$$20221027$$HP$FR$FR
133465025$13346502$5$F$20160130$20220929$20170317$20221004$EXP$$US-TAKEDA-2017TUS005104$TAKEDA$$36$YR$$F$Y$48.526$KG$20221004$$HP$US$US
1335105013$13351050$13$F$20150101$20221128$20170320$20221130$EXP$$US-PFIZER INC-2017107202$PFIZER$$78$YR$$F$Y$73$KG$20221130$$CN$US$US
1335383315$13353833$15$F$20150101$20221228$20170321$20221230$PER$$US-PFIZER INC-2017110744$PFIZER$$63$YR$$F$Y$$$20221230$$CN$US$US
133564493$13356449$3$F$20100101$20221019$20170321$20221021$EXP$$US-TAKEDA-2017TUS005943$TAKEDA$$$$$$Y$$$20221021$$CN$US$US
1335649119$13356491$19$F$20161121$20221012$20170321$20221019$EXP$$DK-SA-2016SA220324$SANOFI AVENTIS$$41$YR$A$F$Y$73$KG$20221019$$HP$DK$DK
1335763314$13357633$14$F$20170301$20220926$20170322$20221004$EXP$$CA-ROCHE-1909497$ROCHE$$44$YR$$F$Y$135$KG$20221004$$CN$CA$CA
133578236$13357823$6$F$$20221013$20170322$20221017$PER$$US-PFIZER INC-2016566868$PFIZER$$73$YR$$F$Y$74.84$KG$20221017$$CN$US$US
133578654$13357865$4$F$20170224$20221214$20170322$20221220$EXP$$US-PFIZER INC-2017077172$PFIZER$$70$YR$$F$Y$$$20221220$$CN$US$US
1335819714$13358197$14$F$$20221215$20170322$20221219$EXP$$AU-ROCHE-1908670$ROCHE$$74$YR$$M$Y$80$KG$20221219$$MD$AU$AU
133583394$13358339$4$F$20170301$20221109$20170322$20221114$EXP$$PHHY2017CA038044$NOVARTIS$$48$YR$$M$Y$$$20221114$$CN$CA$CA
133616822$13361682$2$F$$20221015$20170323$20221029$EXP$$IN-MACLEODS PHARMACEUTICALS US LTD-MAC2017004482$MACLEODS$Nag DS, Samaddar DP, Kant S, Mahanty PR.. Perianesthetic refractory anaphylactic shock with cefuroxime in a patient with history of penicillin allergy on multiple antihypertensive medications.. Revista Brasileira de Anestesiologia.. 2017;67(2):217-220$$$$$Y$$$20221029$$MD$IN$IN
1336401125$13364011$25$F$20170101$20220929$20170323$20221004$EXP$$US-INCYTE CORPORATION-2017IN001912$INCYTE$$$$$$Y$$$20221004$$HP$US$US
133662076$13366207$6$F$20161001$20221227$20170323$20221229$EXP$$US-INCYTE CORPORATION-2016IN006262$INCYTE$$$$$$Y$$$20221229$$HP$US$US
133665444$13366544$4$F$20160101$20221216$20170323$20221221$EXP$$CA-TAKEDA-2017TUS002403$TAKEDA$$26$YR$$F$Y$$$20221221$$CN$CA$CA
133737332$13373733$2$F$$20221004$20170327$20221006$PER$$US-PFIZER INC-2017127522$PFIZER$$58$YR$$M$Y$$$20221006$$HP$US$US
133778742$13377874$2$F$$20221003$20170328$20221012$EXP$$JP-JNJFOC-20170328860$JOHNSON AND JOHNSON$$44$YR$A$M$Y$$$20221011$$MD$JP$JP
133811145$13381114$5$F$$20221025$20170329$20221031$EXP$$US-PFIZER INC-2017132859$PFIZER$$59$YR$$F$Y$52.16$KG$20221031$$MD$US$US
1338203312$13382033$12$F$20160708$20221020$20170329$20221026$EXP$$PHHY2016CA095571$NOVARTIS$$70$YR$$F$Y$$$20221026$$HP$CA$CA
133861053$13386105$3$F$20170317$20221019$20170330$20221028$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002727$ACADIA PHARMACEUTICALS$$64$YR$$M$Y$$$20221028$$CN$US$US
133868705$13386870$5$F$20130101$20220930$20170330$20221006$PER$$US-PFIZER INC-2017136159$PFIZER$$69$YR$$F$Y$57$KG$20221006$$CN$US$US
133904062$13390406$2$F$20170201$20221121$20170331$20221128$PER$$US-PFIZER INC-2017139331$PFIZER$$55$YR$$F$Y$$$20221128$$CN$US$US
1339079018$13390790$18$F$20160101$20221212$20170331$20221216$EXP$$PHHY2016CA039834$NOVARTIS$$50$YR$$F$Y$$$20221216$$CN$CA$CA
133952935$13395293$5$F$$20221103$20170403$20221108$PER$$US-PFIZER INC-2017141650$PFIZER$$70$YR$$F$Y$$$20221108$$CN$US$US
1339894425$13398944$25$F$20160101$20221102$20170404$20221104$EXP$$PHHY2016CA109964$NOVARTIS$$$$$M$Y$$$20221104$$CN$CA$CA
134033904$13403390$4$F$20080101$20221223$20170404$20221227$EXP$$US-JAZZ-2017-US-004064$JAZZ$$$$$M$Y$$$20221227$$CN$US$US
134058258$13405825$8$F$20170403$20221206$20170405$20221212$PER$$US-PFIZER INC-2017147520$PFIZER$$62$YR$$F$Y$$$20221212$$HP$US$US
134083663$13408366$3$F$20130101$20221116$20170406$20221119$PER$$US-JNJFOC-20170207233$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221119$$HP$US$US
134084083$13408408$3$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170208481$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134084824$13408482$4$F$20040101$20221213$20170406$20221214$PER$$US-JNJFOC-20170223643$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221214$$LW$US$US
134085414$13408541$4$F$19980205$20221114$20170406$20221122$PER$$US-JNJFOC-20170224183$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221122$$LW$US$US
134085553$13408555$3$F$20030728$20220928$20170406$20221012$PER$$US-JNJFOC-20170223612$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221010$$LW$US$US
134085563$13408556$3$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170224754$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$HP$US$US
134085935$13408593$5$F$$20221121$20170406$20221129$PER$$US-JNJFOC-20170225229$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134086183$13408618$3$F$20010501$20221213$20170406$20221222$PER$$US-JNJFOC-20170224206$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221222$$LW$US$US
134086274$13408627$4$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170225160$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134088484$13408848$4$F$20020701$20221116$20170406$20221128$PER$$US-JNJFOC-20170224823$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221128$$LW$US$US
134088673$13408867$3$F$20010611$20221221$20170406$20221223$PER$$US-JNJFOC-20170225075$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221223$$LW$US$US
134088853$13408885$3$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170225486$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134089053$13408905$3$F$20040109$20221019$20170406$20221027$PER$$US-JNJFOC-20170109079$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221027$$LW$US$US
134089073$13408907$3$F$20050101$20221121$20170406$20221129$PER$$US-JNJFOC-20170109216$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221129$$HP$US$US
134089295$13408929$5$F$20070823$20220926$20170406$20221006$PER$$US-JNJFOC-20170109470$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221006$$HP$US$US
134089463$13408946$3$F$20090101$20221121$20170406$20221201$PER$$US-JNJFOC-20170109743$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221202$$HP$US$US
134089784$13408978$4$F$20080422$20220926$20170406$20221004$PER$$US-JNJFOC-20170110307$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221004$$LW$US$US
134090063$13409006$3$F$20080101$20221107$20170406$20221110$PER$$US-JNJFOC-20170112677$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221110$$HP$US$US
134090495$13409049$5$F$20100413$20221207$20170406$20221215$EXP$$US-JNJFOC-20170112929$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221215$$HP$US$US
134090523$13409052$3$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170112930$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134090603$13409060$3$F$$20220926$20170406$20221002$PER$$US-JNJFOC-20170113476$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134090613$13409061$3$F$20060101$20220928$20170406$20221006$EXP$$US-JNJFOC-20170113485$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221007$$LW$US$US
134091823$13409182$3$F$20080320$20221213$20170406$20221215$PER$$US-JNJFOC-20170116633$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221215$$LW$US$US
134091854$13409185$4$F$20070716$20221114$20170406$20221121$PER$$US-JNJFOC-20170116472$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221121$$HP$US$US
134091974$13409197$4$F$$20221207$20170406$20221215$PER$$US-JNJFOC-20170116485$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134092024$13409202$4$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170116727$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134092384$13409238$4$F$20020207$20221207$20170406$20221212$EXP$$US-JNJFOC-20170116487$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20221212$$LW$US$US
134092742$13409274$2$F$20020101$20221116$20170406$20221126$PER$$US-JNJFOC-20151100901$JOHNSON AND JOHNSON$$1$DEC$C$M$Y$$$20221126$$LW$US$US
134093184$13409318$4$F$20091230$20221221$20170406$20221227$PER$$US-JNJFOC-20170124612$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221227$$LW$US$US
134094014$13409401$4$F$$20221107$20170406$20221110$PER$$US-JNJFOC-20170124619$JOHNSON AND JOHNSON$$$$$M$Y$$$20221110$$HP$US$US
134094114$13409411$4$F$20110519$20221031$20170406$20221108$PER$$US-JNJFOC-20170124622$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221109$$LW$US$US
134094194$13409419$4$F$20070801$20221116$20170406$20221128$PER$$US-JNJFOC-20170124575$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221128$$HP$US$US
134094304$13409430$4$F$20061205$20221213$20170406$20221220$PER$$US-JNJFOC-20170124641$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221220$$HP$US$US
134094454$13409445$4$F$20030318$20221213$20170406$20221213$PER$$US-JNJFOC-20161005961$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221213$$HP$US$US
134094493$13409449$3$F$20090101$20221012$20170406$20221019$EXP$$US-JNJFOC-20170125907$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221020$$HP$US$US
134094544$13409454$4$F$20070101$20221031$20170406$20221104$PER$$US-JNJFOC-20170126463$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221104$$LW$US$US
134095104$13409510$4$F$20010710$20220928$20170406$20221012$PER$$US-JNJFOC-20170225622$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221009$$HP$US$US
134095154$13409515$4$F$20050506$20221221$20170406$20221227$PER$$US-JNJFOC-20170225851$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221227$$LW$US$US
134095414$13409541$4$F$20050729$20221107$20170406$20221109$PER$$US-JNJFOC-20170127186$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221109$$HP$US$US
134095534$13409553$4$F$20101116$20221228$20170406$20221230$PER$$US-JNJFOC-20170127439$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221230$$LW$US$US
134095874$13409587$4$F$20111101$20221213$20170406$20221214$PER$$US-JNJFOC-20170127374$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221214$$HP$US$US
134097084$13409708$4$F$20001205$20221111$20170406$20221118$PER$$US-JNJFOC-20170224752$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221118$$LW$US$US
134098156$13409815$6$F$$20221122$20170406$20221124$EXP$$US-PFIZER INC-2017071242$PFIZER$$65$YR$$M$Y$$$20221124$$CN$US$US
134099455$13409945$5$F$20121012$20221031$20170406$20221102$EXP$$US-PFIZER INC-2017147004$PFIZER$$50$YR$$M$Y$95.7$KG$20221102$$CN$US$US
134103252$13410325$2$F$$20221213$20170406$20221220$PER$$US-JNJFOC-20170306485$JOHNSON AND JOHNSON$$$$$M$Y$$$20221220$$LW$US$US
134103294$13410329$4$F$20020114$20221129$20170406$20221205$PER$$US-JNJFOC-20170303091$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221205$$LW$US$US
134103402$13410340$2$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170306467$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134103632$13410363$2$F$20091001$20221121$20170406$20221130$PER$$US-JNJFOC-20170306612$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221130$$LW$US$US
134103692$13410369$2$F$$20220926$20170406$20221006$PER$$US-JNJFOC-20170306424$JOHNSON AND JOHNSON$$$$$M$Y$$$20221006$$LW$US$US
134103862$13410386$2$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170306488$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134104142$13410414$2$F$$20220928$20170406$20221012$PER$$US-JNJFOC-20170306543$JOHNSON AND JOHNSON$$$$$M$Y$$$20221009$$LW$US$US
134104514$13410451$4$F$$20220922$20170406$20221001$PER$$US-JNJFOC-20170226376$JOHNSON AND JOHNSON$$$$$M$Y$$$20221001$$LW$US$US
134104923$13410492$3$F$19990715$20221221$20170406$20221229$PER$$US-JNJFOC-20170227583$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221230$$LW$US$US
134105054$13410505$4$F$$20220928$20170406$20221003$PER$$US-JNJFOC-20170227363$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134105654$13410565$4$F$20050201$20221114$20170406$20221119$PER$$US-JNJFOC-20170300133$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221119$$LW$US$US
134105664$13410566$4$F$19980520$20221121$20170406$20221130$PER$$US-JNJFOC-20170300134$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221130$$LW$US$US
134105784$13410578$4$F$20050604$20221107$20170406$20221109$PER$$US-JNJFOC-20170300143$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221109$$LW$US$US
134105873$13410587$3$F$20080322$20221219$20170406$20221227$PER$$US-JNJFOC-20170300315$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221227$$LW$US$US
134105903$13410590$3$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170300463$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134106494$13410649$4$F$20031106$20220926$20170406$20221004$PER$$US-JNJFOC-20170301290$JOHNSON AND JOHNSON$$6$YR$C$M$Y$$$20221004$$LW$US$US
134106614$13410661$4$F$19990921$20220926$20170406$20221007$PER$$US-JNJFOC-20170300107$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221007$$HP$US$US
134107324$13410732$4$F$20180829$20221219$20170406$20221222$PER$$US-JNJFOC-20170301398$JOHNSON AND JOHNSON$$21$YR$A$M$Y$$$20221222$$LW$US$US
134107364$13410736$4$F$$20221012$20170406$20221020$PER$$US-JNJFOC-20170301417$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134107733$13410773$3$F$20020205$20221031$20170406$20221109$PER$$US-JNJFOC-20170307893$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221109$$LW$US$US
134107754$13410775$4$F$20100902$20221019$20170406$20221027$PER$$US-JNJFOC-20170307957$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221027$$LW$US$US
134107864$13410786$4$F$20111101$20221121$20170406$20221130$PER$$US-JNJFOC-20170307961$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221130$$HP$US$US
134108364$13410836$4$F$20120224$20221221$20170406$20221228$PER$$US-JNJFOC-20170302025$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221228$$LW$US$US
134108634$13410863$4$F$$20221116$20170406$20221126$PER$$US-JNJFOC-20170301473$JOHNSON AND JOHNSON$$$$$M$Y$$$20221126$$LW$US$US
134108654$13410865$4$F$20040623$20221219$20170406$20221222$PER$$US-JNJFOC-20170301591$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221222$$LW$US$US
134108713$13410871$3$F$$20221114$20170406$20221127$PER$$US-JNJFOC-20170300096$JOHNSON AND JOHNSON$$26$YR$A$M$Y$$$20221128$$LW$US$US
134108794$13410879$4$F$$20221121$20170406$20221130$PER$$US-JNJFOC-20170300097$JOHNSON AND JOHNSON$$$$$M$Y$$$20221130$$LW$US$US
134109114$13410911$4$F$20050518$20220926$20170406$20221006$PER$$US-JNJFOC-20170302243$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221006$$LW$US$US
134109563$13410956$3$F$20001201$20221012$20170406$20221019$PER$$US-JNJFOC-20170304598$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221019$$LW$US$US
134109793$13410979$3$F$20051228$20221219$20170406$20221221$PER$$US-JNJFOC-20170303447$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221221$$LW$US$US
134109944$13410994$4$F$20150810$20221201$20170406$20221205$PER$$US-JNJFOC-20170304013$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221205$$HP$US$US
134110073$13411007$3$F$20161001$20221003$20170406$20221014$PER$$US-JNJFOC-20170304028$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221014$$LW$US$US
134110204$13411020$4$F$20070625$20220928$20170406$20221012$PER$$US-JNJFOC-20170304578$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221010$$LW$US$US
134110584$13411058$4$F$$20221107$20170406$20221109$PER$$US-JNJFOC-20170304459$JOHNSON AND JOHNSON$$$$$M$Y$$$20221109$$LW$US$US
134110714$13411071$4$F$$20221107$20170406$20221110$PER$$US-JNJFOC-20170304478$JOHNSON AND JOHNSON$$$$$M$Y$$$20221111$$LW$US$US
134110862$13411086$2$F$20050101$20221121$20170406$20221130$PER$$US-JNJFOC-20170306753$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221130$$LW$US$US
134111142$13411114$2$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170306729$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134111382$13411138$2$F$20120330$20221121$20170406$20221129$PER$$US-JNJFOC-20170306735$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221130$$LW$US$US
134111652$13411165$2$F$$20221114$20170406$20221123$PER$$US-JNJFOC-20170306740$JOHNSON AND JOHNSON$$$$$M$Y$$$20221123$$LW$US$US
134112463$13411246$3$F$20060201$20220928$20170406$20221006$PER$$US-JNJFOC-20170306659$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221006$$LW$US$US
134112603$13411260$3$F$20070101$20221207$20170406$20221213$PER$$US-JNJFOC-20170307189$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221213$$LW$US$US
134112634$13411263$4$F$20020411$20221107$20170406$20221114$EXP$$US-JNJFOC-20170306942$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221115$$LW$US$US
134112754$13411275$4$F$20070817$20221114$20170406$20221123$PER$$US-JNJFOC-20170307030$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221123$$LW$US$US
134112792$13411279$2$F$$20221213$20170406$20221219$PER$$US-JNJFOC-20170306432$JOHNSON AND JOHNSON$$$$$M$Y$$$20221219$$LW$US$US
134112974$13411297$4$F$20100812$20221205$20170406$20221212$PER$$US-JNJFOC-20170307184$JOHNSON AND JOHNSON$$13$YR$T$M$Y$$$20221212$$HP$US$US
134113022$13411302$2$F$$20221114$20170406$20221117$PER$$US-JNJFOC-20170306569$JOHNSON AND JOHNSON$$$$$$Y$$$20221117$$LW$US$US
134113152$13411315$2$F$19980101$20221121$20170406$20221128$PER$$US-JNJFOC-20170306586$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134113622$13411362$2$F$20111021$20221116$20170406$20221124$PER$$US-JNJFOC-20170304905$JOHNSON AND JOHNSON$$22$YR$A$M$Y$$$20221125$$LW$US$US
134113755$13411375$5$F$20120801$20221111$20170406$20221123$PER$$US-JNJFOC-20170304535$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221123$$LW$US$US
134113794$13411379$4$F$20071010$20221114$20170406$20221123$PER$$US-JNJFOC-20170304310$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221123$$LW$US$US
134113902$13411390$2$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170304919$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134114142$13411414$2$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170304926$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134114152$13411415$2$F$20000101$20220926$20170406$20221004$PER$$US-JNJFOC-20170304927$JOHNSON AND JOHNSON$$$$$M$Y$$$20221004$$LW$US$US
134114252$13411425$2$F$20061001$20220928$20170406$20221012$PER$$US-JNJFOC-20170304859$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221010$$LW$US$US
134114312$13411431$2$F$$20221012$20170406$20221022$PER$$US-JNJFOC-20170304860$JOHNSON AND JOHNSON$$$$$M$Y$$$20221022$$LW$US$US
134114582$13411458$2$F$$20221205$20170406$20221212$EXP$$US-JNJFOC-20170304896$JOHNSON AND JOHNSON$$$$$M$Y$$$20221213$$LW$US$US
134115123$13411512$3$F$$20221114$20170406$20221119$PER$$US-JNJFOC-20170304979$JOHNSON AND JOHNSON$$$$$M$Y$$$20221119$$LW$US$US
134115232$13411523$2$F$$20221003$20170406$20221013$PER$$US-JNJFOC-20170304964$JOHNSON AND JOHNSON$$$$$M$Y$$$20221013$$LW$US$US
134115242$13411524$2$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170304965$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134115252$13411525$2$F$$20221219$20170406$20221223$PER$$US-JNJFOC-20170304982$JOHNSON AND JOHNSON$$$$$M$Y$$$20221223$$LW$US$US
134116263$13411626$3$F$20050131$20221129$20170406$20221206$PER$$US-JNJFOC-20170302957$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221206$$LW$US$US
134116644$13411664$4$F$$20221107$20170406$20221114$PER$$US-JNJFOC-20170303272$JOHNSON AND JOHNSON$$$$$M$Y$$$20221115$$HP$US$US
134116873$13411687$3$F$$20221228$20170406$20221230$PER$$US-JNJFOC-20170303435$JOHNSON AND JOHNSON$$$$$M$Y$$$20221230$$LW$US$US
134117394$13411739$4$F$$20221114$20170406$20221121$PER$$US-JNJFOC-20170304306$JOHNSON AND JOHNSON$$$$$M$Y$$$20221121$$LW$US$US
134117493$13411749$3$F$20040628$20221114$20170406$20221121$PER$$US-JNJFOC-20170303423$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221121$$LW$US$US
134117604$13411760$4$F$$20221114$20170406$20221119$PER$$US-JNJFOC-20170304307$JOHNSON AND JOHNSON$$$$$M$Y$$$20221119$$LW$US$US
134117783$13411778$3$F$20050303$20220926$20170406$20221006$PER$$US-JNJFOC-20170304278$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221006$$LW$US$US
134118172$13411817$2$F$20090501$20221207$20170406$20221216$PER$$US-JNJFOC-20170304872$JOHNSON AND JOHNSON$$14$YR$T$M$Y$$$20221216$$LW$US$US
134118313$13411831$3$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170304552$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134118473$13411847$3$F$$20220928$20170406$20221003$PER$$US-JNJFOC-20170304283$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134118763$13411876$3$F$20080312$20221019$20170406$20221031$PER$$US-JNJFOC-20170304210$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221031$$LW$US$US
134118804$13411880$4$F$$20221121$20170406$20221128$PER$$US-JNJFOC-20170304323$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134119874$13411987$4$F$20130101$20221228$20170406$20221230$PER$$US-JNJFOC-20170316148$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221230$$LW$US$US
134119974$13411997$4$F$20070101$20221207$20170406$20221213$PER$$US-JNJFOC-20170316578$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221213$$LW$US$US
134120033$13412003$3$F$$20221114$20170406$20221123$PER$$US-JNJFOC-20170316657$JOHNSON AND JOHNSON$$$$$M$Y$$$20221123$$LW$US$US
134120994$13412099$4$F$$20221207$20170406$20221209$PER$$US-JNJFOC-20170316756$JOHNSON AND JOHNSON$$$$$M$Y$$$20221209$$LW$US$US
134121833$13412183$3$F$20080101$20220921$20170406$20221003$PER$$US-JNJFOC-20170314133$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221003$$HP$US$US
134121943$13412194$3$F$$20221219$20170406$20221222$PER$$US-JNJFOC-20161009028$JOHNSON AND JOHNSON$$$$$M$Y$$$20221222$$LW$US$US
134123064$13412306$4$F$20110521$20221129$20170406$20221206$PER$$US-JNJFOC-20170307964$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221206$$HP$US$US
134123242$13412324$2$F$$20221012$20170406$20221020$PER$$US-JNJFOC-20170308357$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221021$$LW$US$US
134123774$13412377$4$F$$20221012$20170406$20221021$PER$$US-JNJFOC-20170310348$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134123874$13412387$4$F$$20220926$20170406$20221003$PER$$US-JNJFOC-20170309978$JOHNSON AND JOHNSON$$$$$M$Y$$$20221003$$LW$US$US
134123924$13412392$4$F$20160606$20221019$20170406$20221026$EXP$$US-JNJFOC-20170309959$JOHNSON AND JOHNSON$$28$YR$A$M$Y$$$20221026$$HP$US$US
134124422$13412442$2$F$$20221213$20170406$20221215$PER$$US-JNJFOC-20170308324$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134124524$13412452$4$F$$20221116$20170406$20221128$PER$$US-JNJFOC-20170308352$JOHNSON AND JOHNSON$$$$$M$Y$$$20221128$$LW$US$US
134124984$13412498$4$F$20020101$20221219$20170406$20221225$PER$$US-JNJFOC-20170309543$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221226$$LW$US$US
134125104$13412510$4$F$20090325$20221019$20170406$20221031$PER$$US-JNJFOC-20170309203$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221031$$LW$US$US
134127504$13412750$4$F$20010510$20220922$20170406$20221001$PER$$US-JNJFOC-20170310766$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221001$$HP$US$US
134127835$13412783$5$F$$20221012$20170406$20221021$PER$$US-JNJFOC-20170312219$JOHNSON AND JOHNSON$$$$$M$Y$$$20221021$$LW$US$US
134128633$13412863$3$F$20070207$20220928$20170406$20221003$PER$$US-JNJFOC-20170312479$JOHNSON AND JOHNSON$$18$YR$A$M$Y$$$20221003$$LW$US$US
134128874$13412887$4$F$$20221021$20170406$20221030$PER$$US-JNJFOC-20170312473$JOHNSON AND JOHNSON$$$$$M$Y$$$20221030$$LW$US$US
134129043$13412904$3$F$20071001$20221006$20170406$20221017$PER$$US-JNJFOC-20161012299$JOHNSON AND JOHNSON$$19$YR$A$M$Y$$$20221017$$HP$US$US
134129764$13412976$4$F$20071119$20221207$20170406$20221213$EXP$$US-JNJFOC-20170312159$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221213$$LW$US$US
134131085$13413108$5$F$20060613$20221111$20170406$20221114$PER$$US-JNJFOC-20170310810$JOHNSON AND JOHNSON$$3$YR$C$M$Y$$$20221114$$LW$US$US
134131233$13413123$3$F$20130401$20221003$20170406$20221014$PER$$US-JNJFOC-20170310918$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221014$$LW$US$US
134131363$13413136$3$F$$20221114$20170406$20221117$PER$$US-JNJFOC-20170311511$JOHNSON AND JOHNSON$$$$$M$Y$$$20221117$$LW$US$US
134132044$13413204$4$F$20060710$20221207$20170406$20221209$PER$$US-JNJFOC-20161015927$JOHNSON AND JOHNSON$$15$YR$T$M$Y$$$20221209$$LW$US$US
134132723$13413272$3$F$20090101$20221205$20170407$20221212$EXP$$US-JAZZ-2017-US-004232$JAZZ$$39$YR$$F$Y$$$20221212$$MD$US$US
134134764$13413476$4$F$20051116$20221012$20170406$20221020$PER$$US-JNJFOC-20170317340$JOHNSON AND JOHNSON$$8$YR$C$M$Y$$$20221020$$HP$US$US
134135873$13413587$3$F$20060801$20221114$20170406$20221124$PER$$US-JNJFOC-20170317752$JOHNSON AND JOHNSON$$11$YR$$M$Y$$$20221124$$LW$US$US
134136574$13413657$4$F$$20221207$20170406$20221209$PER$$US-JNJFOC-20170317860$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221209$$LW$US$US
134137194$13413719$4$F$20090101$20221003$20170406$20221014$PER$$US-JNJFOC-20170313990$JOHNSON AND JOHNSON$$2$DEC$$M$Y$$$20221014$$LW$US$US
134139784$13413978$4$F$20081211$20221121$20170406$20221130$PER$$US-JNJFOC-20170315347$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221130$$LW$US$US
134140074$13414007$4$F$20080101$20221219$20170406$20221227$PER$$US-JNJFOC-20170315349$JOHNSON AND JOHNSON$$20$YR$A$M$Y$$$20221227$$LW$US$US
134140653$13414065$3$F$$20221207$20170406$20221215$PER$$US-JNJFOC-20170318536$JOHNSON AND JOHNSON$$$$$M$Y$$$20221215$$LW$US$US
134142134$13414213$4$F$20090701$20221114$20170406$20221123$PER$$US-JNJFOC-20170319707$JOHNSON AND JOHNSON$$24$YR$A$M$Y$$$20221123$$LW$US$US
134148803$13414880$3$F$20041013$20221219$20170406$20221226$PER$$US-JNJFOC-20170319818$JOHNSON AND JOHNSON$$4$YR$C$M$Y$$$20221226$$LW$US$US
134148964$13414896$4$F$19980101$20221207$20170406$20221209$PER$$US-JNJFOC-20170319804$JOHNSON AND JOHNSON$$$$C$M$Y$$$20221209$$LW$US$US
134155753$13415575$3$F$20170101$20221115$20170407$20221124$PER$$US-JAZZ-2017-US-004199$JAZZ$$$$$M$Y$$$20221124$$CN$US$US
134158524$13415852$4$F$20170101$20221128$20170406$20221203$EXP$$PHHY2017CA047941$NOVARTIS$$$$$M$Y$$$20221203$$CN$CA$CA
134159044$13415904$4$F$20170101$20221207$20170407$20221219$EXP$$US-PFIZER INC-2017149556$PFIZER$$82$YR$$F$Y$$$20221219$$HP$US$US
1341826926$13418269$26$F$20170330$20221118$20170407$20221123$EXP$$CA-TAKEDA-2017TUS007276$TAKEDA$$48$YR$$F$Y$$$20221123$$MD$CA$CA
134191303$13419130$3$F$20110101$20221111$20170407$20221121$EXP$$US-JNJFOC-20170320942$JOHNSON AND JOHNSON$$$$T$M$Y$$$20221122$$LW$US$US
134193864$13419386$4$F$$20221020$20170407$20221102$PER$$US-JNJFOC-20170319591$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221102$$HP$US$US
134194964$13419496$4$F$20080501$20221213$20170407$20221221$PER$$US-JNJFOC-20170323475$JOHNSON AND JOHNSON$$23$YR$A$M$Y$$$20221221$$HP$US$US
134195113$13419511$3$F$20060612$20221221$20170407$20221226$PER$$US-JNJFOC-20170306427$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221227$$LW$US$US
1341979412$13419794$12$F$20170201$20221223$20170407$20221229$EXP$$US-PFIZER INC-2017154081$PFIZER$$57$YR$$F$Y$47$KG$20221229$$CN$US$US
134236044$13423604$4$F$20020101$20221117$20170410$20221129$EXP$$US-ELI_LILLY_AND_COMPANY-US201704001084$ELI LILLY AND CO$$$$$M$Y$$$20221129$$CN$US$US
1342535213$13425352$13$F$20170322$20221114$20170411$20221123$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002878$ACADIA PHARMACEUTICALS$$63$YR$$F$Y$$$20221124$$CN$US$US
134313025$13431302$5$F$20170113$20221024$20170412$20221027$EXP$$FR-ASTELLAS-2017US013355$ASTELLAS$$76$YR$$M$Y$$$20221027$$MD$FR$FR
134338126$13433812$6$F$20170301$20221214$20170412$20221221$EXP$$FR-SHIRE-FR201706721$TAKEDA$$33$YR$$F$Y$44$KG$20221221$$HP$FR$FR
1344115040$13441150$40$F$20160101$20221024$20170413$20221026$EXP$$PHHY2016CA138250$NOVARTIS$$$$$F$Y$$$20221026$$CN$CA$CA
1344176218$13441762$18$F$20170331$20221004$20170414$20221006$EXP$$CA-TAKEDA-2016TUS022087$TAKEDA$$39$YR$$F$Y$$$20221006$$CN$CA$CA
1344302735$13443027$35$F$$20221108$20170414$20221111$EXP$$US-PFIZER INC-2016508384$MYLAN$$$$$F$Y$$$20221111$$CN$US$US
134479263$13447926$3$F$20110208$20221103$20170417$20221110$EXP$$US-JNJFOC-20170416037$JOHNSON AND JOHNSON$$59$YR$A$M$Y$$$20221110$$LW$US$US
134492628$13449262$8$F$20180416$20221219$20170417$20221227$EXP$$US-PFIZER INC-2017102280$PFIZER$$78$YR$$M$Y$95.25$KG$20221227$$CN$US$US
134516319$13451631$9$F$20170101$20221202$20170418$20221205$EXP$$US-PFIZER INC-2017161562$PFIZER$$76$YR$$F$Y$$$20221205$$CN$US$US
134576587$13457658$7$F$$20221025$20170419$20221101$EXP$$CA-PFIZER INC-2017162130$PFIZER$Boileau, M.. Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection with Combination Fumagillin and Albendazole. Open Forum Infectious Diseases. 2016;3(3):10.1093/ofid/ofw158$49$YR$$M$Y$$$20221101$$MD$CA$CA
134609012$13460901$2$F$20130429$20221130$20170420$20221205$EXP$$BE-ROCHE-1220316$ROCHE$$42$YR$$F$Y$85.8$KG$20221205$$MD$BE$
1346209010$13462090$10$F$20170125$20221114$20170420$20221121$EXP$$JP-AEGERION PHARMACEUTICAL, INC-AEGR003026$AEGERION$$$$$$Y$$$20221121$$MD$JP$JP
1346262225$13462622$25$F$20170619$20221104$20170420$20221115$EXP$$CA-CELLTRION INC.-2017CA002002$CELLTRION$$$$$$Y$$$20221115$$CN$CA$CA
1346758110$13467581$10$F$20170101$20221219$20170421$20221222$EXP$$US-PFIZER INC-2017038221$PFIZER$$70$YR$$F$Y$54$KG$20221222$$CN$US$US
134809919$13480991$9$F$20170101$20221018$20170425$20221020$EXP$$CA-TAKEDA-2017TUS008390$TAKEDA$$47$YR$$F$Y$$$20221020$$CN$CA$CA
1348445811$13484458$11$F$20160927$20221102$20170426$20221108$EXP$$PHHY2016CA148710$NOVARTIS$$66$YR$$F$Y$$$20221108$$CN$CA$CA
134866394$13486639$4$F$20170401$20221026$20170426$20221028$PER$$US-PFIZER INC-2017180773$PFIZER$$47$YR$$F$Y$50$KG$20221028$$CN$US$US
1349693436$13496934$36$F$20170425$20221104$20170428$20221107$EXP$$DE-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-023596$BOEHRINGER INGELHEIM$$65$YR$E$M$Y$90$KG$20221107$$MD$DE$DE
1350002510$13500025$10$F$$20221109$20170501$20221116$EXP$$CA-PFIZER INC-2017188696$PFIZER$Thavendiranathan, P.. Left ventricular dysfunction with trastuzumab therapy: Is primary prevention the best option?. Journal of Clinical Oncology. 2017;35 (8):820-825$51$YR$$F$Y$$$20221116$$HP$CA$CA
1350521712$13505217$12$F$20170101$20221215$20170502$20221226$EXP$$CA-TAKEDA-2017TUS009171$TAKEDA$$51$YR$$F$Y$$$20221226$$CN$CA$CA
135167237$13516723$7$F$20141201$20221209$20170505$20221215$EXP$$US-BIOGEN-2015BI072120$BIOGEN$$62$YR$$F$Y$$$20221215$$CN$US$US
1351680010$13516800$10$F$20110101$20221110$20170505$20221117$EXP$$US-BIOGEN-2012BI010881$BIOGEN$$54$YR$$M$Y$$$20221116$$HP$US$US
135169383$13516938$3$F$$20221115$20170505$20221118$PER$$US-PFIZER INC-2017193055$PFIZER$$63$YR$$M$Y$$$20221118$$HP$US$US
135179163$13517916$3$F$20170425$20221207$20170505$20221209$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-037980$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$$$20221209$$HP$US$US
1351935913$13519359$13$F$20000101$20221220$20170505$20221229$EXP$$CA-PFIZER INC-2017196797$PFIZER$$58$YR$$F$Y$52$KG$20221229$$CN$CA$CA
135212729$13521272$9$F$$20221020$20170508$20221025$PER$$US-PFIZER INC-2017192842$PFIZER$$69$YR$$F$Y$70$KG$20221025$$CN$US$US
1352437015$13524370$15$F$20170428$20221109$20170508$20221116$EXP$$PHHY2017CA061628$NOVARTIS$$46$YR$$F$Y$$$20221116$$MD$CA$CA
1352576223$13525762$23$F$20161012$20221212$20170509$20221219$EXP$$CA-ROCHE-1931235$ROCHE$$66$YR$$F$Y$$$20221219$$MD$CA$CA
135277513$13527751$3$F$$20221118$20170509$20221123$EXP$$CA-PFIZER INC-2017200671$PFIZER$$29$YR$$F$Y$$$20221123$$CN$CA$CA
135279808$13527980$8$F$20180701$20221108$20170509$20221111$EXP$$US-PFIZER INC-2017199271$PFIZER$$68$YR$$M$Y$91$KG$20221111$$CN$US$US
135316107$13531610$7$F$20170201$20221026$20170510$20221101$EXP$$PHHY2017CA025217$NOVARTIS$$48$YR$$F$Y$$$20221101$$MD$CA$CA
1353323018$13533230$18$F$$20221025$20170510$20221101$EXP$$CA-PFIZER INC-2017199190$PFIZER$Villeneuve, E.. Management of a mixed overdose in the prehospital setting: a case report. Clinical Toxicology. 2017;55 (5):511$71$YR$$F$Y$$$20221101$$HP$CA$CA
1353492724$13534927$24$F$20170101$20221020$20170511$20221031$EXP$$JP-ABBVIE-17K-087-1968634-00$ABBVIE$$$$$F$Y$44$KG$20221031$$MD$JP$JP
1353686735$13536867$35$F$20080101$20221115$20170511$20221122$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-1374$ORION$$44$YR$A$F$Y$63$KG$20221122$$MD$CA$
135370753$13537075$3$F$20160101$20221120$20170511$20221124$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-1373$ORION$$29$YR$A$F$Y$$$20221124$$CN$CA$
135389854$13538985$4$F$20040623$20221003$20170512$20221013$PER$$US-JNJFOC-20170416710$JOHNSON AND JOHNSON$$7$YR$C$M$Y$$$20221013$$LW$US$US
135421418$13542141$8$F$$20221025$20170512$20221031$EXP$$CA-BAUSCH-BL-2017-014965$BAUSCH AND LOMB$Villeneuve E, Delisle M, Wang J, Gosselin S. Management of a mixed overdose in the prehospital setting: A case report. Clinical Toxicology. 2017 JAN 01;55(5):511.$71$YR$$F$Y$$$20221031$$HP$CA$CA
135436358$13543635$8$F$20170501$20221031$20170515$20221102$EXP$$KR-ROCHE-1933494$ROCHE$$70$YR$$M$Y$60$KG$20221102$$MD$KR$
135450646$13545064$6$F$20170405$20221223$20170515$20221230$EXP$$JP-009507513-1705JPN000736J$MERCK$Matsumoto K, Wakatuki J, Sakuma D, Kin E, Kobayashi Y, Komata M. WS16-3 Immune-related side effects during the first 5 years of use of immune checkpoint inhibitors. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$81$YR$$F$Y$41$KG$20221230$$MD$JP$JP
1354546512$13545465$12$F$20170101$20221209$20170515$20221216$EXP$$US-PFIZER INC-2016460842$PFIZER$$78$YR$$F$Y$59.87$KG$20221216$$CN$US$US
135461403$13546140$3$F$20151023$20170118$20170515$20221208$EXP$$IT-TEVA-2015-29152$TEVA$$49$YR$A$M$Y$$$20221208$$MD$IT$IT
135495299$13549529$9$F$20170430$20221004$20170516$20221014$EXP$$DE-ROCHE-1932235$ROCHE$$72$YR$$M$Y$87$KG$20221014$$MD$DE$
135517933$13551793$3$F$20161201$20221118$20170516$20221123$EXP$$US-BAXALTA-2017BLT004225$TAKEDA$$42$YR$$F$Y$$$20221123$$MD$US$US
135534048$13553404$8$F$20170831$20221115$20170517$20221122$EXP$$CA-ROCHE-1935668$ROCHE$$38$YR$$F$Y$$$20221122$$CN$CA$CA
1355584510$13555845$10$F$20160818$20221212$20170517$20221216$EXP$$CA-TAKEDA-2016TUS015919$TAKEDA$$24$YR$$M$Y$$$20221216$$MD$CA$CA
1355756022$13557560$22$F$20170101$20221114$20170517$20221123$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002993$ACADIA PHARMACEUTICALS$$$$$M$Y$$$20221124$$CN$US$US
1355772815$13557728$15$F$$20221108$20170518$20221111$EXP$$US-PFIZER INC-2017212769$PFIZER$$71$YR$$F$Y$49$KG$20221111$$CN$US$US
135579073$13557907$3$F$20170401$20221014$20170517$20221107$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003177$ACADIA PHARMACEUTICALS$$73$YR$$M$Y$$$20221107$$CN$US$US
135580163$13558016$3$F$20170201$20221031$20170517$20221124$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003267$ACADIA PHARMACEUTICALS$$62$YR$$M$Y$$$20221125$$CN$US$US
1355807312$13558073$12$F$20140101$20221122$20170517$20221215$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-002942$ACADIA PHARMACEUTICALS$$$$$F$Y$59$KG$20221216$$CN$US$US
135586332$13558633$2$F$$20221014$20170518$20221021$PER$$US-JAZZ-2017-US-006236$JAZZ$$$$$F$Y$$$20221021$$CN$US$US
135615405$13561540$5$F$$20221025$20170518$20221104$EXP$$CA-LUPIN PHARMACEUTICALS INC.-2017-02331$LUPIN$Villeneuve E, Delisle M, Wang JJ, Gosselin S. Management of a mixed overdose in the prehospital setting: a case report. Clinical Toxicology. 2017;55(5):511$71$YR$$F$Y$$$20221104$$HP$CA$CA
1356231518$13562315$18$F$20150821$20221220$20170519$20221227$EXP$$CA-ROCHE-1936490$ROCHE$$55$YR$$F$Y$$$20221227$$CN$CA$CA
135625496$13562549$6$F$$20221215$20170519$20221226$EXP$$CA-APOTEX-2017AP011966$APOTEX$$64$YR$$M$Y$74$KG$20221226$$MD$CA$CA
135653773$13565377$3$F$20160501$20221024$20170519$20221031$EXP$$US-JAZZ-2017-US-005619$JAZZ$$54$YR$$F$Y$$$20221031$$CN$US$US
135675432$13567543$2$F$$20221207$20170522$20221213$PER$$US-PFIZER INC-2017219941$PFIZER$$64$YR$$F$Y$$$20221213$$CN$US$US
1356828519$13568285$19$F$20150803$20221215$20170522$20221220$EXP$$AU-SA-2015SA169162$SANOFI AVENTIS$$39$YR$A$F$Y$$$20221220$$HP$AU$AU
135708204$13570820$4$F$$20221003$20170523$20221005$EXP$$US-TAKEDA-2017TUS011346$TAKEDA$$$$$$Y$$$20221005$$CN$US$US
135738742$13573874$2$F$20170101$20221207$20170523$20221216$PER$$US-PFIZER INC-2017219840$PFIZER$$64$YR$$F$Y$$$20221216$$CN$US$US
135739157$13573915$7$F$20170106$20221213$20170523$20221220$EXP$$PHJP2017JP001384$NOVARTIS$$48$YR$$M$Y$$$20221220$$MD$JP$JP
135753943$13575394$3$F$$20221024$20170524$20221107$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-141241$RANBAXY$$$$A$M$Y$$$20221107$$CN$US$US
135785608$13578560$8$F$20170501$20221220$20170524$20221223$EXP$$US-JAZZ-2017-US-006083$JAZZ$$71$YR$$M$Y$$$20221223$$CN$US$US
135787922$13578792$2$F$20160101$20220802$20170524$20221026$PER$$US-JAZZ-2017-US-004882$JAZZ$$$$$M$Y$$$20221026$$CN$US$US
135804002$13580400$2$F$20150529$20221117$20170525$20221123$EXP$$US-SHIRE-US201711036$TAKEDA$$46$YR$$F$Y$$$20221123$$HP$US$US
135829905$13582990$5$F$$20221219$20170525$20221222$EXP$$US-JAZZ-2017-US-006284$JAZZ$$$$$M$Y$$$20221222$$CN$US$US
1358505711$13585057$11$F$20150611$20221212$20170526$20221219$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN076917$VIIV$$$$$$Y$$$20221214$$MD$JP$JP
135876199$13587619$9$F$20170322$20221206$20170526$20221214$EXP$$CA-TAKEDA-2017TUS008487$TAKEDA$$42$YR$$M$Y$$$20221214$$CN$CA$CA
1359000038$13590000$38$F$20130919$20221220$20170529$20221228$EXP$$GB-drreddys-GER/UKI/17/0090884$DR REDDYS$$55$YR$A$M$Y$$$20221228$$MD$GB$GB
135912495$13591249$5$F$20170324$20221118$20170530$20221121$EXP$$US-PFIZER INC-2017127969$PFIZER$$68$YR$$F$Y$$$20221121$$CN$US$US
135923455$13592345$5$F$20111101$20221006$20170530$20221007$PER$$US-PFIZER INC-2017233572$PFIZER$$72$YR$$F$Y$75$KG$20221007$$LW$US$US
135923537$13592353$7$F$20111102$20221006$20170530$20221007$PER$$US-PFIZER INC-2016402029$PFIZER$$60$YR$$F$Y$$$20221007$$LW$US$US
135926288$13592628$8$F$20170501$20221004$20170530$20221007$EXP$$CA-TAKEDA-2017TUS011597$TAKEDA$$19$YR$$F$Y$$$20221007$$CN$CA$CA
1359283810$13592838$10$F$20130919$20221220$20170530$20221229$EXP$GB-MHRA-ADR 23836748$GB-TORRENT-00014939$TORRENT$$55$YR$A$M$Y$$$20221229$$MD$GB$GB
135991773$13599177$3$F$20170521$20221013$20170531$20221019$EXP$$US-ARIAD-2017US008265$TAKEDA$$59$YR$$F$Y$$$20221019$$CN$US$US
1360090413$13600904$13$F$20170521$20221116$20170601$20221118$EXP$$PL-ROCHE-1940860$ROCHE$$56$YR$$F$Y$63$KG$20221118$$MD$PL$
136021315$13602131$5$F$20170207$20221010$20170601$20221013$EXP$$IT-PFIZER INC-2017238938$PFIZER$$13$YR$$M$Y$$$20221013$$MD$IT$IT
1361086621$13610866$21$F$20160804$20221003$20170605$20221005$EXP$$PHHY2017IT021869$NOVARTIS$$13$YR$$M$Y$44$KG$20221005$$MD$IT$IT
136118675$13611867$5$F$$20170620$20170605$20221212$EXP$$ES-TEVA-774045ISR$TEVA$$67$YR$E$F$Y$$$20221212$$MD$ES$ES
136193443$13619344$3$F$20160101$20200627$20170606$20221008$PER$$US-PURDUE-USA-2016-0132275$PURDUE$$59$YR$$F$Y$$$20221008$$CN$US$US
136195624$13619562$4$F$20111101$20221123$20170606$20221130$EXP$$US-JAZZ-2017-US-006353$JAZZ$$27$YR$$M$Y$$$20221130$$MD$US$US
1362375226$13623752$26$F$20171103$20221121$20170608$20221128$EXP$$CA-ROCHE-1946081$ROCHE$$53$YR$$F$Y$90$KG$20221128$$CN$CA$CA
136251504$13625150$4$F$$20220928$20170607$20221012$PER$$US-JNJFOC-20170602495$JOHNSON AND JOHNSON$$$$$M$Y$$$20221010$$LW$US$US
136251904$13625190$4$F$20001109$20220928$20170607$20221007$PER$$US-JNJFOC-20170602379$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221007$$HP$US$US
136270405$13627040$5$F$20151201$20221015$20170607$20221017$PER$$US-PFIZER INC-2017239506$PFIZER$$55$YR$$F$Y$$$20221017$$LW$US$US
136270596$13627059$6$F$20121001$20221001$20170607$20221004$PER$$US-PFIZER INC-2016584463$PFIZER$$58$YR$$F$Y$$$20221004$$LW$US$US
136270673$13627067$3$F$20130201$20221015$20170607$20221017$PER$$US-PFIZER INC-2017239452$PFIZER$$61$YR$$F$Y$$$20221017$$LW$US$US
136287903$13628790$3$F$20120101$20221005$20170607$20221006$PER$$US-PFIZER INC-2016584439$PFIZER$$46$YR$$F$Y$79$KG$20221006$$LW$US$US
136354294$13635429$4$F$$20221122$20170609$20221128$PER$$US-PFIZER INC-2017250307$PFIZER$$53$YR$$F$Y$$$20221128$$CN$US$US
1363703612$13637036$12$F$$20221214$20170609$20221220$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK085504$GLAXOSMITHKLINE$$$$$$Y$$$20221220$$MD$CA$CA
136401705$13640170$5$F$$20221213$20170609$20221219$EXP$$US-BAXALTA-2017BLT005408$TAKEDA$$$$$F$Y$134$KG$20221219$$CN$US$US
136432265$13643226$5$F$20170510$20221208$20170612$20221215$EXP$$CA-TAKEDA-2017TUS012584$TAKEDA$$33$YR$$F$Y$55.329$KG$20221215$$CN$CA$CA
136442425$13644242$5$F$$20221007$20170612$20221012$PER$$US-PFIZER INC-2017252015$PFIZER$$75$YR$$M$Y$113$KG$20221012$$CN$US$US
136461652$13646165$2$F$20170524$20221103$20170613$20221116$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-051724$BRISTOL MYERS SQUIBB$$61$YR$A$F$Y$$$20221116$$CN$US$US
1364725214$13647252$14$F$20161216$20221110$20170613$20221114$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN088088$VIIV$$$$$$Y$$$20221114$$MD$JP$JP
1365101229$13651012$29$F$20170101$20221109$20170614$20221115$EXP$$US-INCYTE CORPORATION-2017IN004526$INCYTE$$$$$$Y$$$20221115$$CN$US$US
1365103610$13651036$10$F$$20221206$20170614$20221212$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK144065$GLAXOSMITHKLINE$$$$$$Y$$$20221212$$CN$BR$BR
136513203$13651320$3$F$$20221117$20170614$20221122$EXP$$AU-PFIZER INC-2017252504$PFIZER$$44$YR$$M$Y$$$20221122$$MD$AU$AU
136585424$13658542$4$F$20220101$20221207$20170616$20221212$EXP$$US-PFIZER INC-2017164379$PFIZER$$69$YR$$M$Y$$$20221212$$CN$US$US
1365857414$13658574$14$F$$20220927$20170616$20221010$EXP$$GB-GLENMARK PHARMACEUTICALS-2017GMK027851$GLENMARK$$$$$$Y$$$20221010$$PH$GB$GB
1365953730$13659537$30$F$20160101$20221019$20170616$20221026$EXP$$PHHY2014CA049928$NOVARTIS$$$$$F$Y$$$20221026$$HP$CA$CA
136612763$13661276$3$F$20131001$20221221$20170616$20221222$PER$$US-PFIZER INC-2017158441$PFIZER$$59$YR$$F$Y$$$20221222$$LW$US$US
136634412$13663441$2$F$$20221024$20170619$20221027$PER$$US-PFIZER INC-2017261500$PFIZER$$36$YR$$F$Y$$$20221027$$CN$US$US
136677834$13667783$4$F$20170516$20221125$20170620$20221129$EXP$$FR-SHIRE-FR201711214$TAKEDA$$51$YR$$M$Y$53$KG$20221129$$HP$FR$FR
136693863$13669386$3$F$20170401$20170608$20170620$20221209$EXP$$CA-TEVA-764373ACC$TEVA$$31$YR$A$M$Y$$$20221209$$CN$CA$CA
136732318$13673231$8$F$$20221215$20170621$20221221$EXP$$CA-ROCHE-1952034$ROCHE$$60$YR$$F$Y$64$KG$20221221$$HP$CA$
136743692$13674369$2$F$$20221026$20170621$20221102$PER$$US-AMGEN-USASP2017091074$AMGEN$$$$A$F$Y$$$20221102$$CN$US$US
136751873$13675187$3$F$20110104$20220926$20170621$20221004$EXP$$US-AstraZeneca-2017SE62631$ASTRAZENECA$$22692$DY$$F$Y$87.3$KG$20221004$$LW$US$
1367670212$13676702$12$F$20180404$20221003$20170622$20221014$EXP$$US-PFIZER INC-2017270929$MYLAN$$57$YR$$F$Y$100$KG$20221014$$CN$US$US
1368227512$13682275$12$F$$20221009$20170623$20221011$EXP$GB-MHRA-MIDB-CCF9279F-D2CB-42FC-ADF9-3A1581D4A5BD$PHFR2017GB004594$NOVARTIS$$47$YR$$F$Y$$$20221011$$PH$GB$GB
136824972$13682497$2$F$20170525$20221109$20170623$20221118$EXP$$CA-JNJFOC-20170617857$JOHNSON AND JOHNSON$$40$YR$A$M$Y$127.01$KG$20221118$$CN$CA$CA
1368793832$13687938$32$F$20121226$20221020$20170626$20221027$EXP$$CA-ROCHE-1196834$ROCHE$$45$YR$$F$Y$75$KG$20221027$$HP$CA$
1368847913$13688479$13$F$$20221122$20170626$20221205$EXP$$GB-AUROBINDO-AUR-APL-2017-35698$AUROBINDO$$47$YR$$F$Y$$$20221205$$PH$GB$GB
1369684235$13696842$35$F$20160914$20221122$20170628$20221201$EXP$$CO-INCYTE CORPORATION-2017IN005035$INCYTE$$$$$$Y$$$20221201$$CN$CO$CO
136979644$13697964$4$F$$20221219$20170628$20221231$EXP$$CA-APOTEX-2017AP013336$APOTEX$$60$YR$$F$Y$64$KG$20221231$$HP$CA$CA
136992574$13699257$4$F$$20221025$20170628$20221031$EXP$$BE-BAUSCH-BL-2017-019916$BAUSCH AND LOMB$Heyrman B, De Becker A, Schots R. A case report of immunosuppression-related Kaposi^s sarcoma after autologous stem cell transplantation. BMC research notes. 2016;9:1-5. doi:10.1186/s13104-016-1991-9$61$YR$$M$Y$$$20221031$$MD$BE$BE
1370316018$13703160$18$F$20170101$20221212$20170629$20221219$EXP$$US-PFIZER INC-2017142637$PFIZER$$78$YR$$F$Y$$$20221219$$CN$US$US
137043299$13704329$9$F$$20221121$20170630$20221210$EXP$$CA-ROCHE-1955170$ROCHE$$$$$F$Y$70$KG$20221210$$HP$CA$
137048737$13704873$7$F$$20221214$20170630$20221226$EXP$$CA-APOTEX-2017AP013514$APOTEX$$85$YR$$M$Y$$$20221226$$MD$CA$CA
137068084$13706808$4$F$20010501$20221116$20170630$20221128$PER$$US-JNJFOC-20170616667$JOHNSON AND JOHNSON$$10$YR$C$M$Y$$$20221128$$LW$US$US
137076147$13707614$7$F$20150101$20221207$20170630$20221214$EXP$$US-JAZZ-2017-US-008350$JAZZ$$$$$F$Y$$$20221214$$MD$US$US
1370783912$13707839$12$F$$20221123$20170630$20221128$EXP$$US-PFIZER INC-2017284135$PFIZER$$71$YR$$F$Y$$$20221128$$CN$US$US
1371085214$13710852$14$F$20170507$20221115$20170703$20221118$EXP$$TR-ROCHE-1932955$ROCHE$$76$YR$$M$Y$78.3$KG$20221118$$MD$TR$
1371148735$13711487$35$F$20170101$20221214$20170703$20221222$EXP$$CA-CELLTRION INC.-2017CA008553$CELLTRION$$$$$$Y$$$20221222$$CN$CA$CA
137145129$13714512$9$F$20170601$20221116$20170704$20221119$EXP$$PHHY2017CA097764$NOVARTIS$$40$YR$$M$Y$$$20221119$$CN$CA$CA
1371571713$13715717$13$F$$20221013$20170705$20221021$EXP$$CA-JNJFOC-20170625604$JOHNSON AND JOHNSON$$50$YR$A$F$Y$110$KG$20221021$$HP$CA$CA
137168045$13716804$5$F$20220203$20221027$20170705$20221104$EXP$$CA-ROCHE-1959369$ROCHE$$75$YR$$F$Y$$$20221103$$MD$CA$CA
1371742525$13717425$25$F$20161114$20221103$20170705$20221108$EXP$$BR-GLAXOSMITHKLINE-BR2015GSK176439$GLAXOSMITHKLINE$$$$$$Y$$$20221108$$CN$BR$BR
137174472$13717447$2$F$$20221212$20170705$20221219$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK101194$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$CA$CA
1371785211$13717852$11$F$$20221202$20170705$20221207$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK060417$GLAXOSMITHKLINE$$$$$$Y$$$20221207$$CN$BR$BR
137180054$13718005$4$F$20160127$20221220$20170705$20221227$EXP$$JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-083600$BRISTOL MYERS SQUIBB$$76$YR$E$F$Y$73$KG$20221227$$MD$JP$JP
137198107$13719810$7$F$20150501$20221220$20170705$20221228$EXP$$US-JAZZ-2017-US-008485$JAZZ$$49$YR$$F$Y$$$20221228$$HP$US$US
137212426$13721242$6$F$20160228$20221026$20170706$20221102$EXP$$CA-ROCHE-1958977$ROCHE$$65$YR$$F$Y$$$20221102$$MD$CA$CA
1372446910$13724469$10$F$20170501$20221114$20170706$20221117$EXP$$CA-PFIZER INC-2017285010$PFIZER$$61$YR$$F$Y$$$20221117$$CN$CA$CA
137245543$13724554$3$F$20160101$20221207$20170706$20221215$EXP$$US-PFIZER INC-2017288743$PFIZER$$69$YR$$F$Y$66.667$KG$20221215$$CN$US$US
137273677$13727367$7$F$20170113$20221206$20170707$20221214$EXP$$PHHY2016CA109137$NOVARTIS$$78$YR$$F$Y$$$20221214$$CN$CA$CA
1373534710$13735347$10$F$20170101$20221109$20170710$20221115$EXP$$PHHY2017CA100155$NOVARTIS$$$$$M$Y$120$KG$20221115$$CN$CA$CA
1373879924$13738799$24$F$20170601$20221205$20170710$20221213$EXP$$CA-CELLTRION INC.-2017CA008652$CELLTRION$$$$$$Y$$$20221213$$CN$CA$CA
137419374$13741937$4$F$20170622$20221007$20170711$20221011$PER$$US-PFIZER INC-2017298881$PFIZER$$64$YR$$M$Y$$$20221011$$CN$US$US
137457707$13745770$7$F$$20221017$20170712$20221025$EXP$$US-PFIZER INC-2017268709$PFIZER$$9$YR$$M$Y$30$KG$20221025$$HP$US$US
137554058$13755405$8$F$20140424$20221012$20170714$20221014$PER$$US-PFIZER INC-2017305436$PFIZER$$70$YR$$F$Y$$$20221014$$MD$US$US
1375543414$13755434$14$F$20170301$20221209$20170714$20221216$EXP$$US-PFIZER INC-2017306034$PFIZER$$57$YR$$F$Y$$$20221216$$CN$US$US
137554607$13755460$7$F$$20221006$20170714$20221007$PER$$US-PFIZER INC-2017303511$PFIZER$$69$YR$$F$Y$$$20221007$$MD$US$US
137555542$13755554$2$F$20150101$20221122$20170714$20221129$PER$$US-AMGEN-USASL2017104973$AMGEN$$74$YR$E$M$Y$$$20221128$$CN$US$US
137578103$13757810$3$F$$20221017$20170717$20221027$EXP$$CA-ROCHE-1962285$ROCHE$$40$YR$$F$Y$$$20221027$$CN$CA$CA
137578184$13757818$4$F$20140801$20221119$20170717$20221201$EXP$$FR-Accord-053593$ACCORD$Bodard Q, Litrowski N, Carre D, Midhat M, Chenal P, Bravard P.. Mycosis fungoides in a heart transplant recipient.. Ann Dermatol Venereol..2017;144(10):624-8.$68$YR$E$M$Y$$$20221201$$HP$FR$FR
1375930214$13759302$14$F$20151110$20180822$20170717$20221003$EXP$$PHHY2016DE115328$NOVARTIS$$2$YR$$M$Y$12.2$KG$20221003$$MD$DE$DE
137612837$13761283$7$F$20140101$20221012$20170717$20221017$EXP$$PHHY2015CR008160$NOVARTIS$$$$$F$Y$56.7$KG$20221017$$CN$CR$CR
137618042$13761804$2$F$20170201$20221010$20170718$20221013$EXP$FR-AFSSAPS-AM20170810$FR-TAKEDA-2017TUS015034$TAKEDA$$55$YR$$M$Y$72$KG$20221013$$HP$FR$FR
1376235313$13762353$13$F$20170703$20221214$20170718$20221220$EXP$$US-PFIZER INC-2017301253$PFIZER$$59$YR$$M$Y$61$KG$20221220$$CN$US$US
137660856$13766085$6$F$20170630$20221114$20170719$20221124$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004619$ACADIA PHARMACEUTICALS$$80$YR$$M$Y$$$20221124$$CN$US$US
137679273$13767927$3$F$$20221212$20170719$20221215$PER$$US-PFIZER INC-2017307830$PFIZER$$72$YR$$M$Y$$$20221215$$HP$US$US
137679849$13767984$9$F$20160201$20221214$20170719$20221227$EXP$$IN-INCYTE CORPORATION-2016IN000807$INCYTE$$$$$$Y$$$20221227$$CN$IN$IN
137700023$13770002$3$F$20160917$20220929$20170719$20221003$EXP$$US-TAKEDA-2017TUS015029$TAKEDA$$30$YR$$F$Y$66.667$KG$20221003$$HP$US$US
137728373$13772837$3$F$20170619$20221208$20170720$20221216$EXP$$JP-SHIRE-JP201716085$TAKEDA$$9$YR$$F$Y$$$20221216$$MD$JP$JP
1377312214$13773122$14$F$20170706$20221012$20170720$20221021$PER$$US-INCYTE CORPORATION-2017IN005517$INCYTE$$$$$$Y$$$20221021$$CN$US$US
1377331615$13773316$15$F$20170101$20220930$20170720$20221004$EXP$$CA-PFIZER INC-2017165290$PFIZER$$62$YR$$F$Y$$$20221004$$CN$CA$CA
137754354$13775435$4$F$20170601$20221207$20170720$20221209$EXP$$CA-TAKEDA-2017TUS015054$TAKEDA$$65$YR$$F$Y$$$20221209$$CN$CA$CA
1377743412$13777434$12$F$20160715$20221209$20170721$20221220$EXP$$CA-ROCHE-1964975$ROCHE$$17$YR$$M$Y$$$20221220$$CN$CA$CA
137788618$13778861$8$F$20170929$20221101$20170721$20221103$PER$$US-PFIZER INC-2017316465$PFIZER$$70$YR$$F$Y$66.22$KG$20221103$$HP$US$US
137790453$13779045$3$F$20130101$20220927$20170721$20221010$EXP$$FR-AUROBINDO-AUR-APL-2015-01074$AUROBINDO$Barbara Doudier, Hugues Vencatassin, Sarah Aherfi, Philippe Colsonb. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France. Journal of Clinical Microbiology. 2014;52(4):1294-1297$77$YR$$F$Y$$$20221010$$HP$FR$FR
137837237$13783723$7$F$$20221121$20170724$20221122$PER$$US-PFIZER INC-2017320556$PFIZER$$69$YR$$F$Y$$$20221122$$HP$US$US
137851605$13785160$5$F$$20221129$20170725$20221202$EXP$$US-ROCHE-1966350$ROCHE$$30$YR$$M$Y$80.812$KG$20221202$$HP$US$
137902963$13790296$3$F$20170101$20170818$20170725$20221027$EXP$$US-VIIV HEALTHCARE LIMITED-US2017113730$VIIV$$$$$F$Y$$$20221027$$PH$US$US
137911163$13791116$3$F$20160527$20221206$20170725$20221215$PER$$US-INCYTE CORPORATION-2017IN003389$INCYTE$$$$$$Y$$$20221215$$CN$US$US
137925767$13792576$7$F$20161129$20221130$20170726$20221204$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-041483$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$75$KG$20221204$$HP$ES$ES
1379432715$13794327$15$F$$20221020$20170726$20221024$PER$$US-PFIZER INC-2017241581$PFIZER$$25$YR$$M$Y$$$20221024$$CN$US$US
137953567$13795356$7$F$20190320$20221018$20170726$20221020$EXP$$US-PFIZER INC-2017324138$PFIZER$$65$YR$$F$Y$84$KG$20221020$$HP$US$US
137981064$13798106$4$F$$20221117$20170727$20221118$PER$$US-PFIZER INC-2017324389$PFIZER$$46$YR$$F$Y$$$20221118$$CN$US$US
138024487$13802448$7$F$20170424$20221201$20170728$20221208$EXP$$CA-ROCHE-1967729$ROCHE$$31$YR$$F$Y$$$20221208$$MD$CA$CA
138056073$13805607$3$F$20150511$20221005$20170728$20221007$PER$$US-PFIZER INC-2016584416$PFIZER$$47$YR$$F$Y$84.8$KG$20221007$$LW$US$US
138056185$13805618$5$F$20131101$20221005$20170728$20221006$PER$$US-PFIZER INC-2017053691$PFIZER$$56$YR$$F$Y$104$KG$20221006$$LW$US$US
138060924$13806092$4$F$20160315$20221007$20170728$20221014$EXP$$PHHY2016CA036453$NOVARTIS$$43$YR$$M$Y$$$20221014$$MD$CA$CA
138066333$13806633$3$F$$20221019$20170728$20221019$EXP$$CA-PFIZER INC-2017325722$PFIZER$$49$YR$$F$Y$$$20221019$$CN$CA$CA
138126095$13812609$5$F$20170724$20221114$20170728$20221117$EXP$$PHHY2017CA111503$NOVARTIS$$46$YR$$F$Y$$$20221117$$CN$CA$CA
1381361619$13813616$19$F$20170716$20221102$20170731$20221108$EXP$$CA-ROCHE-1971321$ROCHE$$22$YR$$F$Y$$$20221108$$MD$CA$CA
138154434$13815443$4$F$$20170801$20170731$20221212$EXP$$GB-TEVA-793081ISR$TEVA$$48$YR$A$F$Y$$$20221212$$MD$GB$GB
138159066$13815906$6$F$20141022$20220912$20170731$20221005$EXP$$PHHY2017IT104422$NOVARTIS$$$$$F$Y$10.7$KG$20221005$$MD$IT$IT
138211993$13821199$3$F$20120501$20221005$20170801$20221006$PER$$US-PFIZER INC-2016584472$PFIZER$$48$YR$$F$Y$68$KG$20221006$$LW$US$US
138227253$13822725$3$F$$20221125$20170801$20221130$PER$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-067963$BRISTOL MYERS SQUIBB$Vivar KL, Deschaine M, Messina J, Divine JM, Rabionet A, Patel N, et al. Epidermal programmed cell death-ligand 1 expression in TEN associated with Nivolumab therapy. Journal of Cutaneous Pathology. 2017; 44: 381-4.doi:10.1111/cup.12876.$50$YR$A$F$Y$$$20221201$$HP$US$US
1382387614$13823876$14$F$20170717$20221117$20170802$20221121$EXP$$US-PFIZER INC-2017331290$PFIZER$$78$YR$$F$Y$82$KG$20221121$$CN$US$US
1382411511$13824115$11$F$20170601$20221124$20170802$20221202$EXP$$AU-BIOGEN-2017BI00437644$BIOGEN$$30$YR$$F$Y$$$20221202$$CN$AU$AU
138241803$13824180$3$F$20120101$20221004$20170802$20221007$EXP$$US-AstraZeneca-2017SE78104$ASTRAZENECA$$61$YR$$F$Y$78.5$KG$20221007$$LW$US$
138257976$13825797$6$F$20170522$20221021$20170802$20221024$EXP$$PHJP2017JP021551$NOVARTIS$$70$YR$$M$Y$92.7$KG$20221024$$MD$JP$JP
138262686$13826268$6$F$20100101$20221109$20170802$20221117$EXP$$US-EMD Serono-7056049$EMD SERONO INC$$45$YR$A$F$Y$88$KG$20221117$$CN$US$
1382796012$13827960$12$F$$20221220$20170803$20221226$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-2277$ORION$$56$YR$A$F$Y$$$20221227$$MD$CA$
1383632415$13836324$15$F$20160101$20221109$20170804$20221116$EXP$$PHHY2017BR113598$NOVARTIS$$$$$M$Y$100$KG$20221116$$CN$BR$BR
138415763$13841576$3$F$20170726$20221102$20170807$20221108$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-067594$BRISTOL MYERS SQUIBB$$74$YR$E$M$Y$99$KG$20221109$$HP$US$US
138441075$13844107$5$F$$20221013$20170808$20221106$PER$$US-AMGEN-USASP2017117244$AMGEN$$$$$F$Y$$$20221106$$MD$US$US
138460474$13846047$4$F$$20221003$20170808$20221108$EXP$$US-ROCHE-737962$ROCHE$$$$$F$Y$$$20221108$$MD$US$
1384660216$13846602$16$F$20170529$20221007$20170808$20221008$EXP$$PHHY2017GR116283$NOVARTIS$$13$YR$$M$Y$60$KG$20221008$$MD$GR$GR
138478844$13847884$4$F$20170707$20200407$20170809$20221008$PER$$US-PURDUE-USA-2017-0139866$PURDUE$$$$$F$Y$$$20221008$$CN$US$US
1384976424$13849764$24$F$20170101$20221212$20170809$20221219$EXP$$CA-ROCHE-1976139$ROCHE$$45$YR$$F$Y$85$KG$20221219$$CN$CA$CA
138499738$13849973$8$F$20170701$20221028$20170809$20221104$EXP$$US-ROCHE-1973193$ROCHE$$54$YR$$M$Y$94.432$KG$20221103$$HP$US$
1385082222$13850822$22$F$$20221017$20170809$20221019$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK044952$GLAXOSMITHKLINE$$$$$$Y$$$20221019$$MD$BR$BR
1385138926$13851389$26$F$$20221201$20170809$20221207$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-069714$BRISTOL MYERS SQUIBB$$54$YR$A$F$Y$$$20221207$$CN$CA$CA
138553479$13855347$9$F$20160611$20221128$20170810$20221206$PER$$US-Vifor (International) Inc.-VIT-2017-05244$VIFOR$$86$YR$$F$Y$73.548$KG$20221206$$CN$US$US
138559915$13855991$5$F$20170701$20221031$20170810$20221108$EXP$$US-EMD Serono-8174566$EMD SERONO INC$$76$YR$E$F$Y$$$20221108$$PH$US$
138564634$13856463$4$F$$20221228$20170810$20221230$EXP$$US-JAZZ-2017-US-010131$JAZZ$$$$$F$Y$$$20221230$$CN$US$US
1385764316$13857643$16$F$$20221221$20170811$20221227$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052306$BRISTOL MYERS SQUIBB$$85$YR$E$M$Y$$$20221227$$MD$CA$CA
138610353$13861035$3$F$$20221031$20170811$20221104$PER$$US-PFIZER INC-2017346776$PFIZER$$64$YR$$F$Y$$$20221104$$CN$US$US
138668264$13866826$4$F$20170601$20221222$20170814$20221229$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003979$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20221230$$CN$US$US
138670185$13867018$5$F$20180430$20220908$20170814$20221003$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003808$ACADIA PHARMACEUTICALS$$73$YR$$F$Y$$$20221003$$CN$US$US
138677886$13867788$6$F$20180513$20221004$20170814$20221013$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003633$ACADIA PHARMACEUTICALS$$42$YR$$F$Y$$$20221014$$CN$US$US
138678762$13867876$2$F$20170401$20220914$20170814$20221006$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-003500$ACADIA PHARMACEUTICALS$$79$YR$$F$Y$$$20221007$$CN$US$US
138679235$13867923$5$F$20170601$20221103$20170814$20221111$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004312$ACADIA PHARMACEUTICALS$$82$YR$$M$Y$$$20221111$$CN$US$US
138679723$13867972$3$F$$20221216$20170814$20221226$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004456$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221226$$CN$US$US
138679883$13867988$3$F$$20221215$20170814$20221223$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004485$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221223$$CN$US$US
138680936$13868093$6$F$20170724$20221007$20170814$20221101$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-004919$ACADIA PHARMACEUTICALS$$75$YR$$F$Y$$$20221101$$CN$US$US
138690014$13869001$4$F$20170510$20220927$20170815$20221004$EXP$$US-TAKEDA-2017TUS016678$TAKEDA$$30$YR$$F$Y$63.5$KG$20221004$$HP$US$US
1386944517$13869445$17$F$20161001$20221102$20170815$20221104$EXP$$GB-PFIZER INC-2017352058$MYLAN$$44$YR$$F$Y$$$20221104$$CN$GB$GB
138701086$13870108$6$F$20170614$20221007$20170815$20221010$EXP$GB-MHRA-EYC 00162837$GB-MYLANLABS-2017M1048814$MYLAN$$39$YR$$F$Y$56$KG$20221010$$CN$GB$GB
138730725$13873072$5$F$20170101$20221002$20170816$20221017$EXP$$GB-AUROBINDO-AUR-APL-2017-38614$AUROBINDO$$39$YR$$F$Y$51$KG$20221017$$CN$GB$GB
1387394518$13873945$18$F$20170612$20221118$20170816$20221124$EXP$$PHHY2017CO102043$NOVARTIS$$57$YR$$M$Y$97$KG$20221124$$CN$CO$CO
138758513$13875851$3$F$$20221222$20170817$20221229$PER$$US-AMGEN-USASP2017122132$AMGEN$$59$YR$A$F$Y$$$20221229$$MD$US$US
1387637910$13876379$10$F$$20221026$20170817$20221031$PER$$US-AMGEN-USASP2017122188$AMGEN$$68$YR$E$F$Y$99.79$KG$20221031$$MD$US$US
138777208$13877720$8$F$20170805$20221129$20170817$20221205$EXP$$PHHY2017MT118533$NOVARTIS$$72$YR$$F$Y$$$20221205$$MD$MT$MT
138805647$13880564$7$F$20160316$20221128$20170818$20221205$EXP$$CA-ROCHE-1743894$ROCHE$$52$YR$$F$Y$$$20221205$$CN$CA$CA
138816473$13881647$3$F$20111201$20221005$20170818$20221006$PER$$US-PFIZER INC-2016584465$PFIZER$$52$YR$$F$Y$98$KG$20221006$$LW$US$US
1388192213$13881922$13$F$20170814$20221023$20170818$20221027$EXP$$VN-ASTELLAS-2017US032784$ASTELLAS$$35$YR$$F$Y$44$KG$20221027$$MD$VN$VN
138824007$13882400$7$F$20170220$20220912$20170818$20221008$EXP$$PHHY2017IT081024$NOVARTIS$$$$$M$Y$50$KG$20221008$$MD$IT$IT
138908193$13890819$3$F$20130101$20221014$20170822$20221019$PER$$US-AMGEN-USASP2017123660$AMGEN$$38$YR$A$F$Y$$$20221019$$HP$US$US
138921482$13892148$2$F$$20221011$20170822$20221026$EXP$$JP-PFIZER INC-2017354669$PFIZER$Naruse, K.. A patent with SGA short stature post Fontan procedure who experienced Protein-losing gastroenteropathy during growth hormone (GH) therapy. The 53rd Chubu Regional Meeting of Japan Pediatric Society. 2017;53rd:53$13$YR$$F$Y$$$20221026$$MD$JP$JP
138927632$13892763$2$F$$20221208$20170822$20221215$EXP$$US-ROCHE-1348333$ROCHE$$72$YR$$M$Y$59.02$KG$20221215$$MD$US$
138956283$13895628$3$F$$20221116$20170823$20221118$PER$$US-PFIZER INC-2017358935$PFIZER$$59$YR$$M$Y$$$20221118$$CN$US$US
1389564415$13895644$15$F$$20221013$20170823$20221017$EXP$$US-PFIZER INC-2016603073$PFIZER$$70$YR$$F$Y$57$KG$20221017$$MD$US$US
138977085$13897708$5$F$20140305$20221003$20170823$20221004$PER$$US-PFIZER INC-2017360446$PFIZER$$66$YR$$F$Y$107$KG$20221004$$LW$US$US
139063625$13906362$5$F$20170710$20191024$20170825$20221101$EXP$$PHHY2017CO108158$NOVARTIS$$75$YR$$M$Y$68$KG$20221101$$CN$CO$CO
139112748$13911274$8$F$$20221212$20170828$20221219$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK130321$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$CA$CA
139124942$13912494$2$F$$20221102$20170828$20221109$PER$$US-INCYTE CORPORATION-2017IN007041$INCYTE$$$$$$Y$$$20221109$$CN$US$US
139125918$13912591$8$F$20160501$20221114$20170828$20221119$EXP$$PHHY2016CA077562$NOVARTIS$$47$YR$$M$Y$$$20221119$$CN$CA$CA
1391742124$13917421$24$F$20161001$20221129$20170829$20221202$EXP$$GB-PURDUE PHARMA-GBR-2017-0048229$PURDUE$$44$YR$$F$Y$$$20221202$$HP$GB$GB
139182179$13918217$9$F$20210510$20220929$20170829$20221007$PER$$US-SA-2017SA040537$SANOFI AVENTIS$$48$YR$A$F$Y$$$20221007$$MD$US$US
139221953$13922195$3$F$$20221109$20170830$20221117$EXP$$IN-SA-2017SA157868$SANOFI AVENTIS$$15$YR$T$M$Y$$$20221117$$MD$IN$IN
139268785$13926878$5$F$20170818$20221021$20170831$20221024$EXP$$GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-076454$BRISTOL MYERS SQUIBB$$72$YR$E$F$Y$108.4$KG$20221024$$MD$GB$GB
139301108$13930110$8$F$20150101$20221108$20170901$20221114$EXP$$US-PFIZER INC-2017379523$MYLAN$$$$$M$Y$$$20221114$$CN$US$US
1393032821$13930328$21$F$20161031$20221020$20170901$20221102$EXP$$PHHY2016CA151784$NOVARTIS$$65$YR$$M$Y$$$20221102$$CN$CA$CA
1393048511$13930485$11$F$20170707$20221018$20170901$20221028$EXP$$IN-INCYTE CORPORATION-2017IN007203$INCYTE$$$$$$Y$$$20221028$$CN$IN$IN
1393173211$13931732$11$F$20170602$20221205$20170904$20221213$EXP$$CA-ROCHE-1986006$ROCHE$$50$YR$$F$Y$90$KG$20221213$$CN$CA$CA
139322145$13932214$5$F$$20221228$20170904$20221229$PER$$US-PFIZER INC-2017379021$PFIZER$$62$YR$$F$Y$$$20221229$$MD$US$US
139347373$13934737$3$F$$20221010$20170905$20221021$EXP$$US-SUN PHARMACEUTICAL INDUSTRIES LTD-2017US-148873$RANBAXY$$$$$M$Y$$$20221021$$MD$US$US
1393654218$13936542$18$F$20170801$20221013$20170905$20221019$EXP$$US-INCYTE CORPORATION-2017IN007200$INCYTE$$$$$$Y$$$20221019$$CN$US$US
139370253$13937025$3$F$20121001$20221005$20170905$20221006$PER$$US-PFIZER INC-2017379826$PFIZER$$38$YR$$F$Y$$$20221006$$LW$US$US
1393769011$13937690$11$F$20170706$20221202$20170905$20221206$EXP$$US-INCYTE CORPORATION-2017IN006594$INCYTE$$$$$$Y$$$20221206$$CN$US$US
139382473$13938247$3$F$20160101$20221201$20170905$20221209$EXP$$US-JAZZ-2017-US-011327$JAZZ$$50$YR$$F$Y$$$20221209$$MD$US$US
1394052634$13940526$34$F$20150301$20221024$20170906$20221028$EXP$$PHHY2015CA034068$NOVARTIS$$39$YR$$F$Y$$$20221028$$MD$CA$CA
139413876$13941387$6$F$20170101$20221122$20170906$20221125$EXP$$PHHY2017CA019786$NOVARTIS$$50$YR$$M$Y$$$20221125$$CN$CA$CA
139421762$13942176$2$F$20120101$20221122$20170906$20221129$EXP$$US-JAZZ-2017-US-011393$JAZZ$$$$$M$Y$$$20221129$$MD$US$US
139426403$13942640$3$F$20170831$20221221$20170906$20221226$EXP$$US-JAZZ-2017-US-011475$JAZZ$$32$YR$$F$Y$$$20221226$$CN$US$US
139430986$13943098$6$F$20170801$20221122$20170907$20221207$EXP$$CA-UCBSA-2017033656$UCB$$40$YR$$F$Y$$$20221207$$MD$CA$CA
1394656310$13946563$10$F$20170601$20221019$20170907$20221026$EXP$$PHHY2017CA131866$NOVARTIS$$26$YR$$F$Y$$$20221026$$MD$CA$CA
1394916131$13949161$31$F$20170607$20221212$20170908$20221219$EXP$$BR-GLAXOSMITHKLINE-BR2016GSK177634$GLAXOSMITHKLINE$$$$$$Y$$$20221219$$MD$BR$BR
139505022$13950502$2$F$$20221115$20170908$20221121$EXP$$PT-MYLANLABS-2017M1055566$MYLAN$Pereira M, Guerra I.. Clinical case: Acute pancreatitis and lipemia. Clin-Chem-Lab-Med. 2016;54 (10):eA321$41$YR$$F$Y$$$20221121$$HP$PT$PT
139515283$13951528$3$F$20130101$20221122$20170908$20221202$EXP$$US-JAZZ-JPI-P-030318$JAZZ$$$$$F$Y$$$20221202$$MD$US$US
139519135$13951913$5$F$20160525$20221013$20170910$20221017$EXP$$PHHY2016CO080191$NOVARTIS$$61$YR$$F$Y$76$KG$20221017$$CN$CO$CO
139530633$13953063$3$F$$20170828$20170911$20221212$PER$$US-TEVA-796677ACC$TEVA$Latif S, Ohri P, Taxel P. Kyphoplasty complicated by short interval and adjacent multiple vertebral compression fractures: Eight is enough. Endocrine Reviews. 2017;38:.$63$YR$A$F$Y$$$20221212$$MD$US$US
139565924$13956592$4$F$20170817$20221109$20170911$20221109$EXP$$JP-BAYER-2017-169779$BAYER$$69$YR$E$M$Y$55.3$KG$20221109$$MD$JP$JP
1395736413$13957364$13$F$20180329$20221110$20170911$20221116$EXP$$PHHY2017CA132557$NOVARTIS$$57$YR$$F$Y$$$20221117$$CN$CA$CA
139619554$13961955$4$F$$20221129$20170912$20221203$EXP$$PHHY2017CO126665$NOVARTIS$$$$$F$Y$58$KG$20221203$$CN$CO$CO
139630684$13963068$4$F$20170101$20221007$20170913$20221012$PER$$US-PFIZER INC-2017393844$PFIZER$$53$YR$$F$Y$$$20221012$$MD$US$US
1396312812$13963128$12$F$20170801$20221103$20170913$20221111$EXP$$US-PFIZER INC-2017231807$PFIZER$$70$YR$$F$Y$95$KG$20221111$$MD$US$US
1396317813$13963178$13$F$20161201$20221209$20170913$20221213$EXP$$CA-TAKEDA-2017TUS001449$TAKEDA$$53$YR$$M$Y$$$20221213$$CN$CA$CA
139639809$13963980$9$F$20170516$20221005$20170913$20221007$EXP$$JP-ABBVIE-17K-087-1995756-00$ABBVIE$$75$YR$$F$Y$46$KG$20221007$$CN$JP$JP
139669767$13966976$7$F$$20221121$20170914$20221122$EXP$$CA-ROCHE-1992036$ROCHE$$$$$F$Y$$$20221123$$MD$CA$
1396707532$13967075$32$F$20161001$20221220$20170914$20221222$EXP$GB-TEVA-801034ACC$GB-JNJFOC-20170905683$JOHNSON AND JOHNSON$$44$YR$A$F$Y$$$20221222$$HP$GB$GB
139684475$13968447$5$F$20170301$20221018$20170914$20221020$PER$$US-PFIZER INC-2017396906$PFIZER$$66$YR$$F$Y$131.5$KG$20221020$$CN$US$US
1397123126$13971231$26$F$20150101$20221123$20170914$20221129$EXP$$US-ASTELLAS-2017US014871$ASTELLAS$$$$$M$Y$$$20221129$$CN$US$US
139723852$13972385$2$F$20210101$20221108$20170914$20221115$PER$$US-AMGEN-USASL2017137811$AMGEN$$$$A$F$Y$$$20221115$$CN$US$US
139742916$13974291$6$F$$20221107$20170915$20221114$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-082672$BRISTOL MYERS SQUIBB$Pf?hler C. Autoimmune thrombopenia or aggravation of a previously unknown werlhof disease?.$73$YR$E$M$Y$$$20221114$$MD$DE$DE
139751876$13975187$6$F$20170516$20221110$20170915$20221118$EXP$$US-SHIRE-US201720939$TAKEDA$$60$YR$$F$Y$78.912$KG$20221118$$MD$US$US
1397559410$13975594$10$F$20170101$20221006$20170915$20221010$PER$$US-PFIZER INC-2017395067$PFIZER$$86$YR$$F$Y$$$20221010$$HP$US$US
139768756$13976875$6$F$20170805$20221128$20170915$20221203$EXP$$PHHY2017IT133922$NOVARTIS$$51$YR$$F$Y$$$20221203$$MD$IT$IT
139806808$13980680$8$F$$20221130$20170918$20221204$EXP$$ES-B.I. Pharmaceuticals,Inc./Ridgefield-2017-BI-050658$BOEHRINGER INGELHEIM$$81$YR$E$M$Y$$$20221204$$MD$ES$ES
139813049$13981304$9$F$20180301$20221020$20170918$20221024$PER$$US-PFIZER INC-2017397283$PFIZER$$67$YR$$F$Y$90$KG$20221024$$CN$US$US
139858876$13985887$6$F$$20221221$20170919$20221227$PER$$US-PFIZER INC-2017401395$PFIZER$$72$YR$$F$Y$$$20221227$$MD$US$US
1398623519$13986235$19$F$20161001$20221019$20170919$20221031$EXP$$GB-AUROBINDO-AUR-APL-2017-40140$AUROBINDO$$44$YR$$F$Y$$$20221031$$HP$GB$GB
139866345$13986634$5$F$$20221007$20170919$20221014$EXP$$CA-GLAXOSMITHKLINE-CA2017GSK144375$GLAXOSMITHKLINE$$$$$$Y$$$20221014$$MD$CA$CA
1398766111$13987661$11$F$20180601$20221209$20170919$20221215$EXP$$US-ASTELLAS-2017US036923$ASTELLAS$$79$YR$$M$Y$$$20221215$$CN$US$US
139879677$13987967$7$F$$20221031$20170919$20221104$EXP$$US-PFIZER INC-2017404513$PFIZER$$48$YR$$F$Y$77.11$KG$20221104$$CN$US$US
139900919$13990091$9$F$20170808$20221128$20170920$20221201$EXP$$US-BIOGEN-2017BI00459495$BIOGEN$$47$YR$$F$Y$$$20221201$$CN$US$US
139915524$13991552$4$F$20100601$20221123$20170920$20221129$PER$$US-JNJFOC-20170802244$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221129$$HP$US$US
139915926$13991592$6$F$$20221003$20170920$20221013$PER$$US-JNJFOC-20170802625$JOHNSON AND JOHNSON$$$$$M$Y$$$20221014$$LW$US$US
139915953$13991595$3$F$20060502$20221228$20170920$20221229$PER$$US-JNJFOC-20170803003$JOHNSON AND JOHNSON$$5$YR$C$M$Y$$$20221229$$LW$US$US
139922834$13992283$4$F$20140517$20221107$20170920$20221110$PER$$US-JNJFOC-20170906272$JOHNSON AND JOHNSON$$16$YR$T$M$Y$$$20221110$$LW$US$US
140029609$14002960$9$F$20171212$20221020$20170922$20221025$EXP$$CA-TAKEDA-2017TUS019399$TAKEDA$$51$YR$$M$Y$$$20221025$$CN$CA$CA
140034722$14003472$2$F$$20220922$20170922$20221004$EXP$$PT-AUROBINDO-AUR-APL-2017-40672$AUROBINDO$Pereira M, Guerra I.. Acute pancreatitis and lipemia.. Clinical Chemistry and Laboratory Medicine. 2016;51(10):eA321$41$YR$$F$Y$$$20221004$$HP$PT$PT
140068515$14006851$5$F$$20221123$20170925$20221128$PER$$US-PFIZER INC-2017409298$PFIZER$$60$YR$$F$Y$$$20221128$$MD$US$US
140070265$14007026$5$F$20170701$20221115$20170925$20221125$PER$$US-LUPIN PHARMACEUTICALS INC.-2017-04741$LUPIN$$62$YR$$M$Y$65.76$KG$20221125$$CN$US$US
1400711314$14007113$14$F$$20221205$20170925$20221208$PER$$US-PFIZER INC-2017407271$PFIZER$$50$YR$$M$Y$81.65$KG$20221208$$CN$US$US
140074969$14007496$9$F$20000101$20221215$20170925$20221220$EXP$$US-PFIZER INC-2017409778$PFIZER$$44$YR$$M$Y$88.5$KG$20221220$$CN$US$US
140080678$14008067$8$F$20170801$20221018$20170925$20221021$PER$$US-PFIZER INC-2017411278$PFIZER$$77$YR$$F$Y$73$KG$20221021$$CN$US$US
1400847539$14008475$39$F$$20221118$20170925$20221212$EXP$$PT-PFIZER INC-2017405189$GLAXOSMITHKLINE$$$$$$Y$$$20221212$$HP$PT$PT
140090955$14009095$5$F$20120501$20221005$20170925$20221006$PER$$US-PFIZER INC-2016584504$PFIZER$$40$YR$$F$Y$68.027$KG$20221006$$LW$US$US
140090984$14009098$4$F$20160211$20221001$20170925$20221004$PER$$US-PFIZER INC-2016586541$PFIZER$$47$YR$$F$Y$105$KG$20221004$$LW$US$US
140106347$14010634$7$F$20170831$20221129$20170926$20221202$EXP$$GB-SHIRE-GB201723650$TAKEDA$$61$YR$$F$Y$$$20221202$$MD$GB$GB
140125315$14012531$5$F$20170911$20180118$20170926$20221211$EXP$$DE-TEVA-808038GER$TEVA$$55$YR$A$M$Y$$$20221211$$CN$DE$DE
140128642$14012864$2$F$20170805$20221011$20170926$20221013$EXP$$CA-TAKEDA-2017TUS019690$TAKEDA$$39$YR$$F$Y$$$20221013$$MD$CA$CA
1401401511$14014015$11$F$$20221013$20170926$20221020$PER$$US-AMGEN-USASP2017143522$AMGEN$$66$YR$E$F$Y$66$KG$20221020$$MD$US$US
140141128$14014112$8$F$$20221202$20170927$20221208$EXP$$CA-JNJFOC-20170923187$JOHNSON AND JOHNSON$$38$YR$A$F$Y$66$KG$20221208$$CN$CA$CA
1401530534$14015305$34$F$$20221118$20170927$20221121$EXP$$PT-JNJFOC-20170921376$JOHNSON AND JOHNSON$$23$YR$A$F$Y$102$KG$20221121$$HP$PT$PT
140166943$14016694$3$F$$20221222$20170927$20221227$PER$$US-PFIZER INC-2017416226$PFIZER$$51$YR$$F$Y$$$20221227$$MD$US$US
140182996$14018299$6$F$20150422$20221206$20170928$20221216$PER$$JP-AMGEN-JPNSP2017144345$AMGEN$Yamada R, Murakami A, Kusakabe E, Yamazawa H, Taguchi K, Nishiyama K, et al.. A case of anti-resorptive agents-related osteonecrosis of jaw in a patient with denosumab for multiple metastases to bone from breast cancer and healing after interruption of denosumab. The 14th Ann Met of The Japanese Breast Cancer Society, Chugoku-Shikoku Branch. 2017;83$$$$F$Y$$$20221216$$MD$JP$JP
1402081129$14020811$29$F$$20221118$20170928$20221121$EXP$$PHHY2017PT139841$NOVARTIS$Lopes JB, Cadinha S, Malheiro D, Brosseron L, Moreira D, Silva J. Multiple drug hypersensitivity syndrome to antihistamines, corticosteroids and nonsteroidal anti-inflammatories in a patient with asthma and urticaria. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;72 (103):219$23$YR$$F$Y$102$KG$20221121$$HP$PT$PT
1402407334$14024073$34$F$20171101$20221214$20170929$20221223$EXP$$CA-CELLTRION INC.-2017CA012918$CELLTRION$$$$$$Y$$$20221223$$CN$CA$CA
140257665$14025766$5$F$20140701$20221001$20170929$20221004$PER$$US-PFIZER INC-2016584462$PFIZER$$67$YR$$F$Y$$$20221004$$LW$US$US
140258075$14025807$5$F$20141001$20221006$20170929$20221007$PER$$US-PFIZER INC-2016584500$PFIZER$$56$YR$$F$Y$93$KG$20221007$$LW$US$US
140263874$14026387$4$F$20170921$20221129$20170929$20221202$EXP$$CA-TAKEDA-2017TUS019872$TAKEDA$$51$YR$$F$Y$$$20221202$$MD$CA$CA
140266275$14026627$5$F$20160101$20221126$20170929$20221206$EXP$$US-ACORDA-ACO_142380_2017$ACORDA$$$$$F$Y$63.5$KG$20221206$$MD$US$US
140274402$14027440$2$F$20220101$20221205$20170929$20221209$EXP$$US-ASTELLAS-2017US038598$ASTELLAS$$$$$M$Y$$$20221209$$CN$US$US
140276768$14027676$8$F$20170401$20221017$20170929$20221019$PER$$US-PFIZER INC-2017419527$PFIZER$$51$YR$$F$Y$55$KG$20221019$$CN$US$US
1403160813$14031608$13$F$20130419$20221214$20171003$20221222$EXP$$CA-ROCHE-2000971$ROCHE$$38$YR$$M$Y$$$20221222$$MD$CA$CA
140324918$14032491$8$F$20170101$20221024$20171003$20221103$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005614$ACADIA PHARMACEUTICALS$$$$$M$Y$59$KG$20221103$$CN$US$US
140326375$14032637$5$F$$20221010$20171002$20221014$PER$$US-PFIZER INC-2017421865$PFIZER$$68$YR$$F$Y$$$20221014$$MD$US$US
140331062$14033106$2$F$20170901$20221026$20171003$20221031$PER$$US-PFIZER INC-2017424362$PFIZER$$37$YR$$F$Y$83$KG$20221031$$HP$US$US
140331384$14033138$4$F$20110301$20221006$20171003$20221007$PER$$US-PFIZER INC-2016586384$PFIZER$$57$YR$$F$Y$$$20221007$$LW$US$US
1403366322$14033663$22$F$$20221116$20171003$20221130$EXP$$PT-AUROBINDO-AUR-APL-2017-41180$AUROBINDO$Lopes JB, Cadinha S, Malheiro D, Brosseron L, Moreira Da Silva JP.. Multiple drug hypersensitivity syndrome to antihistamines, corticosteroids and nonsteroidal anti-inflammatories in a patient with asthma and urticaria. Allergy:. European Journal of Allergy and Clinical Immunology.. 2017;72(103):219$23$YR$$F$Y$102$KG$20221130$$MD$PT$PT
140341782$14034178$2$F$20161221$20170215$20171003$20221212$PER$$US-TEVA-724836USA$TEVA$$40$YR$A$M$Y$93$KG$20221212$$CN$US$US
140345534$14034553$4$F$20130409$20221005$20171003$20221006$PER$$US-PFIZER INC-2016596185$PFIZER$$65$YR$$F$Y$61$KG$20221006$$LW$US$US
140352984$14035298$4$F$20051010$20220928$20171003$20221004$EXP$$US-PFIZER INC-2017425983$PFIZER$$46$YR$$M$Y$115.67$KG$20221004$$CN$US$US
140368748$14036874$8$F$$20221010$20171004$20221014$PER$$US-AMGEN-USASP2017148397$AMGEN$$72$YR$E$F$Y$74.84$KG$20221014$$MD$US$US
140430193$14043019$3$F$20131201$20221005$20171004$20221006$PER$$US-PFIZER INC-2016596182$PFIZER$$45$YR$$F$Y$54$KG$20221006$$LW$US$US
140456102$14045610$2$F$$20220307$20171005$20221013$PER$$US-INDIVIOR LIMITED-INDV-103505-2017$RECKITT BENCKISER$$$$$F$Y$$$20221013$$CN$US$US
1404664912$14046649$12$F$20170901$20221207$20171005$20221214$EXP$$PHHY2017CA144588$NOVARTIS$$49$YR$$F$Y$$$20221214$$CN$CA$CA
140477603$14047760$3$F$$20221111$20171005$20221114$EXP$$PHHY2017AU144587$NOVARTIS$$$$$F$Y$$$20221114$$MD$AU$AU
140581313$14058131$3$F$$20221213$20171006$20221215$EXP$$US-PFIZER INC-2017428648$PFIZER$Dunkel, I.. Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children^s Oncology Group (COG) trial (ARET0321). Journal of Clinical Oncology. 2017;35 (15 Suppl 1):10506-10506$$$C$$Y$$$20221215$$HP$US$US
140581323$14058132$3$F$$20221213$20171006$20221215$EXP$$US-PFIZER INC-2017428901$PFIZER$Dunkel, I.. Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children^s Oncology Group (COG) trial (ARET0321). Journal of Clinical Oncology. 2017;35 (15 Suppl 1):10506-10506$$$I$$Y$$$20221215$$HP$US$US
140619585$14061958$5$F$20120101$20221006$20171009$20221007$PER$$US-PFIZER INC-2016586545$PFIZER$$55$YR$$F$Y$$$20221007$$LW$US$US
140619996$14061999$6$F$20130101$20221011$20171009$20221012$PER$$US-PFIZER INC-2017419128$PFIZER$$44$YR$$F$Y$$$20221012$$LW$US$US
140620534$14062053$4$F$20150327$20221005$20171009$20221006$PER$$US-PFIZER INC-2016584481$PFIZER$$78$YR$$F$Y$113$KG$20221006$$LW$US$US
140650884$14065088$4$F$20131008$20221118$20171009$20221121$PER$$US-PFIZER INC-2017427387$PFIZER$$48$YR$$F$Y$78$KG$20221121$$LW$US$US
140652023$14065202$3$F$20110801$20221013$20171009$20221014$PER$$US-PFIZER INC-2017427385$PFIZER$$52$YR$$F$Y$$$20221014$$LW$US$US
140675125$14067512$5$F$$20221117$20171010$20221118$EXP$$CA-ROCHE-2004147$ROCHE$$59$YR$$F$Y$$$20221118$$HP$CA$
140680927$14068092$7$F$$20221212$20171010$20221220$PER$$CA-AMGEN-CANSP2017151688$AMGEN$$70$YR$E$M$Y$$$20221220$$HP$CA$CA
1406848613$14068486$13$F$$20221201$20171010$20221205$PER$$US-PFIZER INC-2017430392$PFIZER$$62$YR$$F$Y$$$20221205$$MD$US$US
140688604$14068860$4$F$20140101$20221206$20171010$20221212$PER$$US-PFIZER INC-2017434539$PFIZER$$68$YR$$M$Y$$$20221212$$HP$US$US
1406897031$14068970$31$F$20180326$20221104$20171010$20221115$EXP$$CA-CELLTRION INC.-2017CA013585$CELLTRION$$$$$$Y$$$20221115$$CN$CA$CA
140721067$14072106$7$F$20180312$20221026$20171010$20221103$PER$$US-SA-2017SA160185$SANOFI AVENTIS$$28$YR$A$F$Y$53.5$KG$20221103$$MD$US$US
140725638$14072563$8$F$20220318$20221221$20171011$20221227$EXP$$PHHY2017CA147131$NOVARTIS$$55$YR$$F$Y$$$20221227$$CN$CA$CA
1407420322$14074203$22$F$20170510$20221115$20171011$20221118$EXP$$TR-ROCHE-1938068$ROCHE$$59$YR$$M$Y$58$KG$20221118$$MD$TR$
140752883$14075288$3$F$20160301$20221104$20171011$20221108$PER$$US-PFIZER INC-2017438070$PFIZER$$59$YR$$F$Y$100$KG$20221108$$CN$US$US
140758364$14075836$4$F$20120101$20171011$20171011$20221212$EXP$$GB-TEVA-812988ACC$TEVA$$$$$F$Y$$$20221212$$CN$GB$GB
140758734$14075873$4$F$20151027$20221005$20171011$20221007$PER$$US-PFIZER INC-2016584466$PFIZER$$46$YR$$F$Y$63$KG$20221007$$LW$US$US
140784482$14078448$2$F$$20221019$20171012$20221021$PER$$US-PFIZER INC-2017439244$PFIZER$$60$YR$$F$Y$$$20221021$$HP$US$US
140793434$14079343$4$F$20161124$20220912$20171012$20221006$EXP$$PHHY2017IT148353$NOVARTIS$$12$YR$$F$Y$34.5$KG$20221006$$MD$IT$IT
140797325$14079732$5$F$20120301$20221001$20171012$20221004$PER$$US-PFIZER INC-2016584469$PFIZER$$62$YR$$F$Y$59$KG$20221004$$LW$US$US
140797462$14079746$2$F$20141001$20221003$20171012$20221005$PER$$US-PFIZER INC-2016586544$PFIZER$$69$YR$$F$Y$97$KG$20221005$$LW$US$US
140876295$14087629$5$F$20170601$20221215$20171013$20221221$EXP$$US-JAZZ-2017-US-013346$JAZZ$$10$YR$$F$Y$$$20221221$$HP$US$US
140891056$14089105$6$F$20160901$20221116$20171013$20221119$EXP$$PHHY2016CA150097$NOVARTIS$$44$YR$$F$Y$$$20221119$$CN$CA$CA
1409055611$14090556$11$F$$20191121$20171015$20221109$EXP$$PHEH2017US032775$NOVARTIS$$$$$F$Y$$$20221109$$CN$US$US
1409190337$14091903$37$F$20170731$20221004$20171016$20221011$EXP$$PHHY2017AR151832$NOVARTIS$$44$YR$$M$Y$$$20221011$$CN$AR$AR
140987219$14098721$9$F$20160916$20221208$20171017$20221212$EXP$$JP-VIIV HEALTHCARE LIMITED-JP2017JPN156841$VIIV$$$$$$Y$$$20221212$$MD$JP$JP
140990616$14099061$6$F$20170101$20221217$20171017$20221227$EXP$$CA-PFIZER INC-2017205225$PFIZER$$65$YR$$M$Y$$$20221227$$CN$CA$CA
140996047$14099604$7$F$20170501$20221031$20171017$20221104$EXP$$PHHY2016CA127662$NOVARTIS$$22$YR$$F$Y$$$20221104$$HP$CA$CA
141014174$14101417$4$F$20160101$20221202$20171018$20221209$EXP$$US-PFIZER INC-2017447581$MYLAN$$$$$F$Y$89$KG$20221209$$HP$US$US
1410143518$14101435$18$F$20160101$20220929$20171018$20221003$EXP$$US-PFIZER INC-2017448357$PFIZER$$85$YR$$F$Y$79$KG$20221003$$CN$US$US
1410198213$14101982$13$F$20170101$20221202$20171018$20221207$EXP$$US-PFIZER INC-2017446613$PFIZER$$60$YR$$F$Y$$$20221207$$HP$US$US
141040447$14104044$7$F$$20221013$20171018$20221018$EXP$$PHHY2016CA158111$NOVARTIS$$$$$M$Y$$$20221018$$MD$CA$CA
141065769$14106576$9$F$$20221123$20171019$20221128$PER$$US-PFIZER INC-2017447585$PFIZER$$73$YR$$F$Y$63.5$KG$20221128$$CN$US$US
141088986$14108898$6$F$20120822$20220929$20171019$20221008$EXP$$PL-ABBVIE-17P-129-2134389-00$ABBVIE$Jablonowska E. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm.. Kardiochirurgia i Torakochirurgia Polska.. 2017;14 (3):211-213; Marcinkiewicz A. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm.. Kardiochirurgia i Torakochirurgia Polska.. 2017;14 (3):211-213; Zwoliski R. Progression of coronary artery disease in a HIV-infected patient previously treated for ascendi...$35$YR$$M$Y$$$20221008$$MD$PL$PL
1411149610$14111496$10$F$20170727$20221202$20171020$20221207$EXP$$CA-TAKEDA-2017TUS021444$TAKEDA$$52$YR$$F$Y$$$20221207$$MD$CA$CA
1411302422$14113024$22$F$20160505$20221027$20171022$20221108$EXP$$PHHY2017CA152629$NOVARTIS$$27$YR$$F$Y$$$20221108$$CN$CA$CA
1411446714$14114467$14$F$20160101$20221113$20171023$20221115$PER$$US-PFIZER INC-2017453141$PFIZER$$72$YR$$F$Y$53$KG$20221115$$CN$US$US
141145609$14114560$9$F$20180101$20221208$20171023$20221213$PER$$US-PFIZER INC-2017118785$PFIZER$$70$YR$$F$Y$82$KG$20221213$$HP$US$US
141151275$14115127$5$F$$20221027$20171023$20221102$EXP$$US-PFIZER INC-2017455015$PFIZER$$83$YR$$F$Y$67.13$KG$20221102$$CN$US$US
141189155$14118915$5$F$$20221021$20171024$20221025$PER$$US-AMGEN-USASP2017158583$AMGEN$$74$YR$E$F$Y$$$20221025$$MD$US$US
141189833$14118983$3$F$20170922$20221129$20171024$20221202$EXP$$US-SHIRE-US201724065$TAKEDA$$60$YR$$M$Y$$$20221202$$MD$US$US
141190905$14119090$5$F$20170501$20221031$20171024$20221108$EXP$$CA-ROCHE-2010731$ROCHE$$22$YR$$F$Y$$$20221107$$HP$CA$CA
141194454$14119445$4$F$$20221104$20171024$20221108$PER$$US-PFIZER INC-2017455586$PFIZER$$66$YR$$F$Y$$$20221108$$MD$US$US
141195794$14119579$4$F$$20221206$20171024$20221209$PER$$US-PFIZER INC-2017455204$PFIZER$$71$YR$$F$Y$$$20221209$$MD$US$US
141217587$14121758$7$F$20120822$20221114$20171024$20221121$EXP$$PL-MYLANLABS-2017M1065817$MYLAN$Zwolinski R, Kamerys J, Jablonowska E, Marcinkiewicz A, Jaszewski R, Krecki R, et al.. Progression of coronary artery disease in a HIV-infected patient previously treated for ascending aorta aneurysm. Kardiochirurgia i Torakochirurgia Polska. 2017;14 (3):211-13$35$YR$$M$Y$$$20221121$$HP$PL$PL
141231576$14123157$6$F$20170725$20221123$20171025$20221129$EXP$$US-ROCHE-1958822$ROCHE$$$$A$F$Y$83.99$KG$20221129$$HP$US$
141243284$14124328$4$F$$20221021$20171025$20221025$PER$$US-PFIZER INC-2017452708$PFIZER$$76$YR$$F$Y$$$20221025$$MD$US$US
141249839$14124983$9$F$20170101$20221007$20171025$20221014$EXP$$CA-TAKEDA-2017TUS012787$TAKEDA$$26$YR$$F$Y$$$20221014$$CN$CA$CA
141259743$14125974$3$F$$20221122$20171025$20221129$EXP$$US-JAZZ-2017-US-013759$JAZZ$$$$$F$Y$$$20221129$$CN$US$US
141268668$14126866$8$F$$20221202$20171025$20221208$PER$$US-AMGEN-USASP2017158588$AMGEN$$68$YR$E$F$Y$$$20221208$$MD$US$US
141274112$14127411$2$F$$20170515$20171026$20221212$PER$$US-TEVA-765967ACC$TEVA$$$$$M$Y$$$20221212$$CN$US$US
141334162$14133416$2$F$20131225$20221013$20171026$20221014$PER$$US-PFIZER INC-2017460494$PFIZER$$58$YR$$F$Y$$$20221014$$LW$US$US
141405059$14140505$9$F$$20221214$20171030$20221219$EXP$$US-PFIZER INC-2017461544$PFIZER$$71$YR$$F$Y$$$20221219$$CN$US$US
141407467$14140746$7$F$$20221107$20171030$20221109$PER$$US-PFIZER INC-2017465703$PFIZER$$66$YR$$F$Y$$$20221109$$MD$US$US
1414134610$14141346$10$F$20170811$20221125$20171030$20221205$EXP$$GB-TEVA-818638ACC$TEVA$$29$YR$A$M$Y$$$20221205$$HP$GB$GB
141420935$14142093$5$F$$20221222$20171030$20221229$PER$$US-AMGEN-USASP2017163353$AMGEN$$70$YR$E$F$Y$$$20221229$$MD$US$US
141448448$14144844$8$F$20140514$20221101$20171031$20221104$EXP$$US-SHIRE-US201726642$TAKEDA$$61$YR$$F$Y$$$20221104$$CN$US$US
141455669$14145566$9$F$20040314$20211231$20171031$20221005$EXP$$GB-BAUSCH-BL-2017-030139$BAUSCH AND LOMB$$66$YR$$M$Y$77.4$KG$20221005$$MD$GB$GB
141461874$14146187$4$F$20171001$20221019$20171031$20221028$EXP$$IT-JNJFOC-20171031905$JOHNSON AND JOHNSON$$66$YR$E$F$Y$$$20221028$$MD$IT$IT
141468655$14146865$5$F$$20220930$20171031$20221005$EXP$$CA-PFIZER INC-2017460118$PFIZER$$59$YR$$F$Y$$$20221005$$CN$CA$CA
141473857$14147385$7$F$20120718$20221117$20171101$20221125$EXP$$US-AstraZeneca-2017SF10090$ASTRAZENECA$$24630$DY$$F$Y$68$KG$20221125$$LW$US$
141481088$14148108$8$F$20170101$20221128$20171101$20221130$EXP$$US-PFIZER INC-2017467374$PFIZER$$94$YR$$F$Y$58$KG$20221130$$CN$US$US
141488275$14148827$5$F$20221004$20221104$20171101$20221111$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK076533$GLAXOSMITHKLINE$$$$$$Y$$$20221111$$CN$BR$BR
141492546$14149254$6$F$20171016$20180208$20171101$20221010$PER$$GB-AMGEN-GBRCT2017160102$AMGEN$$52$YR$A$M$Y$84.5$KG$20221010$$MD$GB$GB
141498325$14149832$5$F$$20221117$20171101$20221121$EXP$$PHHY2017CA158824$NOVARTIS$$$$$F$Y$$$20221121$$MD$CA$CA
141502032$14150203$2$F$$20161222$20171101$20221020$PER$$US-NOVOPROD-524861$NOVO NORDISK$$70$YR$$F$Y$$$20221020$$CN$US$US
141502202$14150220$2$F$$20160908$20171101$20221020$PER$$US-NOVOPROD-510902$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502252$14150225$2$F$20160907$20160912$20171101$20221020$PER$$US-NOVOPROD-511668$NOVO NORDISK$$69$YR$$F$Y$$$20221020$$CN$US$US
141502272$14150227$2$F$20150101$20161102$20171101$20221020$PER$$US-NOVOPROD-518555$NOVO NORDISK$$60$YR$$F$Y$$$20221020$$CN$US$US
141502722$14150272$2$F$$20170104$20171101$20221020$PER$$US-NOVOPROD-522980$NOVO NORDISK$$66$YR$$F$Y$$$20221020$$MD$US$US
141502732$14150273$2$F$20160101$20170410$20171101$20221020$PER$$US-NOVOPROD-541174$NOVO NORDISK$$65$YR$$F$Y$$$20221020$$CN$US$US
141502742$14150274$2$F$$20170215$20171101$20221020$PER$$US-NOVOPROD-533141$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502752$14150275$2$F$$20170630$20171101$20221020$PER$$US-NOVOPROD-553323$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502762$14150276$2$F$$20170801$20171101$20221020$PER$$US-NOVOPROD-557888$NOVO NORDISK$$$$$F$Y$$$20221020$$PH$US$US
141502842$14150284$2$F$20170607$20170609$20171101$20221020$PER$$US-NOVOPROD-550367$NOVO NORDISK$$67$YR$$F$Y$$$20221020$$HP$US$US
141502862$14150286$2$F$$20161217$20171101$20221020$PER$$US-NOVOPROD-524010$NOVO NORDISK$$56$YR$$F$Y$$$20221020$$PH$US$US
141502882$14150288$2$F$$20161206$20171101$20221020$PER$$US-NOVOPROD-522615$NOVO NORDISK$$$$$F$Y$$$20221020$$CN$US$US
141502892$14150289$2$F$20170201$20170216$20171101$20221020$PER$$US-NOVOPROD-533317$NOVO NORDISK$$66$YR$$F$Y$$$20221020$$CN$US$US
141502912$14150291$2$F$$20170605$20171101$20221020$PER$$US-NOVOPROD-549595$NOVO NORDISK$$$$E$F$Y$$$20221020$$CN$US$US
141503844$14150384$4$F$$20221117$20171101$20221128$EXP$$US-JAZZ-2017-US-014147$JAZZ$$$$$F$Y$$$20221128$$CN$US$US
141507586$14150758$6$F$$20221123$20171102$20221125$EXP$$CA-ABBVIE-17K-028-2145793-00$ABBVIE$$$$$M$Y$$$20221125$$MD$CA$CA
141575454$14157545$4$F$20171009$20221021$20171103$20221028$EXP$$BR-TAKEDA-2017TUS022779$TAKEDA$$29$YR$$F$Y$75$KG$20221028$$CN$BR$BR
141615294$14161529$4$F$20170915$20221223$20171106$20221230$EXP$$JP-009507513-1710JPN003595J$MERCK$Matsumoto K, Wakatuki J, Sakuma D, Kin E, Kobayashi Y, Komata M. WS16-3 Immune-related side effects during the first 5 years of use of immune checkpoint inhibitors. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022$58$YR$$M$Y$57$KG$20221230$$MD$JP$JP
1416298558$14162985$58$F$20160929$20221228$20171107$20221230$EXP$$CA-ROCHE-1837378$ROCHE$$58$YR$$F$Y$140$KG$20221230$$CN$CA$
1416514010$14165140$10$F$20190101$20221201$20171107$20221206$EXP$$US-PFIZER INC-2017474236$PFIZER$$58$YR$$M$Y$92.971$KG$20221206$$CN$US$US
141660256$14166025$6$F$20140106$20221208$20171107$20221216$EXP$$JP-MYLANLABS-2013S1024256$MYLAN$$17$YR$$M$Y$39.3$KG$20221216$$MD$JP$JP
141676254$14167625$4$F$20220401$20221004$20171107$20221010$EXP$$US-JAZZ-2017-US-014566$JAZZ$$34$YR$$F$Y$$$20221010$$MD$US$US
1416890311$14168903$11$F$20171101$20221107$20171108$20221109$PER$$US-PFIZER INC-2017474746$PFIZER$$60$YR$$F$Y$$$20221109$$PH$US$US
1416928110$14169281$10$F$20150119$20221221$20171108$20221228$EXP$$PHHY2011CA34112$NOVARTIS$$52$YR$$M$Y$$$20221228$$HP$CA$CA
1416957317$14169573$17$F$20170715$20221223$20171108$20221230$EXP$$PHHY2017CA107620$NOVARTIS$$55$YR$$F$Y$$$20221230$$CN$CA$CA
141715565$14171556$5$F$$20221122$20171108$20221125$PER$$US-BIOGEN-2017BI00478416$BIOGEN$$$$$F$Y$$$20221125$$CN$US$US
1417204311$14172043$11$F$20170116$20221213$20171108$20221220$EXP$$PHHY2017CA009421$NOVARTIS$$56$YR$$F$Y$$$20221220$$CN$CA$CA
141721956$14172195$6$F$20170101$20221020$20171109$20221028$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005979$ACADIA PHARMACEUTICALS$$$$$F$Y$$$20221028$$CN$US$US
141726957$14172695$7$F$20160601$20221207$20171109$20221215$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005197$ACADIA PHARMACEUTICALS$$76$YR$$M$Y$64$KG$20221216$$CN$US$US
141728412$14172841$2$F$20170701$20220930$20171109$20221024$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005288$ACADIA PHARMACEUTICALS$$69$YR$$M$Y$$$20221025$$CN$US$US
141730263$14173026$3$F$$20221005$20171109$20221011$PER$$US-AMGEN-USASL2017167815$AMGEN$$68$YR$E$M$Y$$$20221011$$CN$US$US
141730938$14173093$8$F$$20221220$20171109$20221222$EXP$$CA-Orion Corporation ORION PHARMA-TREX2017-3466$ORION$$58$YR$A$F$Y$$$20221222$$MD$CA$
141731986$14173198$6$F$20210101$20221208$20171109$20221216$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005673$ACADIA PHARMACEUTICALS$$$$$M$Y$123$KG$20221216$$CN$US$US
141742448$14174244$8$F$20161116$20221222$20171109$20221229$EXP$$JP-MYLANLABS-2017M1068472$MYLAN$$18$YR$$F$Y$30.4$KG$20221229$$MD$JP$JP
141747713$14174771$3$F$20111001$20211210$20171109$20221019$PER$$US-ALLERGAN-1716615US$ALLERGAN$$68$YR$$F$Y$$$20221019$$MD$US$US
141759932$14175993$2$F$20170722$20221118$20171109$20221121$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-071340$BRISTOL MYERS SQUIBB$$$$$M$Y$$$20221121$$HP$US$US
141771233$14177123$3$F$$20221117$20171110$20221121$PER$$US-PFIZER INC-2017481323$PFIZER$$58$YR$$F$Y$$$20221121$$CN$US$US
1417714814$14177148$14$F$20170101$20220930$20171110$20221006$EXP$$US-PFIZER INC-2017484503$PFIZER$$80$YR$$F$Y$64$KG$20221006$$CN$US$US
141778675$14177867$5$F$20200901$20221114$20171110$20221208$PER$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005203$ACADIA PHARMACEUTICALS$$70$YR$$M$Y$$$20221209$$CN$US$US
141782092$14178209$2$F$20170907$20221010$20171110$20221020$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-005758$ACADIA PHARMACEUTICALS$$77$YR$$M$Y$83$KG$20221020$$CN$US$US
141793463$14179346$3$F$20180401$20221101$20171110$20221110$EXP$$US-ACADIA PHARMACEUTICALS INC.-ACA-2017-006014$ACADIA PHARMACEUTICALS$$83$YR$$M$Y$$$20221111$$CN$US$US
1418295313$14182953$13$F$20211001$20221004$20171113$20221007$EXP$$BR-GLAXOSMITHKLINE-BR2017GSK111501$GLAXOSMITHKLINE$$$$$$Y$$$20221007$$CN$BR$BR
141831116$14183111$6$F$20170101$20221117$20171113$20221122$PER$$US-BIOGEN-2017BI00478420$BIOGEN$$$$$F$Y$$$20221122$$CN$US$US
141865887$14186588$7$F$20171023$20221209$20171114$20221216$EXP$$JP-ABBVIE-17P-087-2162696-00$ABBVIE$$48$YR$$M$Y$$$20221214$$MD$JP$JP
1418942914$14189429$14$F$20171017$20221101$20171115$20221104$EXP$$US-ROCHE-2019577$ROCHE$$58$YR$$F$Y$54.934$KG$20221103$$CN$US$
141911337$14191133$7$F$$20221003$20171115$20221006$EXP$$CA-TAKEDA-2017TUS023263$TAKEDA$$46$YR$$F$Y$$$20221006$$CN$CA$CA
141920425$14192042$5$F$20180101$20220301$20171115$20221012$PER$$US-CELLTRION INC.-2017US014375$CELLTRION$$$$$$Y$$$20221012$$MD$US$US
142055784$14205578$4$F$$20221114$20171120$20221118$EXP$$TR-ALEXION-A201712866$ALEXION$Oruc A, Ayar Y, Aktas N, Yildiz A, Yavuz M, Ersoy A, et al.. Hepatoxicity associated with eculizumab treatment. Nephrology Dialysis Transplantation. 2017;32(Suppl 3):iii137$39$YR$$M$Y$$$20221118$$HP$TR$TR
142063095$14206309$5$F$20171115$20220929$20171120$20221006$PER$$US-JAZZ-2017-US-015228$JAZZ$$64$YR$$F$Y$$$20221006$$CN$US$US
142092174$14209217$4$F$$20221220$20171121$20221229$EXP$$JP-ASTELLAS-2017US047784$ASTELLAS$$35$YR$$M$Y$$$20221229$$MD$JP$JP
142152857$14215285$7$F$20220101$20221005$20171122$20221012$EXP$$PHHY2017CA137159$NOVARTIS$$$$$F$Y$$$20221012$$MD$CA$CA
1421591612$14215916$12$F$20161001$20221013$20171122$20221018$EXP$$PHHY2016CA151751$NOVARTIS$$24$YR$$F$Y$$$20221018$$MD$CA$CA
142189532$14218953$2$F$20080101$20221012$20171123$20221025$PER$$US-JNJFOC-20171012099$JOHNSON AND JOHNSON$$3$DEC$A$M$Y$$$20221025$$LW$US$US
142192744$14219274$4$F$20070101$20221031$20171123$20221108$PER$$US-JNJFOC-20171031358$JOHNSON AND JOHNSON$$17$YR$T$M$Y$$$20221108$$LW$US$US
142192802$14219280$2$F$20010201$20220926$20171123$20221006$PER$$US-JNJFOC-20171031521$JOHNSON AND JOHNSON$$11$YR$C$M$Y$$$20221006$$LW$US$US
142192833$14219283$3$F$$20221219$20171123$20221226$PER$$US-JNJFOC-20171031532$JOHNSON AND JOHNSON$$$$A$M$Y$$$20221226$$LW$US$US
1421982416$14219824$16$F$20171201$20221012$20171123$20221017$EXP$$CA-TAKEDA-2017TUS024098$TAKEDA$$57$YR$$F$Y$$$20221017$$CN$CA$CA
142200043$14220004$3$F$19980211$20221107$20171123$20221110$PER$$US-JNJFOC-20171116664$JOHNSON AND JOHNSON$$12$YR$T$M$Y$$$20221110$$LW$US$US
142200903$14220090$3$F$20030430$20221207$20171123$20221214$PER$$US-JNJFOC-20170923847$JOHNSON AND JOHNSON$$9$YR$C$M$Y$$$20221214$$LW$US$US
